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The segmentation of the axial skeleton and peripheral nervous system involves a 
complex integration of multiple patterning molecules. For the latter, axon-repelling 
molecules in the posterior half-sclerotome are particularly important. This study built on 
a previously performed mouse microarray screen for novel candidate genes in the 
posterior half-sclerotome. Multiple candidates were selected for whole-mount in situ 
hybridization in chick. Two were expressed in the posterior half-sclerotome: thrombin 
receptor (F2R) and fibronectin leucine rich transmembrane protein-2 (Flrt2). Flrt2 was 
selected for siRNA-mediated knockdown and a new in ovo transfection technique for 
somites successfully developed. Scrambled siRNA-transfection did not affect 
morphogenesis, somite patterning or axon guidance. However, Flrt2 siRNA-
transfection resulted in defects in notochord, dermomyotome and neural tube 
morphogenesis, and in the de-fasciculation and mis-targeting of spinal axons into the 
posterior half-sclerotome and dermomyotome. Hence, Flrt2 may be a chemorepellent 
for spinal axons.  
 An unidentified peanut agglutinin (PNA)-binding glycoprotein in the posterior 
half-sclerotome was previously shown to repel spinal axons. In this project, the 
expression of a family of mucin-type O-glycosylation enzymes (which could 
glycosylate the PNA-binding protein) was investigated by whole-mount in situ 
hybridization in chick, but none was differentially expressed in the posterior half-
sclerotome. One candidate for the PNA-binding glycoprotein, Presenilin1, was 
investigated because of previously published loss of spinal nerve segmentation in 
Presenilin1 mutants. However, analysis of Presenilin1-hypomorphic mutant mouse 
embryos showed this was not the PNA-binding molecule. Live-immunostaining for a 
second candidate, prolyl 4-hydroxylase, beta polypeptide (P4HB), showed its 
expression coincided with PNA-binding at the surface of posterior half-sclerotome cells. 
P4HB siRNA-transfection into somites reduced PNA binding and disrupted spinal axon 
segmentation and expression of a posterior sclerotome marker, Uncx4.1. Overall, these 
results suggest that P4HB is a strong candidate to be the key PNA-binding glycoprotein 
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1.1- Vertebrate segmentation 
 
During embryogenesis, elaboration of the main body axis starts by sequential 
subdivisions, from head to tail. Segmentation underlies the body-plan of both 
protostome and deuterostome animals and defines one of the traits of the vertebrate 
subphylum, namely, the segmented vertebrae of the axial skeleton (Richmond and 
Oates, 2012). 
 The basic tissue organization underlying all vertebrate and many invertebrate 
embryos is called metamerism that consists of a repeated sequence of segments. This 
segmental organization offers two major advantages. First, it provides the articulation of 
the skeletal elements, providing flexibility to the otherwise rigid and immotile skeleton. 
Secondly, it offers a degree of modularity and semi-autonomy differentiation within the 
segments (Maroto and Whittock, 2009). 
 
1.1.1- Segmentation of the adult vertebrate 
Many tissues in the vertebrate body are segmented. One of the most well-known 
examples is the axial skeleton with its display of vertebrae and intervertebral discs. The 
segmentation provides flexibility-with-rigidity to the structure, and also protection for 
the nervous system within the vertebral foramen. In addition, the musculature of the 
thorax is another segmented structure. This close relationship provides the motility to 
the vertebrate trunk (Christ et al., 2000).  
The vertebrate skeleton has an exo- and endoskeletons. The endoskeleton is 
mainly the notochord and axial skeleton and is divided into vertebral column, cranium 
and the pectoral and pelvic girdles and during development remains cartilaginous or 
ossifies later during development. By contrast, the exoskeleton consists of various 
mineralized structures, such as dermal bones, plates and scales.   
Vertebrate bone is a vascular tissue composed of osteocytes embedded in an 





avascular tissue composed of chondrocytes, and the ECM contains type II collagen 
(Pourquié, 2009).  
 Superimposed on the segmental structure of the axial skeleton is the 
segmentation of the peripheral nervous system (PNS) of the trunk. Spinal nerves have 
two components, motor and sensory axons, that emerges from the spinal cord in pairs 
on each side of the midline of the vertebral body and leave by the intervertebral foramen 
(Fig.1.1) (Hughes et al., 2009). The axons of motor neurons exit the ventral spinal cord, 
while the axons of sensory neurons collected in the segmentally arranged dorsal root 
ganglia (DRG) enter the dorsal spinal cord. These axons together form the mixed spinal 







Figure 1.1- Diagram showing the segmental arrangement of vertebrae with the 
imposition of the nervous system. (A) Spinal nerves exit through the intervertebral 
foraminae (ivf) localised dorsal to the vertebral body, and vertebral bodies are separated 
by intervertebal discs (ivd). Schematic adapted from Hughes et al. (2009). (B) Diagram 
of a transverse section of the spinal cord. Motor axons exit the spinal cord ventrally and 
sensory axons from neurons in the dorsal root ganglia (DRG) enter the spinal cord 
dorsally. Boundary cap cells are localised at both entry and exit zones. Schematic from  





1.1.2- Embryonic segmentation 
Somitogenesis occurs dynamically as new tissue is being formed. It is this 
process that offers the basic pattern of the musculoskeletal system; blood vessels and 
the peripheral nervous system (Maroto and Whittock, 2008). Somitogenesis is the most 
important example of vertebrate segmentation. It represents the most segmented 
structure of the body plan, that gives rise to both segmental (e.g. axial skeleton) and 
metameric (dermis and skeletal muscle) elements. Somites also play a key role in 
controlling different aspects of the central and peripheral nervous system organization 
(Sharpe and Mason, 2008). 
Somites develop from the segmental plate mesoderm (pre-somitic mesoderm) in 
an anterior-posterior sequence on either side of the notochord; and they are sequentially 
added to the growing embryo elongating its axis and organizing vertebral skeleton, 
muscles, nerves and blood vessels. The dorsal portion of the somite remains epithelial 
and forms the dermomyotome, which differentiates into muscle and dermis, while the 
ventral portion undergoes an epithelio-mesenchymal transition, leading to the formation 
of the sclerotome. The sclerotome will later give rise to the vertebrae, ribs, 
intervertebral discs and tendons (Pourquié, 2009).  
There are many processes by which segments can be formed within embryos, 
but morphologically they can be categorised into one or two processes. One involves 
simultaneously the specification of segments with the division of pre-existing domains 
into smaller segments. The other process by which segments may form involves the 
sequential addition of segments to one end of a domain, resulting in a progressive 
elongation of segmenting domains until they bud off.  
 
1.2- Formation of the pre-somitic mesoderm during gastrulation 
The mesoderm arises during the process of gastrulation, which generates the 
three germ layers – mesoderm, endoderm, and ectoderm. The mesoderm forms the 
somites and yields the largest pool of cells in the vertebrate body that will later give rise 





al., 2007). The endoderm forms the gut and associated organs, while the ectoderm will 
develop into the skin and nervous system (Wolpert et al., 2007). 
In amniotes, the primitive streak is the site of gastrulation. The primitive streak 
is formed due to collective ingression of epiblast cells towards the primitive streak 
promoted by the fibroblast growth factor (FGF)-regulated transcription factor Snail. 
These cells are stem-like progenitor cells (Maroto et al., 2012) and different regions of 
epiblast cells around the primitive streak give rise to specific tissues (Fig. 1.2). At the 
tip of the primitive streak there is Hensen’s node that plays a role in the induction of the 
nervous system and acts as an organizer of cell movement during late gastrulation 
(Vasiev et al., 2010).  
 
Figure 1.2- Fate-map of the epiblast regions that will give rise to specific tissues. 
Figure from Standring (2005). 
 
Epiblast cell ingression is a continuous process that starts anteriorly and goes on 
until the primitive streak retreats caudally. Definitive endoderm is generated from cells 
of lateral epiblast origin that move towards the primitive streak and ingress through it 
(Lawson and Schoenwolf, 2003) (Fig. 1.3). At stage 3+ in the chicken embryo 
(Hamburger & Hamilton, 1951), presumptive dorsal foregut cells ingress from the 





the middle layer and then move laterally; they only enter the lower layer when they 
reach the lateral border of the middle layer (Kimura et al., 2006) (Fig. 1.3). As Hensen’s 
node regresses, the notochord (axial mesoderm) is laid down in the midline from 
progenitors ingressing through the node (anterior streak). More lateral regions of 
mesoderm (paraxial, intermediate, lateral plate) arise from progenitors ingressing from 
progressively more posterior regions of the streak (Fig. 1.3 and Fig. 1.4).   
 
Figure 1.3- Epiblast cells ingress through the primitive streak to form the 
endoderm and mesoderm. On the left is a photograph of a Hamburger-Hamilton (HH) 
stage 3+ chicken embryo in dorsal view, showing the location of Hensen’s node at the 
tip of the primitive streak. On the right is a diagram showing cell migration through the 








Figure 1.4- Cells ingressing at progressively more posterior regions of the 
primitive streak form progressively more lateral regions. Top schematic (endoderm) 






The somites bud from the anterior pre-somitic mesoderm (PSM). PSM cells are 
not committed to a somitic fate, their differentiation is controlled by inductive external 
signals (Pourquié, 2001; Maroto et al., 2012). Somites are formed in pairs from the 
paraxial mesoderm on either side of the notochord. During segmentation, the length of 
the segmental plate remains fairly constant comprising the material for 12 prospective 
somites, which means that the rate of somite formation must be somehow linked to 
proliferation. Morphologically, somite differentiation involves the formation of defined 
boundaries by an epithelial-to-mesenchymal transition (EMT) in the ventral half of the 
somite that divides the somite into epithelial dermomyotome dorsally and mesenchymal 
sclerotome ventrally. The newly formed somite is an epithelial ball with a central cavity 
called a somitocoele containing mesenchymal cells (Kuan et al., 2004). The number of 
somitocoeles corresponds to the number of prospective somites that are contained 
within the segmental plate. The borders between individual somitocoeles are not well 
delineated and they do not represent compartments before somites are formed The first 
step in the EMT is the loss of the cell-cell cohesion between individual cells in the 
epithelium, primarily by downregulation of cadherins, this step is known as 
“activation”. E-cadherin downregulation contributes to the accumulation of free -
catenin in the cell, important for transducing Wnt signals. This step is followed by the 
stimulation of cell motility “migration” in order for the mesenchymal cells to disperse 
(Maroto and Whittock 2008). 
The newly formed somites are already pre-patterned along the anteroposterior 
(AP) axis into anterior and posterior divisions (Takahashi et al., 2010) (see section 1.4). 
As new somite formation involves budding off from the PSM, and then morphological 
changes can be observed in the anterior portion, where the cells increase in number and 
become denser and are arranged in a simple epithelium at the periphery of the paraxial 
mesoderm (Stern and Keynes, 1987). Once somites are formed from the more posterior 
PSM, the more anterior somites become mature. Consequently, the somites are most 
easily identified in terms of their position relative to the PSM; the youngest somite 
(immediately anterior to the PSM) is termed somite I (Christ et al., 2007) (Fig. 1.5). 





somites decrease in length as they expand laterally. When a younger somite (II in Fig. 
1.5, section A) is compared to a mature somite (VII from Fig. 1.5, section B), the width 
decreases by a factor of two, while the length increases by half. From this perspective, it 
can also be seen that the somite height also increases progressively (compare Fig. 1.5 
sections A and B). 
 
 
Figure 1.5- Somite maturation. Left: Schematic illustration of somite organization in 
the vertebrate body plan (adapted from Maroto and Whittock, 2008). Dotted lines show 
the level of the sections shown in A and B. Right: (A) Transverse section of a young 
epithelial somite. (B) Transverse section of a mature somite with an epithelial 









Somites are sequentially formed in an anterior-posterior direction, making the 
anterior somites older than the posterior ones, therefore in Fig. 1.5, somite XII is the 
oldest formed somite. Each 90 minutes a chick somite is formed and in chick there are 
50 somites, in mice there are 65 somites and 500 in snake (Gomez et al., 2008). The 
process by which somites are formed involves a periodic molecular mechanism (Fig. 
1.6) and a cell movement described in Fig. 1.7 and in more detail in section 1.4. 
 
 
Figure 1.6- Dynamic gene expression in the PSM during somitogenesis. (a) Periodic 
waves of gene expression present during chick development across the PSM, with a 90-
minute periodicity. (b) The intersection of various extracellular signalling gradients (left 
hand side of diagram) determines the location within the PSM of the “determination 
front”, anterior to which cells become segmentally determined, and clock oscillations 
slow down (right hand side of diagram). Figure from Gomez et al. (2008). 
 
Time-lapse experiments have revealed cell movements involved in formation of 
new somite boundaries within the anterior PSM (Kulesa and Fraser, 2002). There are a 
small number of cells in the anterior-medial region of the segmental plate (Fig. 1.7A, 
white dot) next to the neural tube and anterior to the presumptive somite boundary 
(white arrow) that come together and form a distinct subgroup and separate slightly 
from the PSM (Fig. 1.7B). This subgroup movement appears like a sleeve of about one 





segmental plate (white arrow). About the same time a different set of cells within the 
segmental plate come together (Fig.1.7A,B; near black dot), and initiate tissue 
separation. This group of cells extend about four cell diameters posterior to the PSM 
border between s0 and the segmental plate (white arrow). 
After tissue separation, epithelialisation seems to first occur at the anterior and 
medial border of the somite s0, then it starts to orchestrate cell exchanges, where the 
group of cells within the s0 (white dot) move towards the posterior direction while the 
second group of cells within the segmental plate (black dot) move in the anterior 
direction. These opposing movements create a gap on the medial side of the segmental 
plate (Fig. 1.7B-D), leading to the formation of the somitic border. In order for s0 to 
separate from the segmental plate, the cells of the somite and the segmental plate 
propagate in the medial-to-lateral direction (Fig. 1.7B-F, white arrow) conferring sI 
status to somite s0. It now has an appearance of an epithelial structure, resembling a ball 







Figure 1.7- Confocal time-lapse imaging series of somite boundary formation. (A) 
Initiation of somite s0 separation from the segmental plate is marked by the separation 
of a sleeve of cells (white dot). At the same time, a second subgroup of cells in the 
segmental plate (black dot) coalesce. The presumptive somite boundary (white arrow) 
and anterior border of s0 (asterisk) are labeled. (B) The sleeve of cells (white dot) 
moves in the posterior direction, and the second subgroup of cells (black dot) begins to 
move in the anterior direction. (C) The anterior movement of the second subgroup of 
cells (black dot) leaves a gap in the tissue in the anterior portion of the segmental plate 
(black arrow). (D) The sleeve of cells (white dot) folds into the gap in the segmental 
plate while the second subgroup of cells (black dot) becomes integrated into s0. (E) The 
sleeve of cells (white dot) becomes part of the anterior border of the segmental plate, 
and the cells from the segmental plate (black dot) form part of the posterior border of 
s0. (F) Completion of the posterior border transforms s0 into s1. Scale bar, 50 µm; 





1.4- Anteroposterior Polarization of the Presomitic Mesoderm 
The anterior-posterior polarization of the PSM and hence the patterning of the 
peripheral nervous system in the trunk depend upon the set-up of the anterior-posterior 
axis of the embryo. One aspect is the large scale arrangement of the vertebrate body by 
the Hox code (Wolpert et al., 2007). Hox genes affect not only AP body axis formation 
but also the patterning of different body segments (Gilbert, 2006). First found in 
Drosophila, they turned out to be highly conserved during evolution. The Hox genes 
encode homeodomain-containing transcription factors and in vertebrates, Hox genes are 
organised in four clusters (A, B, C and D) (Fig.1.8). Hox gene expression is initiated 
during the formation of the primitive streak, and after gastrulation their initial patterning 
function is complete (Maroto and Whittock, 2008). The expression of different Hox 
genes in different regions of the body (Fig. 1.8) (Gilbert, 2006) forms a ‘Hox code’ that 
imparts regional differences along the body axis e.g. different vertebral identities (e.g. 
lumbar vs thoracic) are imparted by different combinations of Hox genes.  
Despite the ancestral relation between mouse and chicken, they differ in the 
number of vertebrae, which is reflected in changes in Hox gene expression. Mice (like 
all mammals) have only seven cervical vertebrae (Fig. 1.9). These are followed by 13 
thoracic vertebrae, 6 lumbar vertebrae, 4 sacral vertebrae and a variable number of 
caudal vertebrae. In the chicken, there are 14 cervical vertebrae, 7 thoracic vertebrae, 
12-13 lumbosacral vertebrae and 9 sacral vertebrae (Fig. 1.9) (Gilbert, 2006). Fig. 1.9 
shows the somites contributing to the different vertebrae and the corresponding Hox 
gene expression patterns in the chicken versus mouse. 
How somite polarization along the anteroposterior axis first arises has been 
intensively investigated. Somite polarization in the pre-somitic mesoderm (PSM) is 
governed by a molecular oscillator termed the segmentation clock. It was first 
postulated by Cooke and Zeeman (1976) (cited in Kulesa et al., 2007), and has now 
been confirmed by the expression of several genes showing cyclic patterns in the PSM 
(Gridley, 2006). The oscillations observed within cells at the posterior end of the PSM 
are synchronized through the intercellular interaction between neighbouring cells 





cells anterior to them and cause them to epithelialize and separate (Kulesa and Fraser, 
2002). Two important molecules have been identified which mediate the property of 
boundary induction: Notch and Lunatic fringe (Wolpert et al., 2007). 
 
Figure 1.8- Parallels between Drosophila and human Hox genes. The different 







Figure 1.9- Similarity between mouse and chick in the Hox patterning and somite 
fate. Figure from Gilbert (2006). 
 
Notch, a transmembrane protein, acts as a receptor for the transmembrane 
ligands Delta and Serrate: their binding to Notch results in its proteolytic cleavage, 
releasing the Notch intracellular domain (NICD), which enters the nucleus where it 
interacts with DNA-binding proteins and activates target gene expression (Fig.1.10). 
Notch target genes include the Hes/Hey genes, which encode basic helix-loop-helix 
transcriptional repressors. Lunatic fringe, a glycosyl transferase, is encoded by a Notch 
target gene and at the same time negatively modulates Notch activity.  
 





Somite polarity starts to be predetermined in the PSM triggered by a genetic 
cascade initiated by Notch/Tbx6-dependent activation of the transcription factor Mesp2  
just anterior to the determination front in the PSM (Fig. 1.6; Fig. 1.11) (Maroto et al., 
2012). Mesp2 is subsequently downregulated in the posterior half of the prospective 
somite but remains active in the anterior half; Mesp2 induces Eph-ephrin signalling 
leading to somite boundary formation (Fig. 1.11) (Maroto et al., 2012).  
 
 
Figure 1.11- Somite boundary formation and anterior-posterior patterning. A 
genetic cascade initiated by Notch/Tbx6-dependent activation of the transcription factor 
Mesp2 just anterior to the determination front leads to activation of Eph/ephrin 
signalling and the formation of a new somite boundary. Downregulation of Mesp2 in 
the posterior half of the presumptive somite and its maintenance in the anterior half is 
critical for the specification of anterior and posterior somite compartments. Figure from 
Maroto et al. (2012). 
 
Notch and its ligands, Delta-like1 (Dll1) and Delta-like3 (Dll3) have a key role 
in somitogenesis. Mouse Notch-1 is expressed in the whole presomitic mesoderm, with 
a peak of expression in the next-to-be-formed somite. Dll1 and Dll3-mediated Notch 
signalling and Mesp2 keep the stripe segmentation on the PSM. Feedback loops of Dll1 
and Mesp2, in which Dll1-Notch signalling induces Dll1 and Mesp2 expression and 
Mesp2 suppresses Dll1 expression, are essential for anterior-posterior polarity, while 
Dll3 is necessary for localization and integration of expression and Dll1 and Mesp2 





somitogenesis and defects in somite development characterized by irregular border 
formation (Conlon et al., 1995) and cause development defects. Dll3-null mice have a 
shortened trunk and a small tail and a disorganised axial skeleton and a similar 
phenotype is present in embryos that lack any of the genes involved in the pre-
patterning of the PSM. 
 
 
Figure 1.12- Genetic interactions in the PSM that are important for establishing 







Notch is a large transmembrane receptor that recognizes two other 
transmembrane proteins, Delta and Serrate. Fig. 1.12 and Fig. 1.14 shows a model of 
somitogenesis involving Notch and its ligands, Delta-like1 (Dll1) and Delta-like3 
(Dll3), and the γ-secretase complex component Presenilin 1 (Ps1), leading to a periodic 
arrangement of signalling and receiving cells in the presomitic mesoderm and 
establishment of somite boundaries. The transmembrane protein Notch binds to its 
transmembrane ligands on adjacent cells; first the ∂-secretase complex and then the 
gamma-secretase complex (which includes Presenilin1) cleave the Notch receptor and 
the Notch intracellular domain (NICD) translocates to the nucleus (see Fig. 1.10)  
(Koizumi et al., 2001, Johnson et al., 2009). Presenilin is one of the markers of 
somitogenesis and it is required for segmentation of the presomitic mesoderm into 
somites (Donoviel et al., 1999). In mammals presenilin has two isoforms 1-2: presenilin 
is a multi-pass transmembrane protein that together with nicastrin, Aph-1 and PEN-2 
forms the gamma-secretase complex that cleaves Notch at S3 and S4 (Fiúza and 
Martinez Arias, 2007). This complex releases the Notch intracellular domain (NICD) 
from the membrane to the nucleus where it is enrolled in a correct somite boundary 
formation via segmentation clock, also inhibits muscle cell differentiation via Wnt 
suppression (Fiúza and Martinez Arias, 2007). 
 
1.4.1- Molecular oscillation clock within somitogenesis 
The segmentation of the PSM involves a dynamic and periodic mRNA 
expression of different genes, called ‘clock’ genes. The existence of this molecular 
clock within the segmental plate in the cells destined for somite formation involves the 
Notch target genes Hairy1 and Hairy2 in chick and Hes1 and Hes7 in mouse across the 
PSM (Koichiro et al., 2009). All of these genes appear to be regulated by the Delta-
Notch pathway (Andrade et al., 2007), Wnt and Fgf signalling (Pourquié, 2001), and 
essential for segmentation of the segmental plate (Stockdale et al., 2000). This cyclic 
gene pattern can be thought of as a “travelling wave” movement that is present in a 
synchronized periodic fashion across the PSM until the anterior limit of the PSM where 






A number of other genes in the PSM have been identified that include 
components of the Notch, Wnt and Fgf pathways that are connected (Fig. 1.13; Fig. 
1.14). Components of these pathways are cyclically present in the PSM suggesting their 
dynamic involvement in the wavefront. As previously described, Notch signalling is 
required to keep negative-feedback loops encoded by Hes7 and Lunatic fringe (Lfng). 
The downregulation of Wnt signalling arrests oscillation in the anterior PSM ensuring 
that the oscillations occur with the correct periodicity. Cells posterior to the 
determination front are maintained in a non-determined state due to FGF activity, and 
changes in FGF signalling are reflected in somite size (Maroto et al., 2012). 
This cyclic gene pattern can be thought of as a “travelling wave” movement; the 
area of high expression moves from a posterior to anterior direction where it is arrested 
by Mesp2, nevertheless, it is the Notch-dependent cell-cell interactions that are 
responsible for synchronization of the clock genes (Andrade et al., 2007).  It is 




Figure 1.13- Different patterns of expression of the Notch ligand gene deltaC in the 
PSM in the zebrafish. Phases are designated from I to III+ to match the terminology 








Figure 1.14- Segmentation clock during somitogenesis, regulation of Notch, Fgf 
and Wnt pathways. Notch and Fgf-regulated genes oscillate asynchronously to cycling 
genes of the Wnt pathway. Figure from Maroto et al. (2012). 
 
1.4.2- Other signalling pathways important for somite formation 
A key component for symmetric somite formation (i.e. the co-ordination of left 
and right somites) is retinoic acid. Retinoic acid regulates somite boundaries through 
signalling. This is a gradient signal that runs in the opposite direction of an anterior 
gradient of fibroblast growth factor (FGF) 8 and Wnt3A (Figure 1.15) (Gridley, 2006). 
Retinoic acid biosynthetic enzyme retinaldehyde dehydrogenase type 2 (RALDH2), 
also acts upon the somite synchronization across the left-right axis. 
Dynamic FGF8 expression occurs in the posterior part of the PSM. As the axis 
elongates, the wavefront of FGF8 moves in a posterior direction so that signalling 
levels remain constant to the PSM moving. Cells move up through the PSM as 
development proceeds so that cells are initially part of the region where FGF signalling 
prevails but levels start to get lower as the gradient becomes less. FGF8 perturbations 
result in the formation of abnormally small somites and in one abnormally large somite 






Figure 1.15- Major signalling pathways besides Notch regulating somitogenesis. 
Molecular oscillator and the segmentation clock in somite formation. Genes comprising 
this clock have a cyclic expression pattern in the presomitic mesoderm progressing from 
posterior to anterior direction (dotted black arrow). The periodic signal is converted into 
a repeated array of regularly spaced somite boundaries by a mechanism that involves 
decreasing posterior-anterior gradient of Fgf8 and Wnt3a expression (green arrow). The 
function of these two genes is controlled by a gradient of retinoic acid signalling, the 
decreasing expression of Raldh2 that runs in the opposite direction (red arrow) and also 
on the left-right axis (double red arrow). S1, most recently formed somite; S0, somite in 
the process of forming the posterior somite boundary; S-1, region of the presomitic 
mesoderm that will form the next somite. Figure from Gridley (2006). 
 
1.5- Somite fate  
Different regions of a somite have different fates.  The older somites start to 
differentiate earlier than recently formed somites, and start to acquire morphological 
differences that allow distinction between different types of tissue. The dorsal half of 
the somite keeps its epithelial character, differentiating into the dermomyotome. The 
dermomyotome later subdivides into a superficial dermatome and a deeper myotome. 
The dermatome will give rise to the dermis while the myotome develops into epaxial 
muscles (vertebral column muscles) from its dorsal component and hypaxial muscles 





somite will become sclerotome by an EMT. This polarization of the somite therefore 
leads to two somitic compartments, the dermomyotome and the sclerotome (Fig. 1.16 
(Christ et al., 2007). In addition, there is a sclerotomal fissure, von Ebner’s fissure, that 
divides the sclerotome into anterior (A-half) and posterior (P-half) halves. This 
morphological marker reflects the site of resegmentation of the sclerotome into the 
vertebral bodies at a later stage of development (Maroto and Whittock, 2008) (see 
section 1.5.2). 
Somites are ultimately responsible for the arrangement of the different 
segmental structures, the vertebrae and the intervertebral discs, the ribs, muscles, 
tendons, ligaments, dorsal root ganglia, peripheral spinal nerves, and blood vessels of 
the adult vertebrate trunk.  
 
Figure 1.16- Somite cross sections at different levels during development, showing 
how somite differentiation differs from anterior to posterior. The anterior somites 
have already differentiated into sclerotome and dermomyotome while the pre-somitic 





1.5.1- Formation of the dermomyotome and myotome  
The dermomyotome is formed as an epithelium overlying the sclerotome (Figs. 
1.16 and 1.17). This sheet expands, becoming rectangular, and eventually it becomes 
separated by the inter-somitic blood vessels. This epithelial region later undergoes EMT 
to form the dermatome which will give rise to the connective tissue, endothelium and 
dermis of the back (Gilbert, 2006).  
 Cells at the lips of the dermomyotome undergo local de-epithelialisation and 
migrate under the dermomyotome or central dermomyotome that span the 
anteroposterior length of the somite, and together form the myotome that will later give 
rise to the epaxial muscles. These muscles are formed from a region closest to the neural 
tube and will give rise to the intercostal musculature between the ribs as well as the 
deep muscles of the back. There are also myoblasts formed in the region further from 
the neural tube producing the epaxial muscles of the body wall, limbs, and tongue 
(Gilbert, 2006). Dermomyotomal fate is determined and maintained by dorsalizing 
signals from adjacent structures (e.g. neural tube and ectoderm) (Figs. 1.16 and 1.17) 
(Christ et al., 2007).  
Neurotrophin-3 from the neural tube specifies the dermatome, the precursor of 
dermis tissue (Maroto et al., 2012). The removal of the neural tube leads to cell death 
and degeneration in the medial dermomyotome (Fleming et al., 2001). Consequently, 
the dorsal dermis and the epaxial muscles, both derived from the dermomyotome, are 
absent or deformed. Subsequently, if the neural tube is replaced by the induction of 
Wnt-1 expressing cells, some but not all of the dermomyotome tissues are recovered. 
Therefore, Wnt-1 appears to be responsible for the formation of the dermis but not of 
the epaxial muscles, suggesting the importance of other signals originating from the 
ectoderm, and also demonstrating the cooperation of both structures in dermomyotome 







Figure 1.17- Signalling pathways and transcription factors involved in myotome 
formation. Somite cells receive signals from surrounding tissues including Wnts, Sonic 
hedgehog, Noggin and BMP4, inducing expression of the myogenic transcription factor 
genes Myf5 and MyoD and commitment to the myogenic lineage. Committed myoblasts 
migrate laterally to form the myotome (MT), which eventually forms the skeletal 
musculature. Pax3 promotes myogenesis in the lateral myotome. E, ectoderm; DM, 
dermomyotome, LP, lateral plate mesoderm; SC, sclerotome; NC, notochord; NT, 
neural tube. Adapted from Chargé and Rudnicki (2004). 
 
1.5.2- Sclerotome fate 
Sclerotome formation is characterized by an epithelio-mesenchymal transition 
(EMT) of the ventral half of the somite and the migration of mesenchymal cells under 
the notochord to form the peri-notochordal tissue (Christ et al., 2007). The sclerotome is 
separated into anterior and posterior halves by a morphological feature called von 
Ebner’s fissure. The halves have different areas (central, dorsal, lateral, ventral) and 
markers (Fig. 1.18) and each one of them participates in the formation of the axial 







Figure 1.18- Sclerotome divisions according to molecular markers and the fate 
map of their contribution to vertebrae. (Nt) neural tube, (Nc) notochord, (Sc) spinal 
cord. Figure from Pourquié (2009). 
 
Sclerotome subdomains receive signals from the surrounding structures, as 
described in section 1.5.1, to differentiate into their final structures. These genes are 
expressed under the influence of signals from the midline notochord and floorplate 
(Kuan et al, 2004).  It is the anterior-central half-sclerotome that is ultimately 
responsible for ensuring that the spinal nerves exit the spinal cord and are not trapped 
by bone. The trajectory of spinal nerves is controlled by surrounding tissues induced by 
the notochord. Somite grafting has shown that a single somite generates a single muscle 
segment but it contributes to two adjacent vertebrae; where a single vertebra derives 
from a recombination of the anterior half of one somite with the posterior half of the 
next-anterior somite in the series is a process called resegmentation (Saga and Takeda, 
2001) (Fig. 1.19). The resegmentation hypothesis stipulates that the region of the somite 
that forms the vertebrae is the sclerotome, and that its polarization into anterior and 
posterior halves is critical in positioning the early elements of the nervous system 





studies, involving surgical grafting of half-somites from quail into chick embryos, 
confirmed that vertebral bodies arise from cells of adjacent somites (Aoyama and 
Asamoto, 2000). It is this arrangement that allows for a flexible and strong vertebral 
column.  
 
Figure 1.19- Segmentation and resegmentation in amniotes to form the mature 
vertebral column. “During resegmentation, the sclerotome is formed from the caudal 
and rostral halves of two adjacent somites, such that the middle of the resegmented 
sclerotome lines up with the intersomitic cleft (IC). Both the axial sclerotome (Scl-A) 
and lateral sclerotome (Scl-L) develop dense and loose zones. The dense zone of the 
lateral sclerotome (Ld) becomes the neural arch (NA) and pedicle (P), which is attached 
to the rostral part of the vertebral body (VB) formed from chondrification of the loose 
(Al) and part of the dense zones (Ad) of the axial sclerotome. The rostral layer of the 
dense zone of the axial sclerotome soon forms the intervertebral boundary zone (IBZ) 
containing intervertebral boundary mesenchyme (IBM), which ultimately forms the 
annulus (A) and, together with notochord remnants (NC), the nucleus pulposus (NP) of 
the intervertebral disc (ID). The loose zone of the lateral sclerotome (Ll) does not form 
bone but promotes emergence of the nerve roots (NR). Thus, the neural arch is derived 
from a single somite but the vertebral body receives contributions from two adjacent 
somites. IV intersomitic vessel. Arrows indicate developmental fates of the 
sclerotomes”. Figure and legend from Pang and Thompson (2011).  
 
 Parallel to resegmentation, the notochord also undergoes a differentiation 
process, as a result of the orchestration of signals such as Noggin, Fgf and Shh together 





intervertebral discs and the annulus fibrosus, where the continuous notochordal cells 
become incorporated into the intervertebral discs (Fig. 1.20) (McCann et al., 2012). 
 
 
Figure 1.20- The notochord forms the intervertebral discs. Cell lineage studies 
using embryos from a notochord-specific Cre driver line crossed with a ubiquitous 
β-galactosidase reporter line (Notocre/+;R26R/+). Staining pattern of β-
galactosidase, demonstrating the localization of notochord-derived cells through 
development (stages indicated) showing expression within the intervertebral discs from 
the tail to the upper thoracic spine. Figure from McCann et al. (2012).  
 
1.6- Sclerotome and Peripheral Nervous System development 
As has been described in earlier sections, the sclerotome is divided into anterior- 
(A-half) and posterior-halves (P-half), with distinct molecular, cellular and functional 
characteristics. It is the difference between these two halves that is responsible for the 





nerves to the anterior-half sclerotome was initially described by Remak in 1855, and 
later by Thus Tellu in 1923, but it was suggested that motor axons first grow towards 
the myotome and then become confined to the posterior half (as referenced in Maroto 
and Whittock, 2008).  It was only in 1984 that Keynes and Stern discovered that axons 
only cross over the anterior sclerotome (Keynes and Stern, 1984). Since then many 
studies have been carried out to try to explain the mechanism behind this finding but it 
is still poorly understood. However, what is known is that the structures responsible for 
this mechanism are the somites which guide axons after they exit the spinal cord: this 
was determined in the following manner. 
             Rotation experiments were carried out in neural tube and in segmental plate 
mesoderm (Fig. 1.21) (Keynes and Stern, 1984). First, a portion of neural tube opposite 
2 or 3 somites was rotated 180º around the anteroposterior axis prior to axon outgrowth, 
so that the previous anterior half-somite came now to lie in the opposite half. After two 
days of recovery it was possible that the rotation of the neural tube did not have any 
effect on the orientation of the axons, since they had still grown out through the anterior 
halves (Fig. 1.21-a). Second, a portion of segmental plate mesoderm, 2-4 presumptive 
somites long, was rotated 180º around the anteroposterior axis; this time, however, the 
rotation had an impact on the axons, which traversed the posterior (original anterior) 
halves of the somite (Fig. 1.21b). This last rotation led to a new milestone in research 
into patterning of the peripheral nervous system in the trunk, by proving that the somites 







Figure 1.21- Diagram showing neural tube (A) and segmental plate (B) rotation 
experiments. A- 180º rotation of the neural tube did not have any impact on axonal 
patterning. B- 180º rotation of the PSM demonstrated the importance of the somites for 
axonal patterning. Figure from Keynes and Stern (1986). 
 
To try to further understand how each somite half contributes to axon patterning 
a new grafting assay was done, this time anterior or posterior half-somites were grafted 
into the place of a whole somite of the host chick embryo (Fig. 1.22) (Stern and Keynes, 
1986). Grafting an anterior half-somite gave rise to a sclerotome with an unusually wide 
anterior portion containing wide spinal nerves (Fig. 1.22a). As expected, the grafting of 





portion with the spinal nerves more distantly spaced than usual (Fig. 1.22b) (Stern and 
Keynes, 1986). The same experiments also showed that the somitic environment was 
responsible for confining migrating trunk neural crest cells - which give rise to the 
sensory dorsal root ganglia that differentiate in the anterior half-sclerotome (see section 
1.7) - to the anterior half-sclerotome (Stern and Keynes, 1986). The molecular control 
of the patterning of trunk neural crest cell migration through the anterior half-
sclerotome has been intensively studied since this discovery (see section 1.7). 
  
 
Figure 1.22- Diagram showing the procedures for constructing compound somites. 
(A) Compound anterior somites. (B) Compound posterior somites, produced in the 
corresponding way. Compound anterior somites give rise to a longer segment through 
which passes an abnormally wide spinal nerve. Compound posterior somites give rise to 
a longer segment whose caudal portion is abnormally wide and without nerves. Figure 






These experiments suggested that it is due to the permissive environment in the 
anterior-half that the developing PNS axons grow and migrate through it, while the 
posterior-half has repulsive barriers not allowing PNS axon passage, imposing the 
segmental arrangement of the spinal nerves. The differences between the two somite-
halves are responsible for the arrangement of bones and nerves, in the trunk which 
defines the structure of the vertebral column and allows a flexible spinal cord while 
maintaining protection of the delicate spinal cord. This arrangement is orchestrated to 
allow the correct neural connection between the spinal cord and periphery. 
These assays allowed a clear understanding of the fundamental differences 
between both halves: the anterior-half sclerotome forms a permissive environment in 
which neural crest cells can differentiate to form the dorsal root ganglia (see next 
section), as well as for motor and primary sensory axons. Several studies have 
investigated how the antero-posterior patterns of the PNS is established, but despite 
many breakthroughs the mechanisms are still not completely understood. However, 
many molecular differences have been found in an attempt to explain this segmentation. 
As described in section 1.4, antero-posterior polarity in the somite is linked to the 
segmentation process by the molecular clock that regulates mesodermal segmentation, 
and to Notch-Delta signalling associated with it (Kuan et al., 2004). The transcription 
factor Mesp2 not only participates in regulating interactions with the Notch1 pathway to 
arrest the segmentation clock, but also plays an important role in the subdivision of the 
somite. The creation of a Mesp2-null mice led to interesting results where the mutant 
not only displayed altered expression of the posterior-half-somite markers meox1 and 
dll1, but also lacked the anterior-half-somite marker Notch2, suggesting that Mesp2 
functions in the control of anterior- and posterior-half-somite specification (AP-
polarity). Furthermore, Mesp2 mutants did not have an anteroposterior polarization and 
almost all somites had posterior-half characteristics, giving rise to mice with fused 







Figure 1.23- Neurofilament immunostaining in wild-type mouse and Mesp2-null 
mouse embryos at 10.5 d.p.c. reveals defects in spinal nerve patterning. (A,B) 
Axonal segmentation can be seen in the wild-type embryos, with the spinal nerves 
exiting through the anterior somite towards the ventral area of the embryo. (C,D) In the 
Mesp2-null mutant, cervical nerves so not exit through the centre of the sclerotome, 
while thoracolumbar spinal nerves do not exit through the sclerotome at all except to 
innervate the limbs. The dorsal root ganglia are also disrupted. (The cranial nerves and 
ganglia are unaffected.) Figure from Saga et al. (1997). 
 
 In the same way that Mesp2 expression is restricted to the anterior half of the 
sclerotome, there are a number of other genes that have been shown to have restricted 
expression within the sclerotome (Figure 1.24) (Kuan et al., 2004). The role of many of 




Figure 1.24- (On next page) Summary of molecules showing differential expression 
in the anterior versus posterior half of somites. The molecules are subdivided into 
four main groups. At the top is shown a schematic diagram of somite formation from 
the presomitic mesoderm (segmental plate, blue). The anterior/posterior somite polarity 
is indicated by the division of each somite into anterior (green) and posterior (red) 
halves, and the expression patterns of individual molecules are shown in blue 
(presomitic mesoderm), green (anterior half- somite) and red (posterior half-somite). 
Molecules with temporally dynamic expression patterns in the presomitic mesoderm are 












The interaction of Mesp2 with Dll1- and Dll3- mediated Notch signalling has an 
impact on the anterior- and posterior- somite-half divisions reinforcing anteroposterior 
identities, and the further elaboration of anterior- and posterior-half-somite fate, via the 
reciprocal activation and suppression of anterior- and posterior-half-somite markers 
such as Cer1 and Uncx4.1 (Maroto and Whittock, 2008).  In addition, the different 
molecular expression patterns within the anterior versus posterior halves of somites are 
responsible for the formation of a set of different tissues.  
As described earlier, somites can be subdivided into anterior and posterior 
halves, which exhibit different characteristics. The establishment of somite borders and 
anterior and posterior somite-halves has received considerable attention. In 1987, Stern 
and Keynes demonstrated that cells from the same sclerotome half could mix between 
themselves, whereas those of opposite halves remained separate when juxtaposed (Stern 
and Keynes, 1987). Consequently, the anterior and posterior somite-halves form distinct 
cellular boundaries. From further analysis, it was concluded that this is responsible for 
the formation of segmental borders while the determination of anterior and posterior 
compartments in the somite occurs at the level of the pre-somitic mesoderm. 
 Additional insight into the relationship between somite anteroposterior 
polarisation and border formation derives from the analysis of EphA4 and ephrinB2. 
Ephrins and Ephs are cell-surface molecules that have been implicated in the formation 
and maintenance of somite boundary, and that are selectively expressed in prospective 
anterior or posterior compartments in the anterior PSM. The expression of these 
molecules has been conserved among vertebrates, and in mouse and chick PSM, both 
EpHA4 and EphrinB2 are expressed in similar domains but have different functions 
(Pourquié, 2001). In zebrafish, EphA signal blockage results in complete lack of 
somites. Conversely, ectopic EphA4 can induce ectopic boundaries in the zebrafish 
mutant fused somites. The Eph-related family also play an important role in axon 
guidance and cell migration. Development of the peripheral nervous system (PNS) 
spinal nerves is influenced by the somite, in particular, the ventromedial somite 
derivative, the sclerotome.  As mentioned, it is within the sclerotome that the 
anteroposterior polarisation/division of the somite is maintained during somite 





components – not just motor axons, but also neural crest-derived sensory dorsal root 
ganglia (DRG) (see section 1.7) - are found.  
 Neuronal connections are made by axons that migrate to a specific target by a 
growth cone, which detects molecular guidance cues in the surrounding environment. 
Studies have come up with explanations for such guidance. It seems that axons respond 
to four possible guidance forces: attractive and repulsive cues, which can either be 
short-range or long-range (Kolodkin and Tessier-Lavigne, 2011). Most work on trunk 
PNS patterning has concentrated on the repulsive nature of posterior half-somites and 
that is why today it is known that a set of genes is differentially expressed on both 
sclerotomal halves (Fig. 1.24).  
Several classes of molecules have been found in the somites consistent with the 
axonal guidance function; these include peanut agglutinin (PNA)-binding molecules, 
chondroitin sulphate proteoglycans, T-cadherin, Semaphorin3A, neuropilins (Roffers-
Agarwal and Gammill, 2009) and ephrins (Hughes et al., 2009). Some of the molecules 
are already well characterised and their role in axonal guidance was found to be 
important but not vital, suggesting the involvement of alternative pathways and 
additional molecules. However, double knock-out of Sema3F/Neuropilin2 and 
Sema3A/Neuropilin1 signalling had an impressive effect on the organization of the 
peripheral nervous system, as motor axons sprout in an apparently unsegmented pattern 
along the spinal cord and dorsal root ganglia are fused, although sympathetic ganglion 
segmentation was unaffected (Fig. 1.25) (Roffers-Agarwal and Gammill, 2009). 
Nevertheless, motor axons still keep together in fasciculated bundles in the double 
mutant embryos, rather than exploring the surrounding tissues, suggesting that another 







Figure 1.25- Nrp1 and Nrp2 are required for segmentation of motor axons and 
dorsal root ganglia. (A-D) E10.5 embryos show initial motor axon projections from 
the spinal cord in dorsal sections, whereas the bottom panels show the fasciculation of 
the same projections in more ventral sections of the same embryos. (A) Wild-type 
embryo, motor axons project only into the anterior sclerotome, fasciculating into a 
single ventral root in each segment. (B) Nrp2-/- mutant, motor neuron projection is 
initiated along the entire length of the somite, but fasciculate into a single ventral root. 
(C) Nrp1Sema-/- motor axons project adjacent to the anterior somite, but ventral roots are 
defasciculated within the anterior sclerotome. (D) Nrp1Sema-/-;Nrp2-/- motor neurons 
initiate projections all along the spinal cord and these projections are defasciculated 





are organized in a single bundle in the anterior sclerotome of wild-type embryos. The 
plane of section captured a length of the nerve. (F) Nrp2 mutant embryos exhibit a 
single bundle of spinal nerves in the anterior somite. (G) Nrp1Sema-/- spinal nerves 
fasciculate into multiple bundles within the anterior sclerotome. (H) Double mutant 
embryos contain multiple spinal nerve bundles distributed throughout the length of each 
segment. a, anterior; p, posterior. Anterior is to the left. Scale bars: in A, 50 μm in A-D; 
in E, 100 μm in E-H, all longitudinal sections stained with β-tubulin (TuJ). Figure from 
Roffers-Agarwal and Gammill (2009). 
 
1.7- Neural crest formation and migration  
During gastrulation, the neural induction process also begins, i.e., the 
development of the neural plate. At the border of the neural plate, the neural crest is 
induced. After the neural tube forms during neurulation, the neural crest separates from 
neuroepithelial cells by an epithelial-to-mesenchymal transition (EMT) and then neural 
crest cells migrate extensively through the embryo to give rise to a wide variety of 
derivatives including most neurons and all glia of the peripheral nervous system, many 
cartilages and bones of the face and skull, and pigment cells (reviewed by Theveneau 
and Mayor, 2012; Clay and Halloran, 2011).   
Neural crest migration involves loss of cell-cell adhesion and myosin-based 
forces. Changes in cadherin expression are critical for NC migration, including adhesion 
functions together with promotion of RhoGTPases (Rho) and Rho Kinase (ROCK) 
signalling. It is at this point that the first oscillation of gene expression starts with the 
downregulation of N-cadherin protein that mediates the adhesion between cells and is 
anchored to the actin cytoskeleton via catenin complex. N-cadherin downregulation is 
achieved via BMP signalling resulting in the reduction of cell adhesion and in the 
cleavage of N-cadherin, releasing a cytoplasmic fragment to the nucleus that induces the 
transcription of pro-EMT genes such as Cadherin6B, which promotes a de-
epithelialization during which premigratory neural crest cells lose polarity and start to 
migrate. (Fig.1.26). Another cadherin necessary for migration is Cad11, which is 
upregulated during neural crest migration; in the absence of Cad11 neural crest fail to 







Figure 1.26- Cadherin expression and function during neural crest cell migration. 
(A) Transverse section of neural tube and migrating neural crest cells, showing cadherin 
expression patterns. (B) Cell-cell adhesion and signalling functions of different 
cadherins in neuroepithelial cells, before and during epithelial-mesenchymal transition 
(EMT) and during neural crest migration. Figure from Clay and Halloran (2011).  
 
Different neural crest derivatives can be found along the entire neural axis (Fig. 
1.27). Cephalic neural crest cells contribute to cartilages and bones of the face and neck, 
and form the odontoblasts (dentine-producing cells) of teeth. Neural crest cells are also 
important for the formation of the cardiovascular system: they form the connective 
tissue of the aorticopulmonary septum that separates the pulmonary and systemic 
circulations, as well as pericytes and smooth muscle in the carotid arteries and systemic 
aorta and pulmonary arteries (Le Douarin and Kalcheim, 1999). Neural crest cells form 
the neurons and glia of all peripheral autonomic ganglia (sympathetic, parasympathetic, 
enteric), and the chromaffin cells of the adrenal medulla. They also form most 
peripheral sensory neurons (the remainder, in specific cranial sensory ganglia, arise 






Figure 1.27- Neural crest cell derivatives can be found along the entire neural axis. 
Neural crest give rise to different types of ganglia at different somite levels. Figure from 
Le Douarin and Kalcheim (1999). AD.GL., adrenal gland; C.G., ciliary ganglion; Mes, 
mesencephalon; S, somite; S.C.G., superior cervical ganglion. 
 
 The sensory neurons of the peripheral nervous system (PNS) transmit 
information from the peripheral targets to the spinal cord and brain. These neurons are 
collected into ganglia: the dorsal root ganglia (DRG) organized bilaterally along the 
spinal cord, and the sensory ganglia of the cranial nerves in the head. Sensory neurons 
within these ganglia originate from the neural crest and certain cranial neurogenic 
placodes; all peripheral glia, including the satellite glia of sensory ganglia, arise from 
the neural crest. Brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) 
signalling from the neural tube promote the development of neural crest cells into DRG, 





only occurs once the somite is dissociated into dermomyotome and sclerotome in 
anterior to posterior direction and display segmented pattern through anterior somitic 
halves (Le Douarin and Kalcheim, 1999). 
During early migration, around stage 14 HH in chick and E9.0 in mouse, neural 
crest migrates ventrally between the somites along intersomitic vessels (1-Fig. 1.28) and 
between the neural tube and somites (2-Fig. 1.28). Shortly after, around stage 15/16 HH 
in chick and E9.5 in mouse, neural crest starts to migrate ventrolaterally into the anterior 
sclerotome (3- Fig. 1.28) towards the dorsal aorta (4- Fig. 1.28). In mouse, some neural 
crest cells also migrate over the dermomyotome however this does not happen in chick. 
Around stage 20 HH in chick and E10.5 in mouse, neural crest cells in the anterior 
sclerotome condense into segmental dorsal root ganglia (5- Fig. 1.28) while the neural 
crest present in the dorsal aorta segregate into sympathetic ganglia (6- Fig. 1.28). Also 
at this stage, neural crest cells start to migrate dorsolaterally above the dermomyotome 
in chick (7- Fig. 1.28) (Gammill and Roffers-Agarwal, 2010). 
In chick, mouse and rat, migrating neural crest cells are restricted to the anterior 
sclerotome that expresses EphA/B receptors while the posterior sclerotome, from which 
neural crest cells are excluded, expresses ephrin-B ligands. Furthermore, semaphorins 
3A and 3F are also expressed in the posterior sclerotome (Theveneau and Mayor, 2012). 
(Fig. 1.28). The inhibition of either ephrin or Sema3F/Neuropilin2 (Nrp2) signalling 
leads to ectopic migration through the posterior sclerotome and unsegmented migration 
of trunk neural crest but the patterning of the ganglia is not affected (Gammill and 
Roffers-Agarwal, 2010). However, DRGs are no longer segmented when both 
Sema3F/Nrp2 and Sema3A/Nrp1 signalling are blocked, leading to the model of 
sequential Neuropilin signalling presented in Fig. 1.28. The migration of the neural crest 
along the dorsolateral pathway is controlled by endothelin and Slit/Robo signalling from 
the surrounding tissues (Gammill and Roffers-Agarwal, 2010). Table 1.1 summarises 
what is known about the molecules involved in patterning trunk neural crest cell 
migration (and also, where relevant, in patterning motor axon trajectories). Despite 
progress in identifying the function of some of these molecules, there is still much to 
discover. For example, application of the lectin peanut agglutinin (PNA) to chick 





anterior sclerotome, suggesting that PNA-binding glycoproteins are required for 
segmental trunk neural crest migration (Krull et al., 1995).  
 
 
     
Figure 1.28- Diagram of the different pathways of neural crest migration during 
different stages of somite maturation, leading to neural crest cell migration 
through the anterior somite. Figure from Gammill and Roffers-Agarwal (2010). Early 
stages represent stage 14 HH in chick and E9.0 in mouse; middle stages are between 
15/16 HH in chick and E9.5 in mouse; and late stages represent stage 20 HH in chick 






Table 1.1- The phases of trunk neural crest migration and the responsible 
environmental guidance cues identified so far. Different proteins have different roles 
dependent on their position.  Table adapted from Gammill and Roffers-Agarwal (2010).  
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1.7.1- Identification of a repulsive cue for DRG axons in the posterior half-
sclerotome 
Culture assays have also given information about the selectivity and preferences 
of DRG axons relative to surrounding tissues that help confine sensory axons to the 
anterior sclerotome (Fig. 1.29) (Tannahill et al., 2000). An interesting study involving a 
lectin, peanut agglutinin (PNA), demonstrated the importance of PNA-binding 
molecules in the segmentation of the PNS. Within the somites, this lectin only binds to 
cells of the posterior- but not anterior-half-sclerotome (Stern et al. 1986). Normally in 
the presence of a somite extract, the growth cones of cultured DRG neurons collapse, 
but when PNA is present in the somite extract, growth cone collapse is blocked (Davies 
et al., 1990). This assay not only indicates that PNA binds to an axon-repelling 
molecule that could be responsible for PNS segmentation, by not allowing DRG axons 
to pass through the posterior half-sclerotome, but also that the molecule responsible for 
the segmentation is in the posterior half-sclerotome. Furthermore, as described in 
section 1.7 on neural crest cell migration, PNA application to chick explants also 
abolishes the segmental migration of neural crest cells (Krull et al., 1995), suggesting 
that the same PNA-binding glycoprotein could block both the migration of both neural 
crest cells and neural crest-derived DRG axons in the posterior-half-sclerotome.  
Subsequent SDS-PAGE analysis of the PNA-binding glycoprotein fraction 
localised two molecules of molecular weight 48kD and 55kD (Davies et al., 1990). A 
rabbit antiserum raised against the 48 and 55 kD proteins was able to eliminate the 
growth cone collapse, and when chick embryo sections were stained with this 
antiserum, its staining was comparable to PNA staining, i.e., staining was only seen in 
the posterior half of the sclerotome (Davies et al., 1990). Due to the scientific 
technology of the time, the full amino acid sequence was not available, however the 
assay has been redone and fragments of the sequence were obtained (Keynes et al. 
unpublished). In this work, I have used siRNA knockdown to study the importance of 







Figure 1.29- Chemorepulsion between different tissues demonstrated in a collagen 
gel culture of chick stage 28 dorsal root ganglia surrounded by different tissues. 
(A) With a piece of stage 17 notochord, residual peri-notochordal mesenchyme cells are 
visible. (B) Dermomyotome next to a dorsal root ganglion: the axons migrate radially 
from the DRG on the side opposite the dermomyotome. (C) Stage 17 HH notochord 
dropped in a culture of several dorsal root ganglia: all the axons avoided a radius around 
the notochord forming a “halo” effect. (D) Dorsal root ganglia surrounded by a 
notochord on the bottom and dermomyotome on the top, similar to what happens in the 
sclerotome. Scale bar = 200 μm. Figure from Keynes et al. (1997). 
 
1.8- The chicken as a model system 
The chicken embryo has been used as a model in embryological studies, 
including somitogenesis, mainly due to its easy accessibility for manipulation during 
most of its development as well as the more recent development of transfection 
techniques such as in ovo electroporation, which allows plasmid DNA or morpholinos 
to be targeted to specific tissues in vivo, including the neural tube and somites 
(Pourquié, 2001; Scaal et al., 2004; Stern, 2005). As previously discussed, the study of 
the molecular biology of somite development is important in understanding how the 
body plan is established. Many types of experiments can be done either in ovo or in 





 Chicken embryos are staged according to Hamburger and Hamilton (1951), 
based on developing structures and days of embryonic development (Appendix A). 
Furthermore, the use of quail-chicken grafting techniques to label specific cell 
populations enabled many insights into the contribution of the somites and somite 
compartments to different structures, as well as into segmentation and embryological 
development (Christ et al., 2000). 
 The chicken has 14 cervical vertebrae that, except for the atlas and axis, are 
linked with highly mobile apophyseal joints, each with fibrocartilaginous intervertebral 
discs. There are seven rib-bearing thoracic vertebrae, where the second to fifth are fused 
into a bony column. The sixth thoracic vertebrae is free, and the seventh fused with the 
synsacrum, and the articulations within this region are saddle joints (Bellairs and 
Osmond, 1998). The caudal part of the vertebral column is highly specialized. 
 
1.9- Overall Aims 
As discussed above, the processes by which segmentation of the vertebral axial 
skeleton and peripheral nervous system develop involve the complex integration of 
multiple patterning molecules. Of particular note is the importance of repulsive 
molecules present in the posterior half-somite. Since the posterior half-somite is 
responsible for axonal guidance and neural crest migration, understanding the 
differential expression of genes within this half is of great importance.  
This project is a continuation of previous work started at the Wellcome Trust 
Sanger Institute (Hughes et al., 2009) and in collaboration with Professor Roger Keynes 
at the Department of Physiology, Development and Neuroscience at the University of 
Cambridge. The previous work carried out at the Sanger Institute consisted of a 
sophisticated microarray study using dissected mouse half-somites in order to identify 
all differentially expressed genes between anterior and posterior half–somites. Many 
possible candidates for genes involved in anteroposterior somite polarity and axonal 
repulsion were revealed (Hughes et al., 2009). Antisense RNA probes were used to 





 The overall aim of my PhD project was to analyse the role in axial segmentation 
(peripheral axon guidance, neural crest migration and/or vertebral column formation) of 
a selection of the genes identified in the mouse half-somite microarray screen (Hughes 
et al., 2009), using the chick embryo as a model system. 
The original objectives were to clone chicken homologues of candidate mouse 
genes identified in the half-somite microarray screen of Hughes et al. (2009) and to 
localize their expression in chick embryos by whole-mount in situ hybridisation, then to 
select one gene expressed in the posterior-half sclerotome and study its function in 
embryonic segmentation using a loss-of-function approach. Although not anticipated in 
the original objectives, a new technique for transfecting chicken somites in ovo with 
short interfering RNA (siRNA) was developed as part of the project. Finally, given the 
importance of a previously unidentified PNA-binding glycoprotein for axon guidance in 
the somites, the expression was also studied of a family of glycosylation enzymes that 
might be needed to synthesise the PNA-binding glycoprotein, and two candidates for 
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2.1- Incubation and staging of chicken embryos 
Fertilized wild-type chicken (Gallus gallus domesticus) eggs were delivered 
weekly (Winter Egg Farm, Hertfordshire) and stored at 14ºC. Eggs were incubated 
with the long axis placed horizontally in a humidified incubator at 38-39ºC until the 
embryos reached the required embryonic stage. Embryos were staged according to 
Hamburger and Hamilton (1951) (HH stages) or by days of incubation (embryonic 
days, E). 
 
2.2- Synthesis of antisense RNA probes from chicken cDNA using PCR 
2.2.1- Total RNA isolation for cDNA synthesis 
E3 and E5 chicken embryos were rinsed with cold diethylpyrocarbonate 
(DEPC)-treated phosphate-buffered saline (PBS) and transferred to a methanol-
washed Petri dish coated with Sylgard (Dow Corning). The extra-embryonic 
membranes were removed with forceps pre-cleaned with RNAse Zap (Ambion). 
Embryos were placed into RNAlater (Ambion) and stored overnight at 4ºC. For E3 
embryos, total RNA was extracted using the RNeasy kit (Qiagen) according to the 
manufacturer’s instructions. For E5 embryos, 700 µl RLT buffer from the Qiagen 
RNeasy kit (with β-mercaptoethanol, according to the manufacturer’s instructions) 
was added to the embryos, 2-3 embryos per centrifuge tube. The embryos were 
disrupted by vortexing for 30 seconds and using a mortar and pestle, followed by 
homogenisation using a sterile 19-gauge syringe needle. The lysate was spun down at 
4ºC at 12100 x g for 5 minutes. The supernatant was divided into two fresh 
microcentrifuge tubes. 350 µl of 70% ethanol was added and mixed by pipetting. The 
sample, including any precipitate that formed, was placed onto an RNeasy MiniElute 
spin column (Qiagen) in a 2 ml collection tube. The tube was closed and centrifuged 
for 15 seconds at 8000 x g. The flow-through was discarded. The same RNeasy 
MiniElute spin column was loaded with the second supernatant sample. The column 
was closed and centrifuged for 15 seconds at 8000 x g. The flow-through was 
discarded. 700 µl of RW1 buffer (Qiagen RNeasy kit) was added to the RNeasy spin 
column and then re-centrifuged for 15 seconds at 8000 x g. Once the flow-through 
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was discarded, 500 µl of RPE buffer were added to the spin column and centrifuged 
for 2 minutes at 8000 x g. The flow-through was discarded. A second aliquot of 500 
µl of RPE buffer was added to the spin column and re-spun for 2 minutes at 8000 x g. 
The flow-through was discarded, and to dry the column an additional centrifuge was 
carried out at full speed for 1 minute. The spin column was them transferred into a 
new 1.5 ml collection tube, and 30 µl DEPC-treated water was added directly into the 
silica-gel membrane prior to centrifugation at 25000 x g for 1 minute. A further 20 µl 
of DEPC-treated water was added and the column was spun down again at 25000 x g 
for 1 minute. The total RNA concentration and integrity was further analysed using a 
Picodrop spectrophotometer. 
 
2.2.2- cDNA synthesis 
For the cDNA synthesis, the iScript cDNA Synthesis Kit (Bio-Rad) was used. 
7 µl of Reverse Transcription Mix (4 µl of 5X iScript reaction mix, 2 µl of Oligo 
dT20 primer, 1 µl of iScript Reverse Transcriptase) was added to DEPC-treated water 
and 1 µg of total RNA to a final reaction volume of 20 µl. The contents of the tube 
were mixed by pipetting and briefly spun-down in a microfuge (≤1000 x g) to settle 
the contents. The tube was further incubated at 42ºC in a thermal cycler for 75 
minutes followed by a cycle of 85ºC for 5 minutes. The cDNA was stored at -20ºC. 
 
2.2.3- Primer design 
 RNA probes were designed using the following protocol. First, transcript 
sequences for all selected genes were obtained via NCBI GenBank and Ensembl. 
Primer pairs for each transcript were designed using the Primer-Blast tool available 
from the National Center for Biotechnology Information (NCBI) 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/) (Ye et al., 2012). The primers were 
selected according to the following rules: (1) the primer length had to be between 17 
to 30 base pairs, (2) their CG content had to be between 50 to 60%, (3) their melting 
temperature should be between 55 and 80ºC. The resulting amplification product 
should be no longer than 1200 base pairs and no smaller than 400 base pairs. All 
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potential primers were checked against the G. gallus (taxid:9031) genomic database 
using the Basic Local Alignment Search Tool (BLAST) from NCBI. The outputs 
from this last step were used to exclude all primers giving more than one significant 
region of identity (80% cut-off) against the whole chicken genome, or sharing more 
than 70% similarity with other genes. The selected primers were synthesised (Sigma) 
with the T7 primer sequence (TAATACGACTCACTATAGGGAG) appended to the 
5’ end of the reverse primer, so as to allow direct generation of digoxigenin-labelled 
antisense RNA probe by in vitro transcription using T7 RNA polymerase. Primers 
used to produce the RNA probes can be found in Appendix B. 
 
2.2.4- Polymerase chain reaction to prepare template for riboprobe 
synthesis 
cDNA samples (2 µl) were pipetted into a 0.2 ml thin-wall centrifuge tube and 
36 µl of DEPC-treated water, 6 µl of each primer, and 50 µl of Reddy Mix PCR 
Master Mix (AB Gene) was added to each. The contents of the tube were briefly 
mixed and spun down. The tubes were placed on a heating block of a hot-lid thermal 
cycler pre-heated to 95ºC. Cycling commenced with an initial 2-minute denaturation 
step at 95ºC followed by 34 cycles of 95ºC for 25 seconds, annealing at 50ºC for 45 
seconds and elongation at 72ºC for 1 minute. The cycling was finished with an 
extension step of 72ºC for 5 minutes. The PCR product length was then checked by 
agarose gel electrophoresis. The products were stored at -20ºC until needed for 
riboprobe synthesis. 
 
2.2.5- Riboprobe synthesis 
20 µl in vitro transcription reactions were prepared by adding to a 0.2 ml thin-
wall PCR tube in the following order: 9 µl DEPC-treated water, 4 µl nucleoside 
triphosphate (NTP) mix (2.5mM ATP, 2.5mM CTP, 2.5mM GTP, 1.67mM UTP, 
0.833mM digoxigenin-11-UTP), 2 µl T7 transcription buffer (Ambion), 2 µl T7 RNA 
polymerase, 1 µl RNase inhibitor (Invitrogen), and 2 µl PCR product (see preceding 
section 2.2.4). The contents of the tube were mixed by pipetting and briefly spun-
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down in a microfuge (≤1000 x g) to settle the contents. The tube was further 
incubated at 37ºC in a thermal cycler for 2 hours, after which 1 µl DNaseI was added 
and the tube further incubated at 37ºC in a thermal cycler for 15 minutes. To stop the 
reaction, 1 µl of 0.5M EDTA was added and mixed by pipetting and the tube contents 
spun down. The probe was then analysed using a Picodrop spectrophotometer. 
 
2.3- In situ hybridization 
2.3.1- Embryo fixation and dehydration 
HH stage 19-22 embryos were dissected from the egg with fine-tipped forceps 
and washed twice in phosphate-buffered saline (PBS). Forceps and surgical scissors 
were used to remove all extra-embryonic tissue prior to immediate incubation in 4% 
paraformaldehyde for 2 hours at room temperature or overnight at 4ºC. After fixation, 
embryos were rinsed in PBS on a mechanical shaker for 5 minutes, and dehydrated 
through a series of 10-minute washes with 25, 50, 75% methanol/PBS and 100% 
methanol. This was followed by one more 30-minute wash in 100% methanol. 
Embryos were stored in methanol at -20ºC until required. 
 
2.3.2- Whole-mount in situ hybridization 
The method used for whole-mount in situ hybridization (WMISH) is based on 
Wilkinson (1998). Embryos were rehydrated into PBST (PBS with 0.1% Triton-
X100) through a series of 75% methanol/ultra-pure water, 50% methanol/ultra-pure 
water, 25% methanol/PBST. Embryos were transferred into 18-well plates (Nunc). 
Unless specified, all reagents were diluted in PBST and all washes were for 10 
minutes in PBST on a rocking platform at room temperature. To increase permeability 
of the probe, embryos were incubated at room temperature in 10 µg/ml proteinase K 
(Roche) for the following durations: embryos up to stage 15 HH (Hamburger and 
Hamilton, 1951) for 5 minutes, stage 18 HH for 10 minutes and stage 24 HH for 15 
minutes. Embryos were rinsed once, post-fixed for 20 minutes in 4% formaldehyde 
and washed twice to remove the fixative. Embryos were equilibrated with 
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hybridization mix [50% formamide, 5XSSC (Sigma), 2% blocking powder 
(Boehringer, 1096176), 0.1% Triton X-100, 0.1% CHAPS (Sigma), 1 mg/ml tRNA 
(Sigma), 5mM EDTA, 50 µg/ml heparin] by rinsing once in a 1:1 mixture of PBST/ 
hybridization mix and then twice with hybridization mix. Plates were then placed at 
67ºC  in a hybridization rocking oven for a minimum pre-hybridization of 2 hours up 
to 12 hours, after which the solution was changed to pre-warmed hybridization 
solution containing approximately 1 µg/ml RNA probe, and incubated for at least 12 
to 72 hours. In order to avoid cross contamination, WMISH probes were never near 
each other when the hybridization was being done; the vials were leak-proof, and 
each probe was only reused three times. 
After incubation, embryos were rinsed twice and washed once with pre-
warmed hybridization mix, washed twice for 30 minutes with hybridization mix and 
twice with a 1:1 mixture of hybridization mix/PBST or MABT (100 mM maleic acid,, 
150 mM NaCl, 0.1% Triton X-100 pH 7.5) for embryos stage HH 24 at 60ºC. 
Embryos were removed from the oven and rinsed 3 times with PBST or MABT. All 
traces of hybridization solution were removed by seven 30-minute washes in PBST or 
MABT at room temperature in a rocking shaker. 
 To block non-specific binding, embryos were incubated for 2 hours in a 
blocking solution (10% sheep serum in PBST) for 1-3 hours at room temperature. 
This was replaced with blocking solution containing alkaline phosphatase-conjugated 
anti-digoxigenin Fab fragments (Roche) at 1:2000 dilution, and embryos were 
incubated for a further 12-18 hours at 4ºC. The antibody was removed by rinsing the 
embryos 3 times in PBST with 1 mM levamisol, followed by 4 hours of washes with 
buffer changes every 30 minutes; in some cases, embryos were left overnight at 4ºC. 
The alkaline phosphatase was detected by a mixture of 4-nitro blue 
tetrazolium chloride (NBT) and 5-bromo-4-chloro-3'-indolyphosphate (BCIP). 
Initially embryos were washed twice in NTMT (100 mM NaCl, 100 mM Tris-HCl pH 
9.5, 50 mM MgCl2, 0.1% Triton X-100), followed by the addition of the reaction 
mixture (4.5 µl/ml NBT and 3.5 µl/ml BCIP in NTMT). Developing reactions were 
left in the dark until a deep purple colour had developed; this could take 3 hours to 5 
days, in the latter case the stain solution was replaced daily with fresh stain solution. 
Embryos were then washed 3 times in PBST and fixed in 4% paraformaldehyde for 
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12-18 hours at 4ºC. The fixative was removed by several PBS washes. Embryos were 
photographed under a  dissecting microscope (Leica) and prepared for vibratome 
sectioning. 
 
2.3.4- Clearing and photography of embryos after in situ hybridization 
Embryos were dehydrated into methanol through a series of 10-minute washes 
with 25% methanol/PBS, 50% methanol/PBS, 75% methanol/deionised water and 
100% methanol, then washed twice (10 minutes each) in methanol. Embryos were 
transferred to a 2:1 mixture of benzylbenzoate: benzyl alcohol (BABB): methanol and 
left in this solution until they were cleared and the background staining was reduced. 
The embryos were photographed under a  dissecting microscope (Leica), then brought 
back into methanol via three 30-minute washes and stored at 4ºC. 
 
2.4- Transfection of embryonic tissue or cultured  cells  
2.4.1- Preparation of siRNA or plasmid DNA with the transfection agent. 
Lyophilized FITC-labelled RNA duplexes (Dharmacon Thermo Scientific) 
were obtained in 2’ deprotected, annealed and desalted form, dissolved in PCR grade 
water (Roche) at 3 µg/µl and stored in aliquots at -80ºC. The final transfection 
solution was 1µg/µl siRNA, 10% polyethylene glycol (PEG) (Carbowax 6000, Union 
Carbide) and 20% TurbofectTM (Thermo Fisher Scientific, Lafayette. CO; Catalog # 
R0541). For 2.8 µl of siRNA preparation, 1 µl of siRNA, 1.2 µl of 20% PEG stock 
and 0.6 µl of TurbofectTM were incubated at room temperature for 30 minutes before 
application.  
This technique was also tested using pCAβ-EGFPm5 (Bron et al., 2007), a 
kind gift from Dr. Matthieu Vermeren (Department of Physiology, Development and 
Neuroscience, University of Cambridge, UK). The final transfection solution 
contained 2 µg/µl plasmid, 10% PEG and 40% TurbofectTM. For a final 5 µl of 
solution, 1µl of plasmid, 2 µl of 20% PEG stock and 2 µl of TurbofectTM were used. 
This solution could only be used once. 
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 Borosilicate glass capillaries (WPI, outside diameter 1.5 mm, inside diameter 
1.12 mm) were pulled on a Narishige Puller PC-10 at 62ºC. The tips were broken to 
obtain a fine opening and capillaries were then attached to a rubber tube (Sigma). The 
siRNA solution was aspired into the capillary. 
 
2.4.2- Preparation of chick embryos for in ovo transfection 
 After reaching the required embryonic stage, eggs were removed from the 
incubator and left for 1 hour at room temperature to reduce heartbeat. Eggs were 
cleaned with 100% methanol, and then 3-4 ml of albumin removed using a 19-gauge 
syringe needle. The upper side of the egg was reinforced with adhesive tape 
(Sellotape, 1.2 mm width), and a small window (1x1 cm) was cut using curved 
scissors. The embryo was then raised to the level of the window by re-pipetting 
albumen. In order to visualize the embryo, a small amount of 5% India ink (Pelikan 
fount) in PBS was injected using a 22-gauge syringe needle. A small incision (needle-
size) was made in the vitelline membrane in the most posterior part of the embryo 
using a microscalpel Feather® (PFM Medical ref: 200300715) or a bent syringe 
needle tip.  
 
2.4.3- Somite targeting in ovo 
The glass capillary containing siRNA/plasmid transfection solution was 
inserted into the most posterior (newly formed) somite of stage 9-12 HH embryos and 
carefully pushed parallel to the neural tube until the most anterior somite was reached, 
or until resistance was felt from the somite, using small wave movements. Once the 
most anterior somite was reached, the needle was pulled back somite by somite and 
the solution injected into each somite for 5-10 seconds (see Fig. 2.1). It was possible 
to observe the somites filling up with solution and the tissue turned slightly white and 
sticky. When the last somite was filled, the embryo was lowered by removing 5 ml of 
albumin using a 19-gauge syringe needle, then a drop of albumin was dropped on top 
of the embryo and the window closed with sellotape. The egg was immediately 
moved to an incubator and left to develop for a further two days (to 22-24 HH), when 
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somite strips were removed from some embryos for culture (section 2.4.6), or for a 
further five days (to stages 26-27 HH), before fixing in 4% paraformaldehyde for 3 
hours at room temperature or 12 hours at 4ºC. Embryos were then dehydrated into 
methanol as described in section 2.3.1 and stored at -20ºC.  
 
 
Figure 2.1. Schematic representation of somite transfection in ovo. A: Schematic 
dorsal view of the trunk region of a day-2 chick embryo, with anterior to the top. The 
right hand side of the embryo is the manipulated side; the green colour illustrates the 
injection of several somites (in green) using a pulled glass capillary. B: 
Representation of a transfected chick embryo at HH 19 in ovo. 
 
 
2.4.4- Neural tube targeting using in ovo electroporation 
 The glass capillary containing siRNA/plasmid transfection solution was 
placed into the trunk neural tube of stage 16 HH embryos and pushed anteriorly along 
it until it reached the vagal area (level of somites 1-7), where the solution was slowly 
expelled. Once it was possible to see the neural tube walls turning white, the needle 
was removed and the embryo electroporated using the BTX square wave 
electroporator ECM 830 (Genetronics) configured to deliver four 25 millisecond 
pulses of 5V at 10 millisecond intervals across the embryo through a gold-plated 
electrode 0.5 of mm diameter and a platinum-plated electrode of 0.5 mm diameter, 
held 0.6 mm apart with an Adjustatrode electrode holder (Intracel). A drop of albumin 
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was added and the embryo lowered by removing 5 ml of albumin using a 19-gauge 
syringe needle. The window was covered with sellotape, and the eggs replaced in the 
38ºC incubator for 24 hours. 
 
2.4.5- Evaluation of siRNA impact after in ovo transfection 
 After transfection, embryos were incubated in a humidified incubator at 39ºC 
for 16 hours, and the transfection area examined under a fluorescence dissecting 
microscope. The impact of the knockdown was evaluated by assessing blood flow, 
heartbeat, and trunk deformities. Twisted and dead embryos were recorded and 
removed. Surviving embryos were placed in the humidified incubator and assessed 
again 24 hours later. Embryos were kept until stage 22-24 HH. 
 Embryos were sacrificed, fixed and dehydrated into methanol as described in 
section 2.3.1, analysed by either whole-mount in situ hybridization (section 2.3) or 
immunohistochemistry (section 2.5) and photographed.  
 
2.4.6 Culture of in ovo-transfected somite strips 
2.4.6.1- Preparation of in ovo-transfected somite strips for culture 
 Chick embryos in which somites had been transfected (section 2.4.3) at stages 
9-12 HH were incubated until stage HH 22-24, removed from the egg and rinsed in 
warmed L-15 Leibovitz medium (PAA Laboratories Ltd) supplemented with 1% L-
Glutamine-Penicillin-Streptomycin solution (Sigma). Embryos were positioned on 
their sides and pinned down using insect pins (the head and last three somites) in a 
Sylgard-coated culture dish. The endoderm and part of the mesoderm were removed 
with a micro-scalpel Feather® (PFM Medical, ref: 200300715). The neural tube plus 
somites were then pinned ventral-side up, the remaining mesoderm removed and 
somites separated from the neural tube. Somite strips were removed from both sides. 
Three somites at the anterior and posterior extremities were discarded. The non-
transfected side was used as the control side of the embryo.  
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2.4.6.2- Culture of intact in ovo-transfected somite strips 
 Somite strips prepared as described in section 2.4.6.1 were collected into non-
treated 4-well culture slides (BD Falcon) (both strips from the same embryo were put 
in the same well) with warmed L-15 Leibovitz medium (PAA Laboratories Ltd) 
supplemented with 1% L-Glutamine-Penicillin-Streptomycin solution (Sigma), and 
left to recover for 12 hours at 39ºC in a humidified box. To prevent cells from 
differentiating into fibroblasts, a notochord fragment was added into each well 
together with the strips. siRNA knockdown efficiency was evaluated by live 
immunostaining as described in section 2.5.2. 
 
2.4.6.3- Culture of dissociated in ovo-transfected somite strips 
Somite strips from 2 in ovo-transfected embryos were prepared as described in 
section 2.4.6.1 and collected into a 2-ml LoBind tube (Eppendorf) with warmed L-15 
Leibovitz medium (PAA Laboratories Ltd) supplemented with 1% L-Glutamine-
Penicillin-Streptomycin solution (Sigma). Strips were dissociated with a 25-gauge 
syringe needle, and 20 µl of cells were transferred into each well of non-treated 4-
well culture slides (BD Falcon) with 490 µl of pre-warmed medium. To prevent cells 
from differentiating into fibroblasts, a notochord fragment was added into each well 
together with the strips. Slides were cultured in a humidified box at 38ºC for 16 hours. 
siRNA knockdown efficiency was evaluated by live immunostaining as described in 
section 2.5.2. 
 
2.4.7- Transfection of retinal cells and astrocytes in culture 
Chick embryos were removed from the egg at stage HH 22-24, rinsed and 
transferred into a Sylgard-coated culture dish containing pre-warmed L-15 Leibovitz 
medium (PAA Laboratories Ltd) supplemented with 1% L-Glutamine-Penicillin-
Streptomycin solution (Sigma). Eyes were removed with a micro-scalpel Feather® 
(PFM Medical, ref: 200300715) and dissociated as described in section 2.4.6.3. 
Human astrocyte cells (Neu7) were kindly provided by Dr. Elizabeth Muir 
(Department of Physiology, Development and Neuroscience, University of 
Cambridge). Cells were re-suspended in pre-warmed F12 medium with 1% L-
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Glutamine-Penicillin-Streptomycin solution (Sigma), 10X B127 and 5% Nerve 
Growth Factor (NGF, Sigma, N2513) and transferred into 4-well glass slide culture 
dishes (BD Falcon).  
Neu7 cells and chick retinal cells were incubated in a CO2 incubator at 38ºC 
for 16 hours, after which 12.5 µg of siRNA were dissolved in 100 µl of 5% glucose 
and 1.5 µl of TurbofectTM. 10 µl of this transfection mix were dissolved in 490 µl of 
DMEM (Sigma) supplemented with the B127 and NGF as for the F12 medium, and 
added to the cell culture. After incubation in a CO2 incubator at 38ºC overnight, cells 
were washed with DMEM three times and incubated for a further three hours with 
B127/NGF-supplemented DMEM. Once the cells had recovered, live immunostaining 
was carried out as described in section 2.5.2. 
 
2.5- Immunohistochemistry 
2.5.1- Whole-mount immunohistochemistry 
 Dehydrated embryos in methanol were transferred to 2-ml microfuge tubes 
and bleached at room temperature in 6% hydrogen peroxide in methanol for 1 hour or 
until the embryos turned white. Embryos were rehydrated into PBST through a series 
of 10-minute washes in 75%, 50% and 25% methanol in PBST, incubated for 3 hours 
in blocking solution (10% sheep serum in PBST), then incubated for 12-18 hours at 
4ºC with primary antibody diluted in blocking solution (Table 2.1). Where 
appropriate, fluorescein-conjugated or rhodamine-conjugated peanut agglutinin 
(PNA) (Vector Labs, catalogue numbers FL-1071 and RL-1072 respectively) was also 
added at 1:500. Embryos were then washed 4 times for 20 minutes each in PBST, 
before incubation with the appropriate secondary antibody (Table 2.2). After using 
fluorescent secondary antibodies, embryos were washed 3 times with PBST for 10 
minutes each and then prepared for vibratome sectioning. When a biotinylated 
secondary antibody had been used, Neutravidin350 (Alexa Fluor 350 conjugate of 
NeutrAvidin biotin-binding protein; Invitrogen A-11236) was used at 1:1000 in PBS.   
Alkaline phosphatase-conjugated secondary antibodies were used for some embryos, 
in which case the colour reaction was performed as described in section 2.3.2. 
Embryos were then washed seven times for 30 minutes each in MABT and twice for 
Materials and Methods 
62 
 
10 minutes each in PBS and then cleared in series of 25%, 50% and 70% glycerol in 
PBS. Embryos were photographed using a Leica dissecting scope and sectioned using 
a vibratome. 
  
2.5.2- Live immunostaining of cultured tissue/cells 
4-well culture slides containing siRNA-transfected somite strips (intact or 
dissociated; section 2.4.6) or astrocytes (section 2.4.7) were blocked by adding 10% 
sheep serum to the supplemented medium and incubating for 15 minutes. Rhodamine- 
conjugated peanut agglutinin (PNA) (Vector labs) and anti-protein disulfide 
isomerase (PDI) antibody (Sigma) were added to each well except one (negative 
control; also see section 2.5.3) for each slide at a dilution of 1:500, and incubated for 
1 hour at 38ºC. The medium was removed and the cells were fixed in 4% 
paraformaldehyde for 30 minutes, then washed with PBS three times for 5 minutes 
each, and incubated with secondary antibody (for the anti-PDI antibody) for 2 hours 
at room temperature. Wells were removed according to the manufacturer’s protocol 
and slides mounted with Fluoromount G (Southern Biotech). Slides were viewed 
using a Zeiss Axioskop fluorescence microscope.  
 
2.5.3- Controls for anti-PDI immunohistochemistry 
Controls used for PDI binding efficiency were: absence of primary antibody in 
one well per slide; pre-absorbed antibody with PDI at 5x molarity of the anti-PDI 
antibody (Sigma, P3818) in one well of each slide; use of rabbit IgG at the same 
concentration as the anti-PDI antibody instead of the anti-PDI primary antibody in 
one well of each slide. All assays were also carried out using a non-transfected strip. 
Each assay was repeated at least 3 times.  
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Table 2.1- Primary antibodies and dilutions used for immunohistochemistry. 
Antigen Antibody Type Dilution Source, catalog no. 
EphA4 (N-terminal) Rabbit polyclonal 1:50 AbGent, P54764 
Fgfr1 (N-terminal) Rabbit polyclonal  1:50 AbGent, P1136 
Fgfr3 (C-terminal) Rabbit polyclonal 1:50 AbGent, P22607 
Fgfr2 (N-terminal) Rabbit polyclonal 1:50 AbGent, P21802 







Neurofilament-160 kD  Mouse IgG2a 1:250 Zymed/Invitrogen 
Protein Disulfide 
Isomerase (PDI) 
Rabbit polyclonal 1:500 
Sigma, P7496 
 
Table 2.2- Secondary antibodies and dilutions used for immunohistochemistry. 
Antigen Conjugated with Raised in: Dilution Source, catalog no. 




Biotin Goat 1:100 Southern Biotech,  
1080-08 
Rabbit IgG Alexa Fluor 594 Goat 1:2000 Invitrogen,  
A-11012 
 




2.6- Vibratome sectioning 
Embryos were embedded in 10% gelatine (300 Bloom from Sigma)/PBS at 
39ºC for 30 minutes. During this time, cryomoulds were prepared with gelatine and 
left to set at room temperature for 15 minutes. The embryos were transferred into 
cryomoulds and the gelatine flattened and set at 4ºC for 30 minutes. Gelatine blocks 
were cut and fixed with 4% PFA at 4ºC for at least 72 hours. Blocks were subjected to 
three 10-minute washes in PBS then trimmed and mounted onto a Leica VT1000S 
vibratome. Using a steel blade, sections were cut at a thickness of 70 µm, oriented 
onto the surface of glass slides (VWR International), and mounted with Fluoromount 
G (Southern Biotech). Sections were photographed with a camera attached to a Zeiss 
Axioskop fluorescence microscope. 
 
2.7- Alcian blue staining 
 Chick embryos at stage 27 HH (E5) were collected and dehydrated as 
described in section 2.3.1. Embryos were transferred to 70% ethanol and left on the 
shaker for two hours, then transferred into acetic ethanol solution (30% glacial acetic 
acid in ethanol) and left for a further two hours, then transferred into Alcian blue 
solution [20% Alcian Blue (Sigma) in acetic ethanol] and left for 24 hours. Once 
stained, embryos were transferred back into acetic ethanol and left for another 24 
hours. Embryos were then rehydrated through a series of 70%, 50%, 25% of ethanol 
diluted in deionised water for two hours each and then a further two hours in just 
deionised water. To remove muscle and connective tissue, embryos were transferred 
into 30% sodium borate for 24 hours, and then for several hours in 0.1% trypsin in 
30% sodium borate. Once most of the tissue had been removed, embryos were 
transferred back into 30% sodium borate for one hour and graded back to deionised 
H2O. For clearing, embryos were transferred into 0.5% potassium hydroxide for as 
long as necessary. For photographing, they were graded from 0.5% potassium 
hydroxide into 100% glycerol. 
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One of the aims of this project was to investigate whether the genes identified in 
the posterior half-somite of the mouse in a differential microarray screen (Hughes et al., 
2009) are also expressed in the posterior sclerotome in the chick model, and if so, to 
select one of these molecules and study its function in axonal guidance in the chick. The 
differential microarray screen in mouse was performed as shown in Fig. 3.1. 
 
Figure 3.1- Microarray screen procedure from 
Hughes et al. (2009). “(A) Half-sclerotome 
dissection. Strips corresponding to the 10–18th 
most recently formed somites (S10-S18) were 
isolated from mouse embryos at TS15 (9.5–10.25 
d.p.c.). Individual A- (green) or P-sclerotome (red) 
halves were dissected and pooled for further 
processing. V, ventral; D, dorsal; A, anterior; P, 
posterior. (B) Amplification of sclerotome RNA. (i) 
Total RNA was purified individually from pools of 
A- or P-half-sclerotomes. (ii) First strand cDNA 
was synthesized by reverse transcriptase (blue) 
using a modified Clontech SMART primer 
containing oligo (dT), a T7 RNA polymerase 
promoter and an universal primer (UP). (iii) The 
template-independent addition of 3' C residues 
allows second strand synthesis by strand- switching 
of reverse transcriptase using a second UP bearing 
G residues. (iv) Global cDNA amplification by 
limited PCR cycles using a UP alone. (v, vi) Further 
amplification, and generation of antisense-labelled 
probe by in vitro transcription using T7 polymerase 
(red) for hybridization to microarrays.” Figure and 
legend from Hughes et al. (2009) 
 
Gene Expression Atlas 
68 
 
Two genes whose expression had previously been characterized in the chick - an 
anterior sclerotome marker, Tbx18, and a posterior sclerotome marker, Uncx4.1 – were 
used as a positive control. The 12 genes selected from Hughes et al. (2009) whose 
expression patterns in chick are described in this chapter are: glypican-6 (Gpc6); 
hyaluronan synthase 2 (Has2); phosphatase and tensin homologue (Pten); tissue 
inhibitor of metalloproteinase 3 (Timp3); cystatin C (Cst3); coagulation factor II 
(thrombin) receptor (F2r); E26 avian leukemia oncogene 2, 3’ domain (Ets2); fibroblast 
activation protein (Fap); insulin-like growth factor-binding protein 5 (Igfbp5); 
roundabout homolog 1 (Robo1); transforming growth factor beta receptor II (Tgfbr2) 
and fibronectin leucine rich transmembrane protein 2 (Flrt2). This chapter includes for 
each gene a brief introduction to the gene and results and discussion together describing 
the expression pattern and indicating whether the gene could be responsible for the 
repulsive role of the posterior sclerotome in axonal guidance.  
 
3.2- Positive controls: Tbx 18 and Uncx4.1 
In order to validate the whole-mount in situ hybridization (WMISH) data, 
positive control in situ hybridization studies where carried out for molecules already 
known to be expressed in chicken somites: Tbx18 and Uncx4.1. Tbx18 is a T-box 
transcription factor known to control the development of diverse tissues and organs 
during development (Wehn and Chapman, 2010), whose expression in somites is 
restricted to the anterior half-sclerotome (Haenig and Kispert, 2004). Uncx4.1 is a 
homeodomain transcription factor that controls the development of the vertebrate 
skeleton (Leitges et al., 2000; Mansouri et al., 2000), and which is expressed during 
development in the posterior half-sclerotome (Schrägle et al., 2004). Images from the 









Figure 3.2- Representative WMISH images for positive control genes already 
known to be expressed in chicken somites. (A) Tbx18 expression in a chick embryo at 
stage 18 HH. (B) Tbx18 expression in a chick embryo at stage 26 HH. (C) Uncx4.1 
expression in a chick embryo at stage 18 HH. (D) Uncx4.1 expression in a chick embryo 
at stage 26 HH. 
  




Confirmation that the WMISH was successful was provided by positive control 
molecules displaying the expected complementary expression patterns, with Tbx18 in 
the anterior half-sclerotome and Uncx4.1 in the posterior half-sclerotome.  
Tbx18 expression was restricted to the anterior half-somite (Fig. 3.2A,B), 
Expression in the heart was seen by stage 12 HH, but was not visible in the somites 
until stage 16 HH. By stage 19 HH, Tbx18 expression was seen in the limbs. By stage 
29 HH, Tbx18 expression in the somites disappeared, leaving expression only in the 
heart and limbs, as described by Haenig and Kispert (2004). 
 Uncx4.1 expression was reported as restricted to the posterior half-somite from 
stage 16 HH to 26 HH (Mansouri et al., 2000) (Fig. 3.2C,D). By stage 19 HH Uncx4.1 
expression was also seen in the limb buds (Fig. 3.2D).   
 Both positive control genes demonstrated expression patterns as described in the 
literature, validating the WMISH technique. 
 
3.3- Glypican-6 (Gpc6) 
Glypican-6 (Gpc6) belongs to a family of heparan sulphate proteoglycans 
(HSPGs) (Song and Filmus, 2002) that are known to have a role in axonal guidance 
(Bloechlinger et al., 2004). There are six glypicans (Gpc1 to Gpc6) (Song and Filmus, 
2002; Luxardi et al., 2007). Gpc6 was identified in 1999 and found to be expressed in 
the mesenchyme of the mandibular process, the smooth muscle cells of the dorsal aorta, 
the kidney and, interestingly, the intervertebral discs (Veugelers et al., 1999; Song and 
Filmus, 2002). Hughes et al. (2009) showed by WMISH that Gpc6 was present in the 
posterior half-sclerotome, hence Gpc6 was selected to see whether it is also expressed 
in the posterior half-sclerotome of chicken. Amplification of mRNA for this gene was 
successful and WMISH data were obtained for HH stages 22 and 25 (Fig. 3.3). 
 
 




Figure 3.3- Whole-mount in situ hybridization for Gpc6 for chick embryos at 
stages 22 HH (A-C) and 25 HH (D-F). Panels A and D show Gpc6 expression in the 
whole embryo; panels B and E show expression in the vagal and trunk region; panels C-
F show expression in the more posterior trunk. 
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 According to Hughes et al. (2009), Gpc6 expression was detected by the 
microarray and WMISH in the posterior sclerotome of mouse, however the same is not 
visible in the chick model. As shown in Fig. 3.3, Gpc6 appears to be expressed in the 
anterior-half of the sclerotome and in the neural tube, from stage 22 HH to stage 25 HH 
in the chick embryo. Since its expression was not seen in the posterior half-sclerotome, 
further studies were not done. 
 
3.4- Hyaluronan synthase 2 (Has2) 
Hyaluronan synthase 2 (Has2) encodes an enzyme that produces hyaluronan, a 
glycosaminoglycan that is a key component of the extracellular matrix (ECM) (Klewer 
et al., 2006). Its expression is high in mid-gestation mouse embryos in the neural crest 
cell populations and endocardial cushions and it plays a role in EMT, vasculogenesis 
and neural crest survival (Spicer et al., 2002). Zebrafish Has2 is required for multiple 
developmental processes, one of which is the migration of adaxial and sclerotomal cells 
during somite reorganization (Bakkers et al., 2004). After this, Has2-positive cells 
migrate to the lateral walls of the somites, and differentiate into muscle and cartilage 
cells (Spicer et al., 2002).  
Hyaluronan expression has been found around differentiating and proliferating 
cells in the ventrolateral part of the chick spinal cord, including early motor neurons 
(Mészár et al., 2008). The multiple expression domains of the hyaluronan synthase gene 
Has2 connect it to the nervous system, however its full function is still not known. In 
order to investigate this, a null mutant mouse model has been created, but this is not 
viable (Roughley et al., 2011). These mice presented deformities in cartilage and in the 
limb joints, as these were reduced. The embryos were also smaller than usual indicating 
that some abnormalities might be present in the vertebral column area (Roughley et al., 
2011). Furthermore, Hughes et al. (2009) detected Has2 in the posterior half-somites in 
their mouse microarray screen. For this reason Has2 was included in the present study. 
Amplification of mRNA for this gene was successful and WMISH data were 
obtained for HH stages 16, 19, 23 and 26 (Figs. 3.4 and 3.5). 




Figure 3.4- Chick embryos after WMISH for Has2 from stage 16 HH to 26 HH. 
Has 2 is expressed at stage 16 and 19 HH in the epicardium and anterior half-somite. At 
23 HH, it is present in the dorsal root ganglia (DRG) and neural tube, sclerotome, limb 
buds, heart and mesonephros. At stage 26 HH, it is present in DRG and limb muscle. 




Figure 3.5- Sections of embryos after WMISH for Has2. (A) Transverse section of a 
chick embryo at stage HH 16. (B-D) different section planes of a chick embryo at stage 
25 HH, Panels B and D show parasagittal sections at the level of the heart. Panel C 
shows a transverse section at the level of the upper limbs. (s) - somite, (sc) - sclerotome, 
(h) - heart, (mn) - motor neurons, (sn) -sensory neurons. 
 
Has2 is clearly expressed in the anterior half-somite and is also highly expressed 
in dorsal root ganglia (Fig. 3.4 and 3.5), similar to what was described by Mészár et al. 
(2008). In the mouse microarray study by Hughes et al. (2009), Has2 was reported to be 
expressed in the posterior half of the sclerotome, suggesting either an inter-species 
difference or perhaps that Has2-expressing cells that surround the notochord may have 
been included in the dissection of the posterior half sclerotome in the Hughes et al. 
(2009) study. Evidence that Has2 should localise in the anterior sclerotome lies in the 
fact that the hyaluronan receptor CD44 is a well-known anterior sclerotome marker 
(Wheatley et al., 1993), and CD44 was detected by the microarray in the anterior-half of 
the sclerotome by Hughes et al. (2009) while Has2 was in the posterior half-sclerotome, 
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but this might be a false positive result. The majority of HA studies have focused on 
limb morphogenesis. For example, Has2 expression was found in the posterior subridge 
mesoderm in chicken stage 17/18 when the limb bud is being formed (Li et al., 2007). 
However, there was also a functional study in Xenopus in which the loss of XHas2 
caused the disruption of somite pattern resulting in defects in muscle differentiation and 
the migration of hypaxial muscle cells and trunk neural crest cells (Ori et al., 2006). 
Recently, another study in Xenopus described that hyaluronan is not only essential for 
cranial neural crest migration by promoting cell locomotion together with versican, but 
also to ensure neural crest survival post-migration (Casini et al., 2012). 
The present results show that Has2 has a variable expression during chick 
development. At stage 14 HH, Has2 has a non-segmented expression in the sclerotome 
but is absence in the ventral lateral sclerotome (Fig. 3.4; Fig. 3.5A,C). By stage 16 HH 
it becomes segmented and restricted to the anterior half of the sclerotome from the 10th 
somite onwards (Fig. 3.4). Fig. 3.5A shows that Has2 has a stronger expression in the 
ventral sclerotome that spreads through the lateral sclerotome until the dorsal 
sclerotome, and then its expression is also localised in the lateral sclerotome.  
By stage 17 HH, Has2 expression becomes restricted to both motor and sensory 
neurons, mesonephros and heart (Fig. 3.5A,B). Has2 might not play a role in somite 
patterning, but this study and previous work (Ori et al., 2006) suggest that it may play a 
role in PNS development, being strongly expressed in the dorsal root ganglia. Due to its 
absence from the posterior half-sclerotome, further studies were not done.  
 
3.5- Phosphatase and tensin homolog (Pten) 
Phosphatase and tensin homolog (Pten) encodes a lipid and protein phosphatase 
that inhibits numerous molecules involved in cell signalling (Puig et al., 2009). The 
Pten protein has a catalytic N-terminal phosphatase domain that acts on both protein and 
lipid substrates and a C-terminal C2 domain that is responsible for controlling cell 
migration and may have a role in axonal migration (Raftopoulou et al., 2004). Elevated 
levels of Pten have previously been found in the peripheral projections of sectioned 
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DRG neurons from rat, but only small amounts were detected in DRG cultured from 
E18 rat embryos, instead Pten protein was highly enriched in the central domain of the 
growth cone where it accumulated with microtubules (Chadborn et al., 2006). An 
interaction study of Pten with other molecules showed that Pten accumulates at the 
growth cone membrane during Sema3A-induced growth cone collapse (Raftopoulou et 
al., 2004). 
Pten deletion in adult retinal ganglion cells (RGCs) promotes axon regeneration 
after optic nerve injury, and it is likely to act upon intrinsic mechanisms other than 
survival to promote axon regeneration after injury (Park et al., 2008). These findings 
raise questions about the expression and possible roles of Pten in early development. As 
it has been shown to be involved in regeneration and growth cones, this suggests that if 
it is expressed in early development, Pten may be localised in the anterior half of the 
sclerotome. Pten is also found to be involved in bone and cartilage development: Pten 
deletion in osteo-chondroprogenitor cells leads to vertebrae overgrowth, mainly due to 
matrix deposition and accelerated differentiation (Knobbe et al., 2008). These findings 
made it particularly appealing to establish the expression pattern of Pten in the 
developing chick embryo. 
Unfortunately, WMISH results for this gene were particularly hard to obtain. 
Although it was possible to see some weak staining in the somites at stage 19 HH (Fig. 
3.6A,C), by increasing the development time, the somite signal intensity became 
stronger however so did the background staining (Fig. 3.6B,D). Pten had a weak 
expression at stage 19 HH at somite boundaries and extending into the anterior half of 
the somite (Fig. 3.6C,D). Although a rich expression in neurons or even in the neural 
tube was expected, this was not observed. Even though Pten has been shown previously 
to couple with Sema3A signalling during growth cone collapse (Chadborn et al., 2006), 
it does not necessary mean that Pten will have a similar gene expression to Sema3A in 
all situations. The weak Pten expression in the chick embryo suggests that it may not 
play an important role in axon guidance in early chick development, and definitely not 
in somite polarity. Therefore further analysis of this gene was not pursued.  
 





Figure 3.6- Chick embryos after WMISH for Pten at stage 19 HH. Pten is weakly 
expressed at somite boundaries and also in the anterior half of the somite. 
 
3.6- Tissue Inhibitor of Metalloproteinase-3 (Timp3) 
During development, a balance between synthesis and degradation of the 
extracellular matrix (ECM) is continuously maintained. The family of matrix 
metalloproteinases (MMPs) is believed to be responsible for maintaining this balance. 
MMPs function in the turnover of a broad spectrum of ECM proteins including 
collagens, laminins, fibronectin and proteoglycans (Nagase et al., 1997). Their function 
is regulated by interaction with their natural inhibitors, the tissue inhibitors of 
metalloproteinases (TIMPs) (Langton et al., 2000). The balance between MMPs and 
TIMPs plays a key role in a wide range of physiological processes in embryonic 
development, connective tissue remodelling, wound healing, glandular morphogenesis, 
and angiogenesis (Langton et al., 1998). Timp3 was discovered in chicken by Pavloff et 
al. (1992) and its role in the morphogenesis of non-neuronal tissues has since been 
investigated. Timp3 expression during rat development was found in the dorsal root 
ganglia, ventricular zones, cartilage, epithelia of the lung, intestine and kidney, skeletal 
muscle, thymus and whisker vibrissae (Jaworski and Fager, 2000). Timp3 expression 
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was also detected in the posterior half sclerotome by microarray and WMISH (Hughes 
et al., 2009). This result was somehow surprising, as its expression had been found in 
dorsal root ganglia and therefore it would be predicted to be in the anterior and not in 
the posterior half-somite, so this result might be a false positive of the microarray study 
(Hughes et al., 2009). Nevertheless, I studied Timp3 expression in the chick model.  
Amplification of mRNA for this gene was successful and WMISH data were 
obtained for HH stages 18, 22 and 26 (Fig. 3.7). From this study, it appears that there 
are a number of differences in Timp3 gene expression patterns between chicken and 
rodents. In rat, Timp3 is expressed in the dorsal root ganglia, cartilage and gut (Jaworski 
and Fager, 2000), while in chicken, the gene is expressed in the notochord from stages 
18 to 26 HH (Fig. 3.7B,C,N,O,P), consistent with a previous report of notochord 
expression between stages 8 and 14 HH (Cantemir et al., 2004). Notochord expression 
starts to disappear at stage 26 HH, as its expression here becomes restricted to the 
embryo tail (Fig. 3.7O,P). After stage 18 HH, Timp3 also becomes expressed in the 
neural tube, anterior half-sclerotome (Fig. 3.7H,I,M-O), heart (Fig. 3.7D-F,K) and limb 
buds (Fig. 3.7D-F,J-L), suggesting that it might have an important role in embryonic 
development. Brauer and Cai (2002) also detected Timp3 expression in chick heart from 
stage 11-25 HH, being expressed in the myocardium, endocardium and also in the conus 
arteriosus, as detected in this study (Fig. 3.7K). 
MMPs and TIMPs play diverse roles in the migration of the rostral migratory 
stream to the olfactory bulb, and in the postnatal subventricular zone (SVZ), and in glial 
cells to mediate the migration and to promote neurite outgrowth and growth cone 
extension (Jaworski and Fager, 2000: Muir et al., 2002). Despite the presence of Timp3 
in the rodent CNS, it may not have the same role in chick embryos and further studies 
would be required to investigate this possibility. Timp3 expression was not found in the 
posterior half-sclerotome in chick, instead it showed strong expression in the notochord 
and later in the myotome. Its restriction to the central myotome (Fig. 3.7M) suggests 
that Timp3 may be involved in the orchestration of the re-segmentation process. The 
fact that it was not possible to localise Timp3 expression in chicken posterior half-
sclerotome despite the detection of Timp3 in the mouse microarray study (Hughes et al., 
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2009) and that no other studies report Timp3 expression in mouse posterior sclerotome 
suggest that the result obtained by Hughes et al. (2009) might be a false positive.  
 
Figure 3.7- Chick embryos and embryo sections after WMISH for Timp3. Timp3 is 
expressed in the inner sheet of the notochord at all stages examined. At stage 18 HH, 
Timp3 can only be found in the notochord (B, C), while at later stages it also begins to 
be expressed in the limb buds and heart (D-F, J-L), the myotome (G, M-P), inner ventral 
neural tube (H, I, O) and faintly in the anterior sclerotome (G, I, M, N) and dorsal 
muscle precursors (I, N). By stage 26 HH, expression in the heart becomes restricted to 
the conus arteriosus (J,K). (nt)- notochord; (nt)- neural tube; (myo)- myotome; (mp)- 
muscle precursor; (c.a.)- conus arteriosus. Scale bar: 100 µm. 
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  There is one study by Zeng et al. (1998) that connects Timp3 expression 
with developing somites, bones and joints. This was detected through a β-galactosidase 
assay measuring lacZ expression driven by a fragment of the human Timp3 upstream 
region in transgenic mice and although Zeng et al. (1998) did not report Timp3 
expression in somites, they showed expression in the intervertebral discs, which are 
formed from the notochord (McCann et al., 2012) and from the anterior half-sclerotome 
in chick (Bruggeman et al., 2012), adding support to the hypothesis that the result 
obtained by Hughes et al. (2009) was a false positive. Timp3 expression in the 
notochord and in the anterior half sclerotome suggests that Timp3 might have a role in 
intervertebral disc formation, but further studies were not pursued.  
 
3.7- Cystatin C (Cst3) 
The carboxypeptidase inhibitor latexin was detected in the posterior half-somite 
in the Hughes et al. (2009) developing mouse microarray study. Latexin was previously 
used as a neuronal maker in the lateral neocortex of the developing mammalian brain 
(Arimatsu, 1994, Aagaard et al., 2005); it plays an important role in inflammatory 
processes (Aagaard et al., 2005), pain sensitivity (Jin et al., 2006) and also chondrocyte 
differentiation (Kadouchi et al., 2009). The detection of latexin in the mouse posterior 
half-somite (Hughes et al., 2009) and its involvement in chondrocyte differentiation 
(Kadouchi et al., 2009) were intriguing. Although its role in vertebra formation had not 
been studied, it might play an important role in the fate of cells in the posterior half-
somite. At the time I performed this study, there was no evidence that chicken had a 
latexin homologue, so I studied the expression of the cysteine proteinase inhibitor 
cystatin C (Cst3), which shares a high structural similarity with latexin (Liang and van 
Zant, 2008). (However, a chicken latexin sequence has recently become available: 
http://www.ncbi.nlm.nih.gov/gene/771519.) 
Amplification of mRNA for this gene was successful and WMISH data were 
obtained for HH stages 16, 19 and 26 (Fig. 3.8). Cst3 was found to be expressed in the 
notochord in the chick embryo from stage 16 HH to stage 26 HH (Fig. 3.8C,J). It has a 
strong expression from the presomitic mesoderm to the head.  




Figure 3.8- Chick embryos and embryo sections after WMISH for Cst3 from stage 
16 HH to stage 26 HH. Cst3 is present in the inner sheet of the notochord from stage 
16 HH to stage 26 HH (C, K-M). It is expressed in the mesencephalon (B, F, J), retina 
and lens (L), and ventral sclerotome (M white arrow in L). (rt)- retina; (sc)- sclerotome; 
(ms)- mesencephalon. Scale bar: 100 µm.  
19 HH 26 HH 16 HH 
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Contrary to the findings for mouse latexin (Hughes et al., 2009), Cst3 has strong 
localised expression in the mesencephalon and neural tube (Fig. 3.8G,M,H) suggesting 
that it may play an important role in development of the CNS. Cst3 was detected in the 
ventral area of the sclerotome with a segmented pattern (Fig. 3.8E,L), suggesting that 
Cst3 might be involved in the formation of the transverse process of the vertebra, but 
future studies would be needed to confirm this. Since the aim of this project was to 
study genes with potential roles in axon guidance in the somite, further studies for Cst3 
were not carried out.  
 
3.8- Coagulation factor II (thrombin) receptor (F2r) 
Coagulation factor II (thrombin) receptor (F2r), also known as PAR1 or 
protease-activated receptor 1, is a member of a family of G-protein-coupled receptors 
(GPCRs) that becomes activated after cleavage in the extracellular N-terminus (Han et 
al., 2011; Griffin et al., 2001). F2r is able to mediate the cellular responses to thrombin 
(Austin et al., 2013). In the adult, the serine protease thrombin cleaves soluble 
fibrinogen to fibrin monomer, which polymerises to form fibrin matrices and is 
necessary to orchestrate homeostatic and inflammatory responses to tissue injury 
(Griffin et al., 2001). F2r is expressed in heart, hematopoietic cells, blood vessels, brain 
and mesenchymal cells of E9.0- 9.5 mice (Connolly et al., 1996). 
Despite the fact that it has been studied for wound repair, it is thought to have a 
role in the maintenance of the blood-brain barrier as it is expressed in brain neurons and 
astrocytes (Junge et al., 2004). The interference of F2r after cerebrovascular injury 
results in neurite retraction, suggesting that F2r might be responsible for the re-
establishment of the connections between neurons (Suo et al., 2003). F2r, at first glance, 
does not appear a likely candidate for involvement in the polarity of somites, however 
considering the problems that CNS injuries represent, and the fact that F2r was detected 
in the mouse posterior half-somite microarray screen (Hughes et al., 2009), raises the 
question of a possible role in segmentation. 
Amplification of mRNA for this gene was successful and WMISH data were 
obtained for HH stages 16, 19 and 26 (Fig. 3.9). 




Figure 3.8- Chick embryos and embryo sections after WMISH for F2r from stage 
16 HH to stage 26 HH. F2r is expressed in the ventrolateral neural tube, and in the 
sclerotome from stage 16 HH (A) to stage 26 HH (G). (D-E) Sections of a stage 19 HH 
embryo, F2r is present in the posterior dorsal sclerotome. (G) A stage 26 HH embryo. 
(H) Higher magnification view of the vagal and rostral trunk area of the embryo in G. 
(I-K) Serial parasagittal sections of a stage 26 HH chick embryo. F2r is expressed in the 
posterior half sclerotome and neural tube (J-K) and in the dorsal aorta (d.a). Scale bar: 
100 µm. 
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F2r expression in chick embryos begins at approximately stage 16 HH in the 
somite boundaries from somite 13 forward (Fig. 3.8A). As the embryo develops (stage 
19 HH), F2r becomes expressed from the tail to the trunk in the posterior half-somites 
(Fig. 3.9B-F). Despite its presence in the posterior half, it has a stronger expression in 
the central ventral posterior somite and inter-somitic blood vessels. Transverse 
sectioning revealed that F2r also has a strong expression near the neural tube (Fig. 
3.9E,F,I-K). F2r is also present in forming heart within the chick embryo, being 
expressed in the dorsal aorta (Fig. 3.9B,H). This expression is in agreement with the 
already known expression of F2r in the endothelium of forming blood vessels (Vu et 
al., 1991) and with the detection of F2r in the posterior half sclerotome of mice by 
Hughes et al. (2009). However, due to its role in the formation of blood vessels (Vu et 
al., 1991), it is very unlikely that F2r is the gene responsible for axonal repulsion in the 
posterior sclerotome, therefore further studies were not pursued.  
 
3.9- Ets2 
Ets2 (E26 avian leukemia oncogene 2, 3' domain) encodes a transcription factor 
initially identified as a nuclear oncogene with an essential role in embryonic 
development (Ristevski et al., 2002). Ets2 abnormalities result in craniofacial 
morphology in Down’s syndrome (Sumarsono et al., 1996). Ets2 is highly expressed in 
newly formed cartilage in mice (Sumarsono et al., 1996; Ristevski et al., 2002), and in 
osteoblasts (Raouf and Seth, 2000). In mice, Ets2 was found to be expressed in the 
anterior border of the segmenting somitomere, in the anterior portion of newly formed 
somites, and also in the inter-somitic blood vessels (Ristevski et al., 2002). From these 
findings, its role in somite polarity was suggested; however no further studies have been 
done. Despite the findings of Ets2 expression in the anterior half of the somite by 
Ristevski et al. (2002), it was detected in the posterior half-somite in the mouse 
microarray study by Hughes et al. (2009). Although the latter could therefore have been 
a false positive, Ets2 expression was studied in the chick model. 
Amplification of mRNA for this gene was successful and WMISH data were 
obtained for HH stages 16, 19, 23 and 26 (Fig. 3.10). 




Figure 3.9- Chick embryos and embryo sections after WMISH for Ets2 from stage 
16 HH to stage 26 HH. (A,B) At stage 16 HH, Ets2 is expressed in the inter-somitic 
boundaries, and in the heart. (C-G) Ets2 expression at stage 19 HH in whole-mount 
(C,D) and on sections (E-G) Ets2 is present in the limb blood vessels (C) and 
mesonephros (ms; D,E), inter-somitic boundaries (presumably blood vessels; C,D,F), 
and developing blood vessels of the sclerotome (G). (H) Embryo at stage 23 HH. (I) 
Higher magnification view of vagal area of embryo in H. Ets2 is expressed in the inter-
somitic boundaries (arrow) and in the limb buds. (J) Embryo at stage 26 HH. Ets2 is 
expressed in the inter-somitic boundaries, dorsal neural tube (white arrow) and limb 
muscle (black arrow).  
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The findings from the present study suggest that Ets2 has a similar gene 
expression pattern in chicken as reported in mouse (Ristevski et al., 2002), although 
Ets2 expression in the somites and around the neural tube seemed stronger in the chick 
than in the mouse. In chicken, Ets2 is expressed in the developing blood vessels in both 
the limb (Fig. 3.10E) and sclerotome (Fig. 3.10G), suggesting that it may play a role in 
angiogenesis. Ets2 expression between the somites (Fig. 3.10A,B,F,I,J) is likely in inter-
somitic blood vessels, as reported by Ristevski et al. (2002). Ets2 is widely expressed 
within the embryo, and the fact that it was detected in the posterior half-somite in the 
microarray screen in mouse (Hughes et al., 2009) might be related to this finding. The 
gene expression patterns for Ets2 suggest that it does not play a role in axon guidance in 
the somite and therefore further assays for this gene were not carried out. 
 
3.10- Fibroblast Activation Protein (Fap) 
 Fibroblast activation protein (Fap) is a type II cell surface glycoprotein and a 
member of the serine prolyl oligopeptidase family (Niedermeyer et al., 2001). A role 
has been suggested for Fap in degrading the ECM or in activating growth factors at sites 
of tissue remodelling (Niedermayer et al., 2001). Fap is also expressed with collagen 
fibers, fibronectin, and collagen type I (Wang et al., 2005), all important proteins for 
somite development and axon guidance. In mouse, Fap expression was found in the 
posterior half-somite (Hughes et al., 2009). Other studies have also reported Fap 
presence in embryonic mesenchyme including in the somites and primordial cartilage 
(Niedermeyer et al., 2001). For these reasons, Fap was included in the present study. 
 Amplification of mRNA for this gene was successful and WMISH data were 
obtained for HH stages 17, 19 and 25 (Fig. 3.11). Fap is expressed in the notochord 
from at least as early as stage 17 HH (Fig. 3.11A) to stage 25 HH (Fig. 3.7G-M). 
Whole-mount images from stages 25 HH suggest a segmented pattern in the notochord 
(Fig. 3.7H,I), although this could not be seen in coronal section (Fig. 3.11J). Fap 
expression in the notochord is interesting considering that this is a structure that 
undergoes numerous modifications during development (Stemple, 2005). Due to the 
high expression of Fap in the notochord it would be interesting to study whether it has 
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any influence on the migration and condensation of ventral sclerotome cells or in the 
formation of the intervertebral discs. However, because the aim of this study was to 
identify candidate genes involved in axon guidance in the somite, and I did not obtain 
any evidence to suggest an involvement of this gene in somite polarity, further studies 
were not done. 
 
 
Figure 3.10- Chick embryos and embryo sections after WMISH for Fap from stage 
17 HH to stage 25 HH. (A) Stage 17 HH. (B-F) Stage 19 HH. (G-M) Stage 25 HH. 
Fap is present in the notochord at least as early as stage 17 HH until stage 25 HH. 
Sections after WMISH show a very strong expression in the notochord. Whole-mount 
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images at higher magnification (H-I) show that Fap exhibits a segmented pattern within 
the notochord. 
 
3.11- Insulin-like growth factor-binding protein 5 (Igfbp5) 
There are six members of the insulin-like growth factor (IGF)-binding protein 
family: these directly bind IGF1 and IGF2, reducing the availability of IGF for receptor-
binding, although this binding can also stabilize IGF, leading to a net increase in IGF 
signalling (Clemmens, 1998). Igfbp5 overexpression leads to increased neonatal 
mortality, retarded muscle development and whole-body growth inhibition (Salih et al., 
2004). The two latter findings suggest that there may be an impact at the level of the 
somites. As gene expression studies of Igfbp5 localisation within the vertebrae are 
lacking and Hughes et al. (2009) detected Igfbp5 in the posterior half-somite in mice, 
Igfp5 gene expression was studied in the developing chick embryo. Amplification of 
mRNA for this gene was successful and WMISH data were obtained for HH stages 18 
and 22 (Fig. 3.12). 
The pattern of Igfbp5 expression described in this study is similar to that 
reported in rat by in situ hybridization (Green et al., 1994) and immunohistochemistry 
(Cheng et al., 1996). Expression is found in the notochord (Fig. 3.12A-D,J), regions of 
the central nervous system (Fig. 3.12B,H-J) including the olfactory bulb (Fig. 3.12H,I), 
as well as in peripheral neurons in the DRG (Fig. 3.12J). Although expression is seen in 
the myotome (Fig. 3.12C,D,J,K), Igfbp5 is not expressed in the posterior half-somite in 
the chick embryo as detected in the mouse microarray screen (Hughes et al., 2009). 
Detection of Igfbp5 in the posterior half-somite in the mouse microarray screen may 
have been due to expression in surrounding myotome cells. 
Igfpb5 expression in regions of the neural tube (Fig. 3.12B,H-J) suggests a role 
in the central nervous system. Indeed, a recent patent suggests that blocking Igfbp5 may 
help treat central nervous system cancer (Gleave et al. IP 20110152354). 




Figure 3.11- Chick embryos and embryo sections after WMISH for Igfbp5 at stage 
18 HH and 22 HH. (A-D) Stage 18 HH embryo sections after WMISH showing Igfp5 
expression in the notochord (nt), hindbrain (Hind), otic vesicle and myotome (myo). (E) 
Stage 22 HH embryo. (F) Higher-power view of the vagal area and rostral trunk of the 
embryo in E. (G) Higher-power view of the trunk, somites, limbs and mesonephros of 
the embryo in E. (H-K) Sections after WMISH at stage 22 HH. (H) Transverse section 
of the brain. (I) Higher-power view of section in H showing Igfbp5 expression in the 
forebrain and putatively the edges of the paired olfactory bulbs (o.b., boxed). (J,K) 
Sections in the trunk region showing Igfbp5 expression in the myotome, neural tube and 
dorsal root ganglia (drg). Scale bar: 100 µm. 
Gene Expression Atlas 
90 
 
3.12- Roundabout homolog 1 (Drosophila): Robo1 
The Slit-Robo families are well-known axon pathfinding proteins and are 
considered part of one of the most important ligand-receptor connections for axon 
guidance (Ypsilanti et al., 2010). Robo1 protein has immunoglobulin repeats and 
fibronectin type III repeats domains. In Drosophila, Robo1 prevents commissural axons 
from crossing the midline and also prevents re-crossing of axons by serving as a 
receptor for repulsive guidance molecules (Yuan et al., 1999). Robo1 is expressed in 
mice in the midbrain ventricular zone, distal tip of the first branchial arch, and anterior 
sclerotome, becoming eventually segmented into the medial and lateral anterior 
sclerotome (Yuan et al., 1999). Robo1 is also found in the neural tube from E10.5 in the 
motor columns and commissural neurons (Yuan et al., 1999). Robo1 was found in the 
posterior somite in the mouse microarray study (Hughes et al., 2009), therefore Robo1 
expression in chick was studied here. Amplification of mRNA for this gene was 
successful and WMISH data were obtained for HH stages 19, 22 and 26 (Fig. 3.13). 
The expression of Robo1 in chick is very similar to the expression reported in 
mice (Yuan et al., 1999) and also previously in the chick (Jia et al., 2005). From stage 
19 HH to 22 HH, Robo1 exhibited strong expression in the dorsal root ganglia (Fig. 
3.13C-F) and became more restricted to the ventral lateral region of the sclerotome. 
Robo1 expression was also seen in the neural tube (Fig. 3.13C-K): this expression 
pattern most likely represents motor columns and interneurons, as reported by Jia et al. 
(2005). These findings suggest that Robo1 may play a role in establishing neuronal 
connections, and that once the dorsal roots are formed, it becomes down-regulated. As 








Figure 3.12- Chick embryos and embryo sections after WMISH for Robo1. (A) 
Embryo at stage 19 HH. (B) Higher-power view of the trunk of the embryo in A. (C-F) 
Transverse sections at stage 19 HH. Robo1 is expressed in the neural tube and dorsal 
root ganglia. (G) Embryo at stage 22 HH. (H) Higher-power view of thoracic (fore-
limb) area of embryo in G. Robo1 is present in the neural tube, anterior sclerotome and 
wing bud. (I-K) Transverse section at stage 22 HH. Robo1 is expressed in the neural 
tube and possibly neural crest cells on the roof of the neural tube. (L) Embryo at stage 
26 HH. (M) Higher-power view of the vagal and thoracic area of the embryo in L. 
Robo1 is present in the anterior sclerotome, wing and truncus arteriosus. (N) Stage 26 
HH embryo trunk, showing Robo1 expression in the limbs, mesonephros, neural tube, 
and anterior ventral and lateral sclerotome. Scale bar: 100µm. 
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3.13- Transforming growth factor beta receptor II (Tgfbr2) 
Ligands of the transforming growth factor beta (TGFβ) superfamily act through 
a dual receptor system of type I (Tgfbr1) and type II (Tgfbr2) transmembrane receptor 
serine/threonine kinases. After TGFβ binds to type I and type II receptors, Tgfbr2 
signalling is mediated by transcription factors called Smads, that regulate transcription 
of target genes (Wang and Serra, 2012). Tgfβs have previously been shown to be 
involved in skeletal development, especially in cartilage, joints, tendons development, 
and myogenesis (Lorda-Diez et al., 2010). The conditional deletion of Tgfbr2 in 
presumptive skeletal tissue causes abnormalities such as failure in the dorsal closure of 
the neural arches (Wang and Serra, 2012), reduction or loss of the intervertebral discs, 
defective boundary between presumptive intervertebral discs and malformed vertebrae 
(Baffi et al., 2006). Tgfbr2 is also required for the development of limb bones in mice: 
conditional deletion of Tgfbr2 in limb mesenchyme resulted in a decrease in 
chondrocyte proliferation (Seo and Serra, 2007), and in the reduction of the 
mesenchyme adjacent to the forming cartilage (Wang and Serra, 2012). It is clear that 
Tgfbr2 has an important role in skeleton formation, and since it is also expressed in 
mouse posterior half sclerotome (Hughes et al., 2009), it was important to see if Tgfbr2 
is also expressed in the posterior half sclerotome in chick. 
Amplification of mRNA for Tgfbr2 was successful and WMISH data were 
obtained for HH stages 16, 19 and 29 (Fig. 3.14). Tgfbr2 was not expressed in the 
posterior half sclerotome at any of the studied developmental stages in chick embryo; it 
was however expressed in other tissues. From stage 16 HH, Tgfbr2 is expressed in the 
heart and extremities of the embryo, being expressed in the anterior neural tube, then is 
not expressed in the lumbar area of embryo and then becomes expressed in the pre-
somitic mesoderm (Fig. 3.14A,B). By stage 19 HH, Tgfbr2 is still expressed in the heart 
and it becomes expressed in the entire length of the neural tube and also in the 
mesonephros (Fig. 3.14C-E). Transverse sections of embryos after WMISH for Tgfbr2 
showed that Tgfbr2 is not always expressed in the neural tube as at the level of the limb 
(Fig. 3.14F) there was no detection in the neural tube, while in the vagal area it is 
expressed in the medial dorsal neural tube (Fig 3.14G). This expression is maintained at 
stage 29 HH (Fig. 3.14H-N). The expression of Tgfbr2 in the neural tube suggests that 
this gene might have a function in the development of the CNS. 





Figure 3.13- Chick embryos and embryo sections after WMISH for Tgfbr2. (A,B) 
Embryo at stage 16 HH. Tgfbr2 is expressed in the neural tube and heart. (C) Embryo at 
stage 19 HH. (D) Higher magnification view of embryo in C. Tgfbr2 is expressed in the 
neural tube and heart. (E) Higher magnification view of the ventral tail area of embryo 
in C. Tgfbr2 is expressed in the mesonephros, limbs and neural tube. (F) Transverse 
section at stage 19 HH. Tgfbr2 is expressed in the anterior wing and in the neural tube. 
(G) Transverse section at stage 19 HH: Tgfbr2 is expressed in the central neural tube 
and ectoderm. (H) Embryo at stage 29 HH. (I) Higher magnification view of the 
thoracic (wing-level) area of embryo in H. Tgfbr2 is expressed in the limb buds, 
primitive wing muscle and neural tube. (J) Higher magnification view of the tail and leg 
region of embryo in H. Tgfbr2 is expressed in the inner limb and neural tube. (K) 
Longitudinal section at stage 29 HH. Tgfbr2 is expressed in the neural tube, myotome 
and proximal limb. (L) Longitudinal section at stage 29 HH. Tgfbr2 is expressed in the 
myotome, primitive wing muscle and mesonephros. (M) Longitudinal trunk section at 
stage 29 HH. Tgfbr2 is expressed in the centre of the myotome (asterisks) and in the 
inter-somitic boundaries. (N) Transverse section at stage 29 HH. Tgfbr2 is expressed in 
boundary cap cells and in the lateral neural tube. 
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Tgfbr2 is expressed in the myotome at stage 29 HH: it appears to be higher in 
the centre of the myotome at wing level (asterisk, Fig. 3.14M). This expression suggests 
that Tgfbr2 may have a function in the resegmentation process. Tgfbr2 is also expressed 
in the interior of the wings and in the joints between the wing and trunk (Fig. 3.14K,L), 
suggesting that Tgfbr2 may play a role in the formation of the wing, in a similar fashion 
to formation of joints as previously suggested in mouse (Lorda-Diez et al., 2010). 
 Tgfbr2 gene expression patterns during development reported here suggest a 
potentially important role in development, and perhaps in migration events that occur 
during the resegmentation process. As I did not find any evidence of Tgfbr2 being 
expressed in the posterior half sclerotome, further assessment of Tgfbr2 function in 
chicken was not pursued.  
 
3.14- Fibronectin leucine rich transmembrane protein 2 (Flrt2) 
Flrt genes code for glycosylated membrane proteins expressed at the cell surface 
(Haines et al., 2006) with a signal peptide, 10 leucine rich repeats (LRR), type III 
fibronectin-domain (FNIII), transmembrane domain, and a short intracellular tail (Lacy 
et al., 1999; Karaulanov et al., 2006). In mouse, Flrt genes are widely expressed in tissues 
such as kidney, skeletal muscle, lung, brain (Lacy et al., 1999; Haines et al., 2006), and 
cranial neural crest cells (Gong et al., 2009). The roles of Flrt protein domains have 
been studied: the LRR domain plays a role in homotypic cellular recognition (Haines et 
al., 2006) and the FNIII domain is involved in binding to Fgf receptors (Böttcher et al., 
2004). 
Different members of the Flrt family have distinct gene expression patterns. 
Flrt1 is expressed in brain compartmental boundaries; Flrt2 is expressed in the part of 
the sclerotome that will later form tendons, and Flrt3 was found in the part of the 
sclerotome that will later form the ventral vertebral body (Haines et al., 2006). Flrt3 
was also found at the midbrain/ hindbrain boundary (Haines et al., 2006). Cell adhesion 
assays have been carried out more frequently for Flrt3 than Flrt2. FNIII domains 
modulate cell adhesion and cell sorting; they are also calcium dependent and behave 
differently according cell type (Karaulanov et al., 2006). These findings are interesting 
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and relevant to the present study as during somitogenesis, the cells sort themselves 
creating a distinct barrier between the anterior and posterior halves of the somite. In 
addition, Flrt3 was detected in the anterior half-somite while Flrt2, was detected in 
posterior half of the somite in the mouse microarray screen (Hughes et al., 2009). It is 
intriguing that there are two genes of the same family in two different poles of the 
somite, and that these proteins are able to interact with each other. Do they have 
repulsive properties? Or is it the interaction of these two proteins that maintains the cell 
barrier? Does Flrt2 have any repulsive effect on axon guidance through calcium 
modulation? Flrt3 has been proven to modulate neurite outgrowth (Karaulanov et al., 
2009), and also Flrt2 and Flrt3 are repulsive guidance molecules for the netrin receptor 
Unc5D (Yamagishi et al., 2011). However, the Yamagishi studies focused on the brain, 
therefore, Flrt2 was included in the present study to explore a potential role in somite 
polarity. 
Amplification of mRNA for this gene was successful and WMISH data were 
obtained for HH stages 16, 17, 19, 22 and 29 (Fig. 3.15). Flrt2 in the chick embryo has 
a strong expression in the posterior half-somite (Fig. 3.15 all panels). The expression of 
Flrt2 begins at around the level of somite 10 (Fig. 3.15A), while somites are still being 
formed. Around stage 16 HH, Flrt2 expression is stronger in the ventral region of the 
somite and in the myotome, and it is also transiently expressed in the neural tube and 
notochord (Fig. 3.15D-F) since this expression is not visible at the level of later-formed 
somites. As the somites bud off and the embryo develops, at stage 17 HH Flrt2 is 
strongly present in the posterior half of the somites of the 13th somite and forwards (Fig. 
3.15C), in a similar fashion to the expression patterns for the PNA binding molecule (C. 
Casper and R. J. Keynes, personal communication). From stage 19 HH, Flrt2 is 
expressed in all the posterior sclerotome and maintained until later stages (Fig. 
3.15G,J), when it starts to be expressed in the neural arch and body of the vertebrae 
(Fig. 3.15K,L). Flrt2 expression is also found around the neural tube and notochord, 
which suggests a potential role in the development of the CNS, however there is no 
further evidence as yet in the literature to substantiate this. As Flrt2 expression is strong 
and clearly expressed in the posterior half-sclerotome, where it could be playing a role 
in repelling axons, the function of this gene was studied further using knock-down 
experiments (see Chapters 4 and 5). 


















Figure 3.14- (On next page) Chick embryos and embryo sections after WMISH for 
Flrt2. (A) Embryo at stage 16 HH. Flrt2 starts to be expressed from the 10th somite 
forward, with stronger expression surrounding the neural tube. (B) Higher-power view 
of embryo in A. Flrt2 is strongly expressed in the ventral posterior sclerotome near the 
neural tube. (C) Embryo at stage 17 HH. Flrt2 is segmentally expressed in the 
sclerotome from the 13th somite and forwards, and is also expressed in the heart. (D) 
Transverse sections of an embryo at stage 16 HH. Flrt2 is expressed in the posterior 
sclerotome (p), and in the myotome (black arrow). (E) Transverse section at tail level of 
chick embryo at stage 16 HH. Flrt2 is expressed in the sclerotome, notochord and 
neural tube. (F) Transverse section at thoracic level of chick embryo at stage 16 HH. 
Flrt2 is expressed in the medial ventral sclerotome. (G) Embryo at stage 19 HH. Flrt2 is 
segmentally expressed in the sclerotome, in the limbs, heart and mesonephros. (H) 
Parasagittal section of a chick embryo at stage 19 HH. Flrt2 is expressed in the 
posterior sclerotome and in the heart atrium. (I) Transverse section of a chick embryo at 
stage 22 HH. Flrt2 is expressed in the medial ventral sclerotome and around the neural 
tube (black arrow). (J) Coronal section of a chick embryo at stage 22 HH. Flrt2 is 
expressed in the posterior sclerotome (p) and in a continuous line around the neural 
tube. (K) Parasagittal section of chick embryo at stage 29 HH. Flrt2 is expressed in the 
body of the vertebrae, in the atrium of the heart and around the notochord (n). nt. neural 
tube. (L) Parasagittal section of chick embryo at stage 29 HH. Flrt2 is expressed in the 
vertebral body, and in the mesonephros. Scale bar: 100 µm 




Figure 3.15- Legend on previous page.
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My aim in this part of my PhD was to knock down chicken Flrt2 in order to test 
its potential role in axon guidance. Flrt2, which encodes a glycosylated transmembrane 
protein, was identified as expressed in the posterior sclerotome of mouse embryos after 
a differential microarray screen (Hughes et al., 2009). I confirmed that Flrt2 is also 
expressed in the posterior sclerotome of chicken embryos (see section 3.15), which are 
more accessible for manipulation. In this chapter, I introduce different approaches to 
knocking down gene function in chicken embryos and report how I developed an in ovo 
transfection technique using a commercial transfection reagent, TurboFect (Thermo 
Scientific), as a method for introducing interference RNA (RNAi) constructs into the 
somites for functional knockdown. The results of knocking down Flrt2 using this 
technique are described in Chapter 5. 
 
4.1- In vivo transfection using electroporation 
One approach to knocking down gene function in chicken embryos is to use 
electroporation to introduce antisense morpholino oligonucleotides or RNAi constructs. 
Electroporation involves the application of short electric field pulses across cells that 
permeabilize cell membranes by opening tiny pores in them (Haas et al., 2001). During 
the electric pulse, charged molecules (such as plasmid DNA, double-stranded RNA or 
fluorescently-tagged morpholinos) are actively electrophoresed through the pores, while 
uncharged molecules diffuse through them passively (Haas et al., 2001). The 
introduction of in ovo electroporation was a great achievement, enabling plasmid DNA 
and morpholinos to be introduced into cells in an accessible and cheap embryonic 
model system, the chicken embryo. Flrt2 is expressed within the sclerotome (a 
mesenchymal derivative of the somite), and electroporation of mesenchymal cells is 
technically difficult and not very efficient.  
Two main techniques have been developed for targeting somites by 
electroporation in chicken embryos. It is possible to target presumptive somites at 
primitive streak (gastrulation) stages, by performing the electroporation ex ovo in a 
chamber, targeting the region of epiblast that will form the somites, and using New 
culture to maintain the embryos until somites have formed (Voiculescu et al., 2008) 
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(Figure 4.1). However, it is difficult to culture embryos beyond stage 12 HH in New 
culture (Dr. Octavian Voiculescu, personal communication). 
 
Figure 4.1- Ex ovo electroporation of prospective somites in a chick embryo at 
stage 5 HH. (A) Electroporation of epiblast in the anterior primitive streak of a stage 5 
HH chicken embryo, from which segmental plate mesoderm and somites will form on 
both sides of the embryo. (B) Examples of labelled segmental plate mesoderm and 
somites 24 hours after culturing embryos targeted at stage 5 HH. Figure from Iimura 
and Pourquié (2008).  
 
Professor Christophe Marcelle’s lab (Australian Regeneration Medicine 
Institute, Monash University, Australia) has optimised the targeting of specific somite 
regions by in ovo electroporation, using a technique described by Scaal et al. (2004). In 
summary, this approach uses electrodes carefully positioned in the chick embryo to 
target specific regions of recently formed epithelial-stage somites, since epithelia are 
more efficiently electroporated than mesenchyme (Fig. 4.2). A capillary needle 
containing plasmid DNA is inserted at the level of the pre-somitic mesoderm and 
pushed anteriorly, parallel to the neural tube, up to the level of the somite IV (the fourth 
most recently-formed somite). The plasmid DNA is injected into the central cavity 
(somitocoele) of the epithelial somite, then the capillary is moved backwards to somite 
III where DNA is again injected, and so on until all four recently-formed somites have 
been filled. Electrodes are placed on either side of the embryo in order to target the 
medial or lateral somite (Fig. 4.2a,b), or the anterior or posterior somite (Fig. 4.2c), or 
above and below the embryo in order to target the dorsal or ventral somite (not shown). 
The negatively charged DNA moves towards the positive electrode, so the positioning 
of the electrodes allows specific regions to be targeted.  
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Figure 4.2- In ovo electroporation of somites using the technique of Scaal et al. 
(2004). (a) In ovo somite electroporation of an E2 chick embryo via injection of plasmid 
DNA into the centre of the epithelial somite using a finely drawn capillary tube (dorsal 
view). The electrodes are positioned on each side of the embryo so that the DNA 
(negatively charged) will enter the medial somitic cells, moving in the direction of the 
anode (positive electrode). (b) A transverse view of the DNA migration towards the 
positive electrode into medial somite cells. (c) A lateral view of an embryo in which the 
somite is being electroporated craniocaudally, targeting the posterior part of the somite. 
Figure from Scaal et al. (2004). 
 
 This technique was passed to Professor Philippa Francis-West’s lab (Department 
of Craniofacial Development and Stem Cell Biology, King’s College London), where 
Dr. Mulvaney taught me the technique. Dr. Mulvaney used an Intracel Ovodyne 
electroporator with a foot pedal and two separated electrodes, with a platinum wire for 
the positive electrode and a tungsten wire for the negative electrode, and Ringer’s 
solution with penicillin-streptomycin. The electroporation was done by using five 
square-wave 70V pulses, 20 milliseconds apart. Although this was the best technique 
available at the time, it only has a 30% success rate, and therefore a more efficient 
technique was needed. 
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4.2- Post-transcriptional knock-down approaches 
Knock-down assays allow the function of a particular gene in a system to be 
studied; they are more common in in vitro cell cultures, but in vivo knock-down assays 
enable functional studies of a particular gene in its natural cellular system. Different 
approaches can be adopted in order to knock-down the post-transcriptional expression 
of a gene. One approach is to use morpholino antisense oligonucleotides to block the 
translation or splicing of mRNA for the gene of interest. Morpholinos have the 
advantage that gene function can be restored once the morpholinos have been diluted 
out (Sauka-Spengler and Barembaum, 2008). They are also less toxic and more 
resistant, however they require a specific 30 bp stretch of nucleotides spanning the start 
codon which can cause off-target effects (Bill et al., 2009). They can also be designed 
to be splice-blocking, however. If the same phenotype is obtained using either a 
translation-blocking morpholino or a splice-blocking morpholino against the same 
mRNA, this can be used as evidence of specificity. 
Another approach is RNA interference (RNAi) technology, a naturally occurring 
process in which the presence of short double-stranded RNA results in sequence-
specific post-transcriptional silencing, usually by mRNA degradation. Delivery of short 
interfering RNA (siRNA) in duplex form, or plasmids encoding small hairpin RNAs 
(shRNA) that can be cleaved inside the cell to form siRNA, results in the destruction of 
the mRNA of interest. There are several types of RNAi: short interfering RNA (siRNA), 
short hairpin RNA (shRNA), long double-stranded RNA (dsRNA) or  micro-RNA 
(miRNA) and endoribonuclease-prepared siRNA (esiRNAs) or diced riRNAs (d-
siRNAs) (Buchholz et al. 2006; Wang et al., 2010). A short hairpin RNA (shRNA) is a 
DNA-based siRNA production strategy in which siRNAs are produced intracellularly 
from shRNA transcripts (Fig 4.3 and Fig 4.4). The plasmid or viral vector that encodes 
the shRNA utilizes the H1 or U6 promoter to facilitate shRNA transcription via RNA 
polymerase III (Fig. 4.3).  
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Figure 4.3- Design of DNA oligonucleotides for cloning shRNA in a vector. Once 
transcribed by RNA polymerase III from the U6 or H1 promoter, the result is a short 
hairpin of double-stranded RNA that is cleaved by the endoribonuclease Dicer into 
siRNA. Figure from Chen et al. (2008). 
 
Gene silencing occurs post-transcriptionally in the cytoplasm and it is an ATP-
dependent and translation-independent mechanism (Fig. 4.4) (Chen et al., 2008). In the 
cytoplasm, long dsRNAs or shRNAs are cleaved by the endoribonuclease Dicer into 
short dsRNA duplexes or siRNA. There is an enzymatic way of doing this in vitro 
through digestion of long dsRNA with endoribonucleases by using bacterial RNAse III 
to convert the long dsRNA into 18-25 base-pair (bp) siRNAs, creating a heterogeneous 
population of siRNAs to one target mRNA (Buchholz et al., 2006). The siRNAs are 9-
24 bp dsRNA molecules that have a two-nucleotide 3’-overhang that allows them to be 
recognized by the enzymatic RNAi machinery. siRNA are loaded into the RNA-induced 
silencing complex (RISC) that contains Argonaute 2 (Ago-2). Ago-2 cleaves and 
releases one of the dsRNA strands, resulting in an activated form of RISC with a single-
stranded RNA (guide siRNA) that will recognise the mRNA target through 
complementary base pairing. Ago-2 then cleaves the target mRNA relative to the 5’ end 
of the siRNA antisense strand causing mRNA degradation and gene silencing (Moses et 
al., 2010; Chen et al., 2008) (Fig. 4.4). 
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Figure 4.4- Mechanism of RNA interference (RNAi) by introducing a vector 
encoding shRNA (pink arrow), or by introducing long dsRNA (green arrow) or 
siRNA (yellow arrow). Figure from Chen et al. (2008). 
 
Both of the above methods require a transfection technique such as 
electroporation to introduce morpholinos, shRNA-encoding plasmids, long dsRNA or 
siRNA into embryonic cells. The introduction of expression vectors via electroporation 
can often cause morphological disturbances, mis-regulation of non-targeted genes and 
in young embryos, cell death (Mende et al., 2008). For example, even when targeting a 
protein without endogenous cell function like GFP, the shRNA vector pRFPRNAi (Das 
et al., 2006), caused morphological phenotypes, mis-regulation of non-targeted genes 
and activation of the p53 pathway, especially when primitive streak or early-somite 
stage embryos were targeted (Mende et al., 2008). In contrast, this effect was not seen 
when morpholinos were introduced, suggesting that at least for young (early-somite 
stage and younger) embryos, the electroporation of shRNA vectors may cause non-
specific phenotypes (Mende et al., 2008).  
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The genome-wide effect of electroporating the midbrain of stage 10 HH 
embryos with a GFP-containing plasmid was studied by Farley et al. (2011) using 
microarrays. Passing electric current alone, without introducing any DNA, reproducibly 
affected expression of less than 0.1% of genes on the array. Electric current plus GFP 
reproducibly affected expression of less than 0.5% of genes on the array, but did not 
modify any genes involved in regional identity. When the midbrain was electroporated 
with a plasmid encoding a known transcription factor, Dmrt5, there was a change in the 
expression of 309 genes in comparison to the 111 whose expression changed when GFP 
and current were applied. Overall, the authors concluded that the electroporation 
technique for embryos at least as old as stage 10 HH is valid for the study of gene 
function (Farley et al., 2011), but keeping in mind that current alone affected the 
expression of genes that respond to oxidative stress and pH/redox changes, and genes 
that regulate apoptosis (Farley et al., 2011). Furthermore, the three genes whose 
expression was affected in all experimental conditions (i.e., current alone, and current 
plus any plasmid) encoded a protein involved inRNA processing, metabolism and 
transport (Hnrnpk), a chromatin-remodelling enzyme that regulates transcription (Chd1) 
and a redox sensor (Txnl1) (Farley et al., 2011).  
Introducing siRNA duplexes has been shown to silence target genes efficiently 
in chick embryos, at least after early somite-stages (Rao et al., 2004).  Rao et al. (2004) 
compared the use of long (700 bp) double-stranded RNA (dsRNA), endonuclease-
digested duplexes (esiRNA) and short 21 bp RNA duplexes (siRNA). Electroporation of 
the same amount of construct, 200ng/µl, into the neural tube of chick embryos at stages 
11-13 HH resulted in 53% knock-down efficiency for long dsRNA, 29% efficiency for 
esiRNA and 90% efficiency for siRNA. The siRNA also proved not to cause 
deregulation of house-keeping genes and did not increase cell death (Rao et al., 2004). 
In my study, I used siRNA with the same characteristics as described by Rao et al. 
(2004) to knock down Flrt2 (Chapter 5) and a putative PNA-binding protein, P4Hb 
(Chapter 7), by in ovo transfection using a commercial transfection reagent, TurboFect 
in vivo (Thermo Scientific). This is an alternative technique to electroporation that I 
developed during this project. 
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4.2.1- siRNA design rules 
Software such as RNAi Explorer (Gene Link) and Sfold (Wadsworth) was used 
to predict the location of binding of a siRNA to a specific sequence. However, several 
sequences are given and even though they recommend up to four siRNA per sequence, 
the same results can be obtained by using only one siRNA (Rao et al., 2004; Bron et al., 
2004; Aigner, 2006). In order to select the optimal target sequence it is necessary to 
follow some basic rules to optimise gene knock-down. The siRNA needs to be 21 bp 
long and have a dinucleotide - usually two thymidines, though UU is also used - 
overhanging the 3’ terminus. The siRNA needs to have a low CG content, and cannot 
have more than three nucleotides repeated in a row. It is necessary to avoid structured 
(e.g. helical) regions within the gene target, and to know where important protein family 
domains are encoded and if there are any possible variations to the Kozak consensus 
sequence for translation initiation (Kozak, 1984) that will still enable translation after 
siRNA targeting if the mRNA is not fully degraded. When a good target sequence has 
been selected, the Basic Local Alignment Search Tool (BLAST) from NCBI is used to 
compare the target sequence to the organism’s genome to ensure that it is gene-specific 
and to avoid mis-targeting. The specific siRNA design strategy for each gene used is 
given in the relevant results chapter (Chapter 5 for Flrt2; Chapter 7 for P4Hb). 
 
4.3- Developing an in ovo transfection technique for somites 
 
4.3.1- TurboFect in vivo Transfection Reagent 
 TurboFect in vivo Transfection Reagent (from Fermentas, now Thermo 
Scientific; Catalog # R0541) is a commercially available non-lipid reagent based on a 
cationic polymer, polyalkyleneimine (U.S. patent application US20100041739A1), 
instead of the more traditionally used polyethylenimine (PEI). Polyalkyleneimine is a 
stable, low toxicity compound (currently being used in clinical trials for drug treatment; 
European patent application EP2359835A1). TurboFect forms a positively charged 
complex with DNA, facilitating delivery into cells by endocytosis (Fig. 4.5). Once the 
complex is inside the cell, an osmotic swelling causes endosomal rupture, releasing the 
DNA to the cytoplasm, from where it is translocated to the nucleus (Fig. 4.5).  
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 TurboFect had already been tested in mice by intravenous injection (Fig. 4.6), 
however it had not been tested in chicken embryos. The previous mouse in vivo and in 
vitro tests had shown that the reagent does not cause any inflammatory response, at least 
during the first 24 hours post-transfection (Fig. 4.6) and that it transfects cells without 
any increased toxicity (Thermo Scientific). Therefore, I modified the technique until 
optimal delivery was achieved in chick embryos in ovo. 
 
Figure 4.5- TurboFect mechanism of action. TurboFect forms small, diffusible 
complexes with DNA that are readily endocytosed. Once in the cytosol, rapid osmotic 
swelling causes endosomal rupture allowing translocation to the nucleus. Figure from 
TurboFect transfection reagent manual, Fermentas (now Thermo Scientific). 
 
 
Figure 4.6- No inflammatory response for 24 hours after DNA delivery using 
TurboFect in vivo Transfection Reagent. 50 μg of plasmid DNA was administered to 
female BALB/c mice via intravenous injection using TurboFect in vivo Transfection 
Reagent. The inflammatory response was measured by using ELISA to determine the 
concentration of the proinflammatory cytokine TNFα in blood serum samples at defined 
time-points. (LPS- lipopolysaccharides). Figure from Thermo Scientific website 
(http://www.thermoscientificbio.com/transfection/turbofect-in-vivo-transfection-
reagent/). 
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4.3.2- In ovo transfection of somites  
Targeting the somites with a TurboFect/FITC-siRNA complex was similar to a 
previous method used to target somites for electroporation (Scaal et al., 2004), with 
some modifications. The pulled glass capillary needle containing the solution was 
inserted at the PSM level into the most posterior (newly formed) epithelial somite of 
embryos at stages 9-12 HH and carefully pushed to the most anterior somite or until 
resistance was found from the somite using small wave movements (Fig. 4.7). When 
guiding the needle through the oldest somites (which will already have differentiated 
into dermomyotome and sclerotome), the aim was to inject ventrally and as near to the 
neural tube as possible. Once the most anterior somite was reached, the needle was 
pulled back somite by somite and the solution applied for 5-10 seconds per somite. It 
was possible to observe the somites filling up with solution and the tissue turned 
slightly white and sticky. It is important to note that using this technique, more tissues 
are transfected besides the somites. The approach through the PSM results in the 
transfection of PSM cells, leaking back sometimes to the tailbud (which generates the 
PSM on both sides of the embryo) so the use of the non-transfected side as a control is 
not suitable. Likewise, there might be some leakage of the transfection complex out of 
the somites towards the overlying ectoderm and adjacent neural tube. 
 
Figure 4.7- Schematic representation of sclerotome transfection in ovo. (A) Dorsal 
view of the manipulated region in a day 2 chick embryo (anterior to the top), illustrating 
the injection of several somites (in green) using a pulled glass capillary. The right side 
is the manipulated side. Schematic made by the author. (B) Representation of a 
transfected chick embryo HH 19 in ovo when observed under a fluorescent dissection 
scope. Schematic adapted from an image whose original source is unknown. 
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4.3.3- Optimizing TurboFect for in ovo transfection of somites with siRNA 
I tested the manufacturer’s protocol for use in siRNA transfection of 8 chick 
embryos at stage 12 HH, but did not obtain more than a few transfected cells. However, 
I found that increasing TurboFect to a final concentration of 20% was the best for use 
with siRNA in chick embryos: I then used this on 214 chick embryos: 198 were 
transfected with FITC-labelled scrambled siRNA, while 16 controls were subjected to 
the whole transfection procedure but without including siRNA in the solution. I 
increased the concentration of TurboFect further to 30% in 18 chick embryos at stage 
HH 12, but this did not result in a higher number of transfected cells within somites, and 
increasing the TurboFect concentration made the delivery harder by increasing 
precipitation within the solution.  
Using TurboFect to transfect tissues, rather than electroporation (which drives 
charged molecules across the membrane by electrophoresis; Haas et al., 2001), means 
that the time that the solution remains in the tissue is vital for a good transfection. I 
found that the TurboFect/siRNA complex alone was lost too fast from the somite, not 
giving time for the siRNA/TurboFect complex to be taken inside the cells. The addition 
of 1% glycerol to the TurboFect and siRNA mixture improved the solution retention, 
however in all 31 embryos injected with this solution at stage HH 12, the somite tissue 
was still white even 2 days post-injection. The substitution of 10% glucose for glycerol 
resulted in no more than a few transfected cells in the 33 embryos injected with this 
solution at stage HH 12.   
A commonly used cationic agent for transfection is polyethleneimine (PEI), 
however this has a dose-dependent toxicity (Conese et al., 2009). Polyethylene glycol 
(PEG) has often been used with such cationic delivery agents to reduce toxicity and 
degradation by non-specific proteins (Kunath et al., 2003; Moore et al., 2009; Moore 
and Sakiyama-Elbert, 2012) and is known to increase the half-life of an oligonucleotide 
from 1.07 to 57.8 hours (Yu et al., 1999). PEG has low toxicity, and is being used for 
drug delivery in clinical trials (Bolwell et al., 2000). PEG-based vehicles were also 
shown to be internalized into cells non-specifically by interaction with heparan sulphate 
proteoglycans, either alone or in combination with integrins (Moore et al., 2012). I 
found that adding PEG (CarbowaxTM 6000, Union Carbide) to a final concentration of 
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10% made the siRNA/TurboFect complex heavier, enabling the solution to stay inside 
the somites and ensure that the siRNA/TurboFect complex had time to be assimilated 
by the cells. (Increasing the concentration of PEG concentration to 20% in 8 chick 
embryos reduced the number of cells transfected to the point of almost no detection.)  
I used 10% PEG for in ovo transfection of somites in 198 chick embryos 
injected at different developmental stages. The injection technique in the somite is 
comparable to the one used in electroporation of avian somites (Scaal et al., 2004; Bron 
et al., 2004); however, embryonic malformation and lethality were drastically reduced 
because electric current was not used. From 198 injected embryos only 23 died, and all 
the others had at least 3 transfected somites, giving a transfection success rate of 88.4%. 
182 chick embryos that were transfected at stages ranging from stage HH 8 to 19 were 
incubated until stage HH 22-24. 16 embryos were grown until 5 days after transfection, 
6 of which died on day 4. There were no visible differences between the transfected 
embryos and the non-transfected embryos.  
Once the FITC-siRNA mixture had been injected it was possible to visualize in 
ovo the transfected area and follow it up to 72 hours after transfection. Although the 
signal became faint as the tissue became thicker, there was a strong signal up to 48 
hours post-transfection (Fig. 4.8). Anti-FITC immunostaining on wax sections of 
somite-strips from embryos transfected with FITC-labelled siRNA confirmed that the 
combination of PEG and TurboFect delivered siRNA into the cells (Fig. 4.9). 




Figure 4.8- In ovo views of the same embryo at different time-points after 
transfection with FITC-labelled scrambled siRNA at HH stage 12. Anterior is up in 
all panels. (A) 1 hour post-transfection, it is possible to see that the PSM (asterisk) has 
been transfected. (B-D) Embryo at 16 hours post-transfection. (C) Higher-power view 
of the vagal area of the embryo in B. (D) Higher-power view of the tail of the embryo in 
B. (E) 72 hours post-transfection, the siRNA-FITC probe signal is weaker but still 
detectable. 
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Figure 4.9- Using TurboFect and PEG delivers FITC-siRNA into cells. Somites 
were transfected with scrambled FITC-siRNA and the embryo fixed 48 hours post-
transfection, embedded in paraffin wax and sectioned at 6m. Alexa488-conjugated 
anti-FITC immunostaining labelled the transfected cells, revealing siRNA distribution 
within multiple cells. Panel B shows a higher magnification view of A. 
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4.3.4- Transfection of up to 22 somites in a single embryo 
I found that there was a relationship between embryonic stage and the number of 
somites transfected. It was possible to transfect as many somites as the embryo had 
developed up to a maximum of 22 somites, even if the embryo had developed more 
somites than that (Table 4.1). Embryos injected between stage HH 8- to 9 (3-7 somites) 
had 3-5 transfected somites 48 hours post-injection. These embryos took 12 hours to 
recover, i.e., to start developing at the same rate as a non-transfected embryo, and had a 
higher probability of dying (Table 4.1). Embryos injected between stages HH 10 to 14 
(10-22 somites) had 7-20 transfected somites with a visible in ovo signal 72 hours post-
transfection. In this case, embryos only took 4-6 hours to recover and once they reached 
stage HH 18 they showed no differences with non-transfected embryos. At stage HH 19, 
it was only possible to transfect up to 22 somites, even though the embryo had 37-40 
somites. The thickness of the tissue offers a higher resistance as the blood pressure 
tends to expel the solution faster, not allowing enough time for the solution to penetrate 
more cells, as a consequence, the intensity of the signal is weaker (visual observation). 
From stage HH 19 onward, a localized injection into the sclerotome was better (Fig 
4.10): more care was necessary to avoid penetrating the endoderm, but the solution was 
retained inside the somite. It was also possible to transfect both somite strips of the 
chick embryo through the PSM, however there was a higher possibility of targeting 
more just somites (Fig. 4.11). 
 
 
Figure 4.10- Localised transfection of chick embryo at stage HH 19. (A) Chick 
embryo in ovo, one hour post-transfection with FITC-siRNA. (B) Higher power view of 
transfected region of embryo in A showing overlay of GFP channel and bright field. (C) 
Green channel only, showing transfected somites one hour post-transfection. 
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Table 4.1- Breakdown of the embryonic stage at injection, number of somites at 
injection, number of transfected somites and survival rate of 198 embryos 
transfected with FITC-labelled scrambled siRNA. The number of somites transfected 
per HH stage correlated with the number of somites already formed at the time of 
injection.  
*Note: 16 control embryos injected with transfection solution alone (without siRNA) 









Nº Dead by 
stage HH 22 
% survival 
8- to 9 3-7 3-5 10 3 70.0 
10 10 7 10 1 90.0 
11 13 11 24 1 95.8 
12 16 14 19 1 94.7 
13 19 16 59* 1 98.3 
14 22 20 51 0 100.0 
16 26-28 22 15 0 100.0 




Figure 4.11- Transfection of somites on both sides of the neural tube, presumably 
via transfection of cells in the tailbud, which generates the PSM on both sides. (A) 
Low-power view of chick embryo in ovo at stage 16 HH with somites transfected on 
both sides with scrambled FITC-siRNA. (B) Higher power view of embryo in A. 
Somites from both sides are transfected. On one side all the somites were transfected in 
a row, while on the other only a few somites were transfected. Signal is also detected in 
the limb bud.  
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4.3.5- Optimizing TurboFect for in ovo transfection of somites with DNA 
Using the same siRNA ratio to form a delivery complex with an enhanced green 
fluorescent protein (EGFP) expression vector (pCAβ-EGFPm5; Bron et al., 2007), I 
was able to transfect somites in ovo in 25 chick embryos between stages 10 and 12 HH 
(Fig. 4.12). The delivery of plasmid DNA into the somite required more TurboFect than 
for siRNA delivery, however, probably due to the plasmid size (2.5 kb) and its cell 
membrane internalization. By keeping the PEG concentration the same (10%) and 
increasing the TurboFect concentration to 40%, it was possible to transfect somites (Fig. 
4.12). It was necessary to wait 6-8 hours for sufficient GFP to build up before the 
targeted area could be visualized. GFP-targeted cells could be followed using a UV 
light under a dissecting microscope for up to 72 hours after transfection.  
 
Figure 4.12- In ovo transfection of somites with an EGFP expression vector using 
TurboFect. (A) Transverse section of an embryo collected 16 hours post-transfection. 
(B) Same section as in A, showing GFP expression in the somite on the targeted side. 
 
4.3.6- Transfected embryos developed normally 
 The transfected embryos developed normally; however some morphological 
changes could have been induced, so I treated 40 FITC-siRNA-transfected embryos and 
6 plasmid (GFP)-transfected embryos with rhodamine-conjugated PNA and immuno-
stained them for neurofilament (NF-M) (Fig. 4.13). No abnormalities were found on 
sections of the transfected embryos (Fig. 4.13A-I). Anti-caspase3 immunostaining on 5 
transfected embryos did not reveal any increase in cell death (Fig. 4.13I); I assumed 
necrosis was not occurring since the embryo was able to develop normally. 
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Figure 4.13- Embryos transfected with FITC-labelled scrambled siRNA develop 
normally. (A-D) Transverse section of a HH stage 22 chick embryo. (E-H) 
Longitudinal section of a HH stage 22 chick embryo. (A,E) Rhodamine-PNA labelling. 
(B,F) Anti-neurofilament (NF-M) immunostaining. (C,G) FITC-siRNA transfection. 
(D,H) Composite of the rhodamine-PNA, anti-neurofilament and siRNA transfection in 
the same section. (I) Caspase3 immunostaining in the same section as E-H. 
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4.3.7- Using TurboFect allowed the voltage to be reduced when 
electroporating the neural tube with DNA 
For successful in ovo neural tube transfection with plasmid DNA at stages 9-16 
HH (Fig. 4.14), it was necessary to combine TurboFect with electroporation, which 
opens pores in the cell membrane and electrophoreses DNA through the pores (Haas et 
al., 2001). But still, by combining electroporation with TurboFect (using the same 
siRNA ratio to form the plasmid delivery complex) it was only necessary to use 5V 
pulses, significantly lower than the 10-30V range usually used for neural tube 
electroporation (e.g. Rao et al., 2004; Itasaki et al., 1999).  
 
4.4- Conclusion  
 In ovo electroporation is a well-established method to introduce genetic material 
into embryonic chicken cells and tissue, and despite various limitations regarding tissue 
targeting and reproducibility there have been no better alternatives. I have developed a 
new in ovo transfection method that can be used to efficiently introduce siRNA or 
plasmids into the somites (and that can be used to transfect the neural tube in 
combination with electroporation pulses at reduced voltage). Employing a combination 
of polyethylene glycol (PEG) and a commercially available transfection reagent 
(TurboFect in vivo Transfection Reagent, Thermo Scientific), I was able to transfect 
somites with a success rate of 88%. Cells could be followed in ovo up to 72h post-
transfection, and embryos survived for up to five days without any apparent 
morphological malformation. Further, neurofilament labelling and cell death analysis 
revealed no difference between transfected and control embryos.  
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Figure 4.14- In ovo tranfection of neural tube with DNA by combining TurboFect 
with 5V electroporation pulses.  (A) In ovo view of neural tube (nt), 12 hours after 
transfection with a GFP expression plasmid at stage 10 HH. s, somites. (B,C) 
Longitudinal sections of an embryo collected 12 hours after the neural tube was 
transfected at HH stage 20. GFP is visible in the dorsal neural tube. (D) Transverse 
section of a transfected embryo: GFP is expressed in the hindbrain. (E.F) Transverse 
sections through the trunk showing transfected cells in the neural tube. 
  
 
CHAPTER 5- ASSESSMENT OF FLRT2 KNOCKDOWN 









The Flrt family of glycosylated membrane proteins has three members, Flrt1, 
Flrt2, and Flrt3, each with conserved fibronectin type III (FNIII) domains that mediate 
binding to the Ig-domain of FGF receptors (Karaulanov et al., 2006). The conserved 
leucine-rich repeats (LRR) and the transmembrane (TM) domains are required for cell 
adhesion and cell recognition (Lacy et al., 1999). The Flrt genes are expressed in many 
of the same tissues where FGF signalling has an important role, and can themselves be 
induced by FGF2 (Haines et al., 2006). Flrt1 is expressed in dorsal root ganglia, 
trigeminal ganglia and facioacoustic ganglia, the midbrain/hindbrain and 
forebrain/midbrain boundaries and the eye (Haines et al., 2006). Flrt3 is expressed in 
the hindbrain and forebrain, eye, heart epithelium and at the edges of the 
dermomyotome (Haines et al., 2006), and was shown to be necessary for cell adhesion 
as knockout led to embryo lethality at 10.5 dpc with defects in head fold fusion, ventral 
closure and endoderm migration (Maretto et al., 2008). Flrt2 is expressed in the 
posterior half-sclerotome, cephalic mesoderm, head mesoderm and epithelia of the body 
wall in mouse (Haines et al., 2006). Flrt2 was selected for study as it was identified in 
the posterior half-sclerotome in the mouse microarray screen of Hughes et al. (2009), 
and shed ectodomains of Flrt2 (and Flrt3) repel Unc5D-expressing axons and neurons 
(Yamagishi et al., 2011). Hence, Flrt2 could repel axons in the posterior half-
sclerotome. As described in section 3.14, I confirmed that Flrt2 is expressed in the 
posterior half-sclerotome of chicken embryos and selected this gene for functional 
knockdown using the transfection technique that I developed during this project, 
described in Chapter 4. In this chapter, I describe the effects on embryo development 
and axon guidance of introducing FITC-labelled siRNAs against Flrt2 into the 
developing somites.  
Also, as mentioned above, Flrts bind FGF receptors and their expression can be 
induced by FGF signalling (Haines et al., 2006; Karaulanov et al., 2006). There are four 
members of the FGF receptor family: Fgfr1-4. All three Flrt proteins bind to Fgfr1 
(Böttcher et al., 2004; Haines et al., 2006). Flrt2 (Wei et al., 2011) and Flrt3 can also 
bind to Fgfr2 (Egea et al., 2008). Also, Flrt2 knockdown in vitro reduces both Fgfr2 
mRNA and Fgfr2 protein expression, while Flrt2 overexpression upregulates Fgfr2 




Fgfr2 are expressed in the neural tube, midbrain and hindbrain and Fgfr1 and Fgfr3 are 
expressed in the somites (Walshe and Mason, 2000). Mouse Fgfr4 is expressed mainly 
at later developmental stages in the liver, kidney and lung (Korhonen et al., 1992), 
while chicken Fgfr4 (FREK) is expressed by proliferating myotome progenitor cells 
from stage 19 HH and plays a role in myotome proliferation and distribution (Kahane et 
al., 2001). To test whether knocking down Flrt2 has any effect on Flrt3 or Fgfr 
expression, I also used antibody staining to study the expression of Flrt3 and Fgfr1-3 
after transfecting Flrt2 siRNA into the somites. 
  
5.2- Flrt2 siRNA design 
Flrt2 is composed of leucine rich repeats (LRR), a type III fibronectin (FNIII) 
domain, a transmembrane domain, and a short intracellular tail (Lacy et al., 1999). The 
leucine rich repeats stretch from 104-198 bp and 928-1080 bp of the cDNA; and the 
FNIII domain from 1283-1522 bp (all identified using the conserved domains tool from 
NCBI (http://www.ncbi.nlm.nih.gov/cdd). Besides its Kozak consensus sequence for 
the initiation of translation at the 5’ proximal ATG codon (Kozak, 1984), Flrt2 also has 
two other possible internal Kozak sequences (Kozak, 1986), one from 1034-1046 bp: 
TCCGAGGTATGGGC, and the other from 1065-1073 bp: GAATATGC (Kozak, 
1986). So in order to knock down Flrt2 not only the conserved protein family domains, 
but also the internal Kozak sequences should not be available for the initiation of 
translation within any cleaved mRNA that escaped degradation.  
The siRNA target sequences were designed following the rules described in 
section 4.2.1 and synthesized with the same parameters as in Rao et al. (2004). Using 
GeneLink siRNA software, a 23 bp siRNA was chosen starting at 36 bp of the Flrt2 
cDNA sequence: TCTGTTCTCATGAAATCATGGCT. Using Software for Statistical 
Folding of Nucleic Acids and Studies of Regulatory RNAs (Sfold; Ding and Lawrence, 
2003; Ding et al., 2005), a second siRNA was chosen starting from 1052 bp of the 
cDNA: GGGAGCTTAATATGAATATG. A scrambled siRNA sequence was 
synthesised from the second siRNA sequence as a negative control. The efficiency of 
the knockdown was assessed by in situ hybridization using a single-stranded antisense 




sequence (Figure 4.8). The RNA probe sequence was submitted to NCBI BLAST for 
sequence alignment to the chicken genome and it only detected Flrt2.  
 
 
Figure 5.1- Schematic showing Flrt2 protein structure and relative position of 
siRNAs and antisense RNA probe. The first siRNA was strategically designed to 
target the translation start site, and the second siRNA to target an internal Kozak 
sequence, to avoid any possibility of translation from any mRNA fragments remaining 
after cleavage. A single-stranded antisense RNA probe was used for in situ 
hybridization to assess the impact of siRNA-mediated knockdown. 
 
Flrt2 knockdown was done by transfecting somites on the right side of chick 
embryos at stages 10-14 HH (using the TurboFect-PEG complex, as described in 
Chapter 4) with both siRNAs simultaneously, aiming to target as many somites as 
possible, a maximum of 22 somites (see section 4.3.4); due to the injection method the 
PSM was also transfected, resulting in a higher number of transfected somites, up to 22. 
As a control, I used a scrambled siRNAs transfected in the same way, at the same 
developmental stage and aiming to target the same number of somites. As described in 
Chapter 4, introduction of scrambled siRNA into chick somites had no effect on 
development. Embryos were incubated until stage 24 HH, visualised using a dissecting 
microscope and any changes in phenotype recorded.  
To study knockdown efficiency in whole embryos, in situ hybridization is 
normally used to assess changes in mRNA expression, while whole-mount antibody 
staining is used to assess effects on protein levels. As there are no commercially 
available antibodies that can detect Flrt2 protein in chick, the only method that could be 





Figure 5.2- Flrt2 expression in an uninjected embryo and in a Flrt2 siRNA targeted 
embryos. Whole mount in situ hybridization for Flrt2. (A) Wild type chick embryo at 
stage 21 HH. (B) Higher magnification view of embryo in A: Flrt2 is expressed in the 
posterior half sclerotome (p). (C) Transfected chick embryo at stage 22 HH, Flrt2 
expression is reduced in targeted somites (thoracic), while abnormal Flrt2 expression is 
seen in other somites (black arrow). (D) Higher magnification view of the embryo in C., 
Flrt2 expression is drastically reduced in some sclerotomes (asterisk) and abnormal in 
others (arrows). (E) Higher magnification view of the tail of the embryo in C, Flrt2 is 
reduced in the trunk and undetectable from the leg bud down to the tail (asterisk). (F) 
High magnification view of a transfected chick embryo at stage 22 HH. Flrt2 is 
irregularly expressed within the sclerotome. (G) A transfected chick embryo at stage 19 
HH, Flrt2 expression is weak throughout the embryo. All images show embryos 
positioned in the same orientation as the embryo in A. 
 
As can be seen in Fig. 5.2, Flrt2 expression was reduced in the targeted somites 
of Flrt2 siRNA-transfected embryos (Fig. 5.2C-G) versus untransfected embryos (Fig. 




performed on 10 chick embryos at stage 22 HH. Out of these 10 transfected embryos, 
seven (70%) had at least three of the targeted sclerotomes without visible Flrt2 signal 
(Fig. 5.2C-G). If this was a representative proportion, then 82 of the 117 transfected 
embryos should have had reduced Flrt2 expression in some of the targeted sclerotomes. 
At the time of injection, the embryos had between 10 and 27 somites, however, 
according to Fig. 5.2 it looks like more somites were affected than those that had 
formed at the time of injection, suggesting that somites in formation in the presomitic 
mesoderm (PSM) were also transfected. In this study, in situ hybridization followed by 
immunolocalisation of the labelled siRNA-FITC was not done in order to prove that the 
somites with Flrt2 expression reduction were indeed transfected. It would be beneficial 
to confirm the presence of the FITC-labelled siRNA in the sclerotomes where Flrt2 
expression was reduced. However, there is a degree of confidence, since all the 
transfected embryos were observed in ovo under UV light using a dissecting microscope 
to confirm the presence of FITC-siRNA, which could be observed even 72 hours post-
transfection, as described in section 4.3.3. 
 
5.3- Phenotypic alterations in Flrt2 siRNA-transfected embryos 
Transfected embryos were observed 18 and 42 hours after transfection, and 
phenotypic modifications were recorded (Table 5.1). The same procedure was used for 
embryos transfected with scrambled siRNA and there were no obvious effects on these 
embryos when compared to non-transfected embryos (Fig. 5.3A; also see section 4.3.6). 
Phenotypic observations from the 117 Flrt2 siRNA-transfected embryos (Table 5.1) 
were collected during the same time period as the observations on the 40 scrambled 
siRNA-transfected embryos which developed normally (Fig. 5.3A; section 4.3.6). Note 
that individual embryos may exhibit more than one abnormality (e.g. Fig. 5.3B). 
One day after transfection of Flrt2-siRNA into developing chick somites it was 
possible to see observe some phenotypes relating to blood supply to the embryo body 
and the extra-embryonic blood vessels (not photographed), which appeared thin and 
fragile, suggesting that vasculogenesis and angiogenesis might have been affected. The 
vitelline arteries were abnormally displayed (compare Fig. 5.3A and B); instead of 




embryos they were asymmetrically displayed, where the right vitelline artery was 
connected directly to the heart (Fig 5.3B). Hence, it is possible that Flrt2 may be 
required for the correct development of blood vessels. 
In order to assess further the impact of Flrt2 siRNA transfection, embryos were 
allowed to grow for longer, however only 5 out of 18 transfected embryos survived to 
E6.0 (stage 28-29 HH). The abnormalities recorded for these 5 embryos are listed in 
Table 5.2. As described in section 3.14, Flrt2 is expressed at later stages of 
development in the neural arch and vertebral body. Alcian Blue staining for cartilage 
suggested that Flrt2 siRNA transfection had an impact on vertebral body formation 
(Fig. 5.4), as these were abnormally bent at the tail level (Fig. 5.4), however it would be 
necessary to repeat this in order to confirm this as a true phenotype. The Alcian blue 
staining also appeared stronger than in scrambled siRNA-transfected embryos, however 
it is possible that this difference might be due to the difference on developmental stages 
between scrambled and Flrt2 siRNA-transfected embryos. Xu et al. (2011) reported that 
reducing Flrt2 expression results in a thicker chondrocyte matrix due to increased cell-
cell interaction, visible by Alcian blue staining. However, to assess if chondrocyte 
matrix becomes thicker in chick embryos after Flrt2 siRNA transfection it would be 
necessary to repeat the Alcian Blue staining with embryos of the same developmental 
stage and also with micromass culture. 
 
 
Figure 5.3- Example of a control (scrambled) siRNA-transfected embryo and a 
Flrt2 siRNA-transfected embryo. Embryos photographed in ovo at 18 hours post-
transfection, which should be stage 18 HH. (A) Scrambled siRNA-transfected chick 
embryo developed normally according to Hamburger and Hamilton (1951). (B) Flrt2 
siRNA-transfected chick embryo had a mislocalized vitelline artery (arrow), an 




Table 5.1- Visible changes in phenotype of 117 Flrt2 siRNA-transfected embryos 
up to 42 hours post-transfection (embryos collected at stages 22 to 24 HH). 
Visible phenotypic modifications % embryos No embryos 
Blood supply (low irrigation, embryo colour) 44.4 52 
 Mislocalized vitelline artery  44.4 52 
Heart formation (increased size) 51.2 60 
Heart beat (increased number of beats) 44.4 52 
Head formation (more rounded) 17.1 20 
No. embryos that died by 18 hours post-
transfection 
5.9 7 






Table 5.2- Visible phenotypic alterations in five Flrt2 siRNA-transfected embryos 
that survived until E6 (stage 28-29 HH). 
Visible phenotypic modifications % embryos  No embryos 
Poor blood supply and coagulation 60 3 
Head formation (more rounded) 40 2 
Movement (increased) 100 5 
Heart (high rhythm) 40 2 
Limb formation (higher to the vertebral body) 40 2 
Embryo position within the egg (not turned) 100 5 
Extra-embryonic angiogenesis (coagulation) 60 3 







Figure 5.4- Alcian Blue staining of cartilage in a scrambled siRNA-transfected 
chick embryo (stage 30 HH) and a Flrt2 siRNA-transfected embryo (stage 29 HH). 
(A) Low-power view of both skeletons. (B,C) Dorsal view of trunk and tail region of 
(B) scrambled siRNA-transfected embryo and (C) Flrt2 siRNA-transfected embryo. 
The Flrt2 siRNA-transfected embryo has a mild deformity in the tail (asterisk). (D,E) 
Dorsal view of cervical vertebrae of (D) scrambled siRNA-transfected embryo and (E) 
Flrt2 siRNA-transfected embryo. (F) Lumbar vertebrae of scrambled siRNA- 
transfected embryo. (G) Lumbar vertebrae of Flrt2 siRNA-transfected embryo. (H) 
Lumbar and tail vertebrae of Flrt2 siRNA-transfected embryo. The tail vertebrae are 





Müller et al. (2011) used an Flrt2-null mouse mutant to show that Flrt2 (which 
is expressed in cardiomyocytes and the epicardium) plays an essential role in heart 
morphogenesis. The Flrt2 siRNA-transfected chick embryos also displayed heart 
phenotypes. Around 40% of transfected embryos had a faster heart beat than controls, 
while half had enlarged hearts (Table 5.2). Of the 13 out of 18 embryos that died before 
reaching stage 29 HH, it could be speculated that most died due to heart defects, as 
happens with Flrt2-null mice, which do not survive beyond day 12 due to cardiac 
insufficiency (Müller et al., 2011). Hearts of transfected chick embryos appeared 
around 40% bigger than controls, which may be consistent with the dilated heart 
phenotype reported by Müller et al. (2011) in Flrt2-null mouse embryos.  
Flrt2 knockdown embryos exhibited a constant modification of blood supply, 
through stage 22-24 HH (Table 5.1) to stage 28-29 HH (Table 5.2). Poor blood supply 
to the heart may also have contributed to early death, as the extra-embryonic blood 
vessels were much thinner than controls and embryo coloration was generally lighter (in 
some cases almost white). A similar phenotype was obtained after Netrin-1 
overexpression in chick embryos (Bouvrée et al., 2008) and on Unc5B stimulation in 
mice (Larrivée et al., 2007). Of particular note is that in the mouse Flrt family, Flrt3 
binds to Unc5B, while Flrt2 binds to Unc5D (Yamagishi et al., 2011). It has also been 
proposed that Flrt2/3 ectodomains can be shed to act at a distance (Yamagishi et al., 
2011), thus knockdown of Flrt2 may also affect Flrt3 signalling. 
As can be seen in Table 5.2, Flrt2 siRNA-transfected embryos surviving to E6.0 
presented with a high number of abnormalities. The most obvious differences were that 
transfected embryos were around 30% larger and displayed excessive sharp rapid 
movements from day 4 when compared with non-transfected embryos, and abnormal 
blood irrigation through the body. It is possible that Flrt2 knockdown causes blood 
vessels to become fragile and rupture with increase blood flow and pressure during 
development, leading to haemorrhage and embryo death, explaining the increase of 
embryo death after stage 24 HH. These embryos were terminated at stage 29 HH (E6.0) 





5.4- Alterations in axonal migration after Flrt2 siRNA transfection 
 Flrt2 was selected for knockdown because of its expression in the posterior half-
sclerotome and its potential role here in axon guidance, especially given the report by 
Yamagashi et al. (2011) that in vitro, Flrt2 together with Flrt3 acts as a chemorepellent 
for Unc5D-expressing cortical neurons, resulting in growth cone collapse and 
modulating cortical neuron migration. My main aim in using siRNA transfection of 
somites to knock down Flrt2 was to investigate whether Flrt2 has a role in repelling 
axons from the posterior half-sclerotome. As reported in section 3.14, Flrt2 is also 
expressed in the myotome, and transiently around the neural tube and notochord. 
 In order to assess any effect of Flrt2 siRNA transfection on axon guidance and 
somite patterning, I used anti-neurofilament immunostaining to label axons, and 
rhodamine-conjugated PNA treatment to label the posterior sclerotome. Control 
scrambled FITC siRNA-chick embryos transfected at stage 9-12 HH and collected at 
stage 20 HH displayed no abnormalities in axonal guidance or somite patterning (Fig 
5.5).  
 The impact of Flrt2 siRNA transfection was assessed in the same way on chick 
embryos transfected at stage 9-12 HH and collected at stage 17 HH (18 hours post-
transfection) (Fig. 5.6). The transfection affected a large number of somites, and the 
FITC-conjugated siRNA was visible on more somites than had formed at the time of 
transfection: 27 somites, corresponding to the vagal and thoracic area, however FITC-
siRNA was present on the trunk and tail (Fig. 5.6A,B), indicating that the PSM had also 
been transfected.  
 Flrt2 siRNA-transfected embryos presented some defasciculation at stage 19 
HH, with axons expanding into the posterior sclerotome (Fig 5.6C,D,F). The total 
number of somites did not change but they were misaligned (Fig. 5.6C,E,F) and 
variable in size, with very small somites next to somites of normal size (Fig 5.6E,F). 
The smaller somites did not present any segmentation of axons, and there was only 
some neurofilament staining present. The adjacent somites exhibited segmentation but 
there were also spots of neurofilament expression in the posterior half-sclerotome (Fig. 
5.6F, arrows), which could represent mis-targeted axon bundles in cross-section and/or 





Figure 5.5- Transfection of a scrambled FITC-siRNA does not affect spinal axon 
patterning. Anti-neurofilament immunostaining (for axons) and rhodamine-PNA 
staining (for neural tube and posterior half sclerotome) of scrambled siRNA transfected 
chick embryos collected at stage 20 HH. (A-D) Transverse section of an anterior half-
sclerotome. (A) Rhodamine-PNA staining (red). The lumen of the neural tube is PNA-
positive. (B) Anti-neurofilament immunostaining for sensory and motor axons (white). 
(C) FITC-siRNA (green) shows transfected sclerotome is on the left side in this view. 
(D) Merge of panels A-C. (E-J) Longitudinal sections. (E) Anti-neurofilament 
immunostaining: axons display a segmented pattern, traversing the anterior half-




posterior half-sclerotomes and neural tube lumen of same section as E). (G) Anti-
neurofilament immunostaining showing sensory and motor axons in the anterior 
sclerotome. (H) High magnification view of sensory and motor axon bundles in the 
anterior sclerotome. (I) Combined PNA and anti-neurofilament immunostaining: PNA 
is strictly in the posterior half-sclerotome while all axons are in the anterior half-
sclerotome. (J) Junction of sensory and motor axons in the vagal area. 
 
Figure 5.6- Transfection of Flrt2 siRNA leads to defects in somitogenesis and axon 
patterning. (A) Chick embryo at stage 19 HH, 18 hours post-transfection: the green 
staining shows the FITC-siRNA transfected somites. (B) Higher magnification view of 
embryo in A showing that, the somites on the right side of the embryo were successfully 
transfected with FITC-siRNA. (C) Longitudinal section of an Flrt2 siRNA-transfected 
embryo, immunostained for neurofilament. Axons still exhibit a segmented pattern; 
however there is a change in the somite alignment (dashed lines). (D) Higher 
magnification view of the misaligned region of the section in C shows that the axon 
bundles are defasciculated, with multiple axons sprouting from the main bundle. (E) 
Longitudinal section of a transfected chick embryo showing that the somites have 
different sizes. Limits are drawn with alternating white and black lines according to the 
dermomyotome. (F) Longitudinal section showing neurofilament staining in the 




 More severe phenotypes were seen in Flrt2 siRNA-transfected chick embryos 
collected for analysis 41-43 hours post-transfection, at stages 22-24 HH (Fig. 5.7). Anti-
neurofilament immunostaining of 21 transfected embryos showed longitudinal branches 
from the main axonal bundle and axons going to the posterior sclerotome (Fig. 5.7A-D), 
although axons still displayed segmentation. Ten of the 21 embryos also displayed 
axons sprouting into the dermomyotome and posterior sclerotome (Fig. 5.7E-H). An 
even more severe effect was seen in five of the 21 embryos (Fig. 5.8 and Fig. 5.9), in 
which there were multiple spots of neurofilament expression within the posterior 
sclerotome (which could represent cross-sections of longitudinally-projecting axon 
bundles in cross-section, and/or mis-placed neural crest-derived DRG neurons) and also 
neural tube defects (Fig. 5.9), In contrast, as described in section 4.3.6, 40 of 198 
scrambled siRNA-transfected embryos at stages 19, 22 and 24 HH were immunostained 
for neurofilament and stained with rhodamine-conjugated PNA and that there was no 







Figure 5.7- (On next page) Flrt2 knockdown leads to abnormal axon growth into 
the posterior half-sclerotome and dermomyotome/myotome. Anti-neurofilament 
immunostaining of Flrt2 siRNA-transfected embryos collected at stage 22 HH. (A-D) 
Lateral views of axons growing aberrantly in the transfected area towards the posterior 
half-sclerotome (arrows). (E) Transverse section showing defasciculation towards the 
dermomyotome, which is also abnormal (arrows). (F) Higher magnification view of E 
showing the sensory and motor axon junction and axons defasciculating towards the 
dermomyotome (arrow). (G) Longitudinal section showing that axons are present in the 
myotome (arrows) and in the posterior half-sclerotome. (H) Transverse section showing 
multiple axons migrating towards the dermomyotome. There are also multiple axons in 
the mid-line of the neural tube; notochord and dermomyotome morphology are also 










Figure 5.8- Continued abnormal axon growth and somite defects in Flrt2 siRNA-
transfected embryos collected at stage 24 HH. (A) Coronal section in bright field, 
showing variation in somite size. (B) The same section as in A, immunostained for 
neurofilament. Spots of neurofilament expression are scattered through both somite 
halves (arrow) while axonal segmentation is still present in the non-transfected control 
side. (C) Neurofilament immunostaining of a longitudinal section shows axonal bundles 
in the anterior half-sclerotome as normal but also spots of neurofilament scattered 
through the posterior sclerotome (arrow). (D) Coronal section showing abnormal neural 
tube morphology, with axons crossing through the lumen of the neural tube (box), and 
spots of neurofilament expression in the posterior half-sclerotome on both sides. (E-G) 
Transverse sections showing spots of neurofilament expression scattered through 
somite-derived tissues, and axons at all levels of the neural tube. Panel F shows some 
axons in the medial neural tube. The morphology of the notochord also seems disrupted 





Figure 5.9- Neural tube defects in an Flrt2 siRNA-transfected embryo collected at 
stage 24 HH. Serial transverse sections in a posterior-anterior sequence show axons 
from the dorsal neural tube (red arrows) migrating ventrally and then medially to form a 
physically separated neural tube with up to five lumens (*). Axons also migrate 
laterally, towards the deformed dermomyotome (green arrows). As the neural tube 
divides, forming new attached neural tubes, the notochord and dermomyotome keep 
changing their morphology. In the last section, the multiple neural tubes appear to erupt 




5.5- Flrt2 siRNA transfection has no effect on somite polarity 
 Somites have a distinct anteroposterior polarity and it may be that Flrt2 
knockdown disturbs the establishment or maintenance of somite polarity. In order to 
test this, I used whole-mount in situ hybridization to examine the expression of 
Uncx4.1, a posterior half-sclerotome marker (Schrägle et al., 2004) and Tbx18, an 
anterior half-sclerotome marker (Haenig and Kispert, 2004) (also see section 3.2), in 
Flrt2 siRNA-transfected chick embryos collected between stages 19 and 22 HH (Fig. 
5.10). These markers were studied in four transfected chicken embryos for each probe, 
and in all of them there was no visible modification to their expression when compared 
with the same number of scrambled siRNA-transfected embryos. Although the chick 
embryos were not all at the same developmental stage, the polarity was constant 
through development. If there had been a change, it would be expected to be present at 
any stage post-transfection. Nevertheless, it would have been beneficial to have tested 
more transfected embryos for the expression of the polarity markers. 
 
5.6- Flrt2 siRNA transfection has little or no clear effect on FGF receptor 
expression 
 All three Flrt family members bind to Fgf receptors (Haines et al., 2006). Flrt2 
interacts with Fgfr1 (Haines et al., 2006) and Fgfr2 (Wei et al., 2011). Furthermore, 
cells transfected with Flrt2 shRNA show reduced expression of Fgfr2 mRNA and Fgfr2 
protein, while cells transfected with Flrt2 cDNA show increased expression, suggesting 
that Flrt2 promotes Fgfr2 expression (Wei et al., 2011). Given the decrease of Flrt2 
mRNA expression in Flrt2 siRNA-transfected chick embryos, I investigated if there 
was any impact on Fgf receptor expression, by immunostaining three Flrt2 siRNA-
transfected embryos each for Fgfr1, Fgfr2 and Fgfr3, and scrambled siRNA-transfected 
embryos as a control. Fgfr4 expression was not studied, since there was no evidence in 
the literature for Flrt interaction with Fgfr4, and Fgfr4 has already been characterized as 
required for myotome progenitor cell proliferation and migration (Kahane et al., 2001).  
 Fgfr1 expression did not differ much between scrambled siRNA-transfected 
embryos (Fig. 5.11A,B) and Flrt2 siRNA-transfected embryos (Fig. 5.11C-E). In a 




and posterior sclerotome (Fig. 5.11A,B). Transverse sections of Fgfr1-immunostained 
embryos after Flrt2 siRNA transfection did not show a clear difference (compare Fig. 
5.11B and D), however the coronal sections (Fig. 5.11A,C,E) showed Fgfr1 expression 
in the myotome in an Flrt2 siRNA-transfected embryo that had abnormal axon bundles 
in somites on the transfected side and spots of neurofilament staining throughout the 
somites on the non-transfected side, as well as abnormal neural tube closure (Fig 5.11F, 
G). Further experiments and analysis of more embryos would be needed to verify this as 
a real phenotype. 
 
Figure 5.10- Flrt2 knock-down does not affect somite polarity. (A)- Tbx18 
expression chick embryo stage 19 HH, Tbx18 is expressed segmentally in the anterior 
half sclerotome. (B)- Tbx18 expression on Flrt2 knockdown chick embryo stage 18 HH, 
Tbx18 is expressed remains expressed in the anterior half-sclerotome. (C)- Uncx4.1 
expression in a chick embryo stage 20 HH, Uncx4.1 is expressed segmentally in the 
posterior half-sclerotome. (D)- Uncx4.1 expression in a Flrt2 knock-down embryo stage 





Figure 5.11- Fgfr1 expression is not significantly affected by Flrt2 siRNA 
transfection. (A,B) Coronal (A) and transverse (B) sections at stage 22 HH after 
scrambled siRNA transfection. Fgfr1 is expressed in the ectoderm, posterior half-
sclerotome (P) and dermomyotome. (C) Coronal section of an Flrt2 siRNA-transfected 
embryo collected at stage 22 HH. Fgfr1 is expressed in the dermomyotome and also the 
myotome. (D) Transverse section of an Flrt2 siRNA-transfected embryo collected at 
stage 24 HH. Fgfr1 is expressed in the ectoderm, dermomyotome (derm) and 
sclerotome. (E) Coronal section of an Flrt2 siRNA-transfected embryo collected at 
stage 24 HH. Fgfr1 expression is reduced in several consecutive somites adjacent to an 
open region of neural tube (nt). (F) Rhodamine-PNA staining (red) plus anti-
neurofilament (blue) and anti-FITC (green) immunostaining of embryo in E shows 
transfection of somites with FITC-siRNA. (G) Higher-power view of neurofilament 
expression in the boxed region in F. Axons are spread through several of the transfected 
somites (arrows) while on the opposite side there are spots of neurofilament expression 




 Fgfr2 expression in Flrt2 siRNA-transfected embryos was unchanged when 
compared to a scrambled siRNA-transfected embryo. In both, Fgfr2 was expressed in 
the ectoderm, dermomyotome and posterior half-sclerotome (compare panels A,B in 
Fig. 5.12 with C,D). Similarly, Fgfr3 expression did not appear to vary much: in 
scrambled siRNA-transfected embryos (Fig. 5.13A,B) versus Flrt2 siRNA-transfected 
embryos (Fig. 5.13C,D); in both, Fgfr3 was expressed in the ectoderm, dermomyotome 
and sclerotome. In Flrt2 siRNA-transfected embryos, it appeared that Fgfr3 was 
overexpressed (compare Fig 5.13A,B with C,D), but further assays and more embryos 
would have to be assessed to verify this. 
 
 
Figure 5.12- Fgfr2 expression is unaffected by Flrt2 siRNA transfection. (A,B) 
Coronal (A) and transverse (B) sections at stage 24 HH after scrambled siRNA 
transfection. Fgfr2 is expressed in the posterior half sclerotome (P), ectoderm, 
dermomyotome and neural tube (nt). (C) Coronal section of an Flrt2 siRNA-transfected 
embryo at stage 24 HH Fgfr2 is expressed in the posterior half-sclerotome and 
ectoderm. (D) Transverse section of an Flrt2 siRNA-transfected embryo at stage 24 
HH. Fgfr2 is expressed in the ectoderm, dermomyotome and sclerotome (arrow). (P)- 





Figure 5.13- Fgfr3 expression in control and Flrt2 siRNA-transfected embryos. 
(A,B) Transverse sections of a scrambled siRNA-transfected embryo at stage 24 HH. 
Fgfr3 is expressed in the ectoderm and sclerotome. (C) Fgfr3 expression in a Flrt2 
siRNA-transfected chick embryo at stage 24 HH. Fgfr3 is expressed in the ectoderm, 
dermomyotome and posterior half-sclerotome. (D) Fgfr3 expression in Flrt2 siRNA a 
transfected chick embryo stage 24 HH. Fgfr3 is expressed in the ectoderm, 
dermomyotome and dorsal anterior half-sclerotome (identified by presence of DRG). 
Scale bar: 100 µm. 
 
5.7- Transfection of Flrt2 siRNA into somites disrupts Flrt3 expression 
 Flrt2 and Flrt3 show different expression patterns in mouse somites (Flrt2 in the 
posterior sclerotome and Flrt3 in the dorsal and ventral lips of the dermomyotome; 
Haines et al., 2006), but they are co-expressed in some regions during craniofacial 
development (Gong et al., 2009). Furthermore, mice lacking Flrt3 exhibited 




2008). Given abnormal neural tube closure in Flrt2 siRNA-transfected embryos, I 
investigated effects on Flrt3 expression by immunostaining 5 Flrt2 siRNA-transfected 
and 3 scrambled siRNA-transfected embryos for Flrt3 (Fig. 5.14). In the control 
embryos, Flrt3 was expressed in the ectoderm and posterior half-sclerotome (Fig. 
5.14A,B) (suggesting a difference between expression in chick and mouse; Haines et 
al., 2006). In two out of the five Flrt2 siRNA-transfected embryos analysed (Fig. 
5.14C-I), Flrt3 expression varied along the embryo (Fig. 5.14C-E) and spots of Flrt3 
expression were seen in the dermomyotome (Fig. 5.14F) and sclerotome (Fig. 5.14H). 
Flrt3 expression was also seen around the neural tube (Fig. 5.14H, I). Although analysis 
of more embryos is needed to verify this as a real phenotype, these results may suggest 
that Flrt2 knockdown disrupts Flrt3 expression in the somites. 
 
5.8- Discussion 
 My results suggest that Flrt2 is not involved in sclerotome segmentation in 
chick embryos, as there were no alterations in expression of either the anterior 
sclerotome marker Tbx18 (Haenig and Kispert, 2004) or the posterior sclerotome 
marker Uncx4.1 (Schrägle et al., 2004) after transfecting somites with Flrt2 siRNA 
(which reduced Flrt2 expression in at least some somites in 70% of targeted embryos, 
where Flrt2 expression was tested; n=10). Flrt2 siRNA transfection caused a series of 
morphological malformations, as well as, most importantly for this study, disturbing the 
normal spinal axonal pattern in the somites. In summary, Flrt2 siRNA transfection led 
to the defasciculation and incorrect growth of axons into the normally repulsive 
posterior half sclerotome and dermomyotome. Spots of neurofilament staining were also 
seen in the posterior half-sclerotome after Flrt2 siRNA transfection: these could 
represent aberrantly positioned axons in cross-section and/or neural crest-derived DRG 
neurons, which are normally confined to the anterior sclerotome. Given that shed 
ectodomains of Flrt2 (and Flrt3) had previously been found to repel Unc5D-expressing 
axons and neuronal cell bodies of cortical neurons (Yamagishi et al., 2011), my study 
suggests that Flrt2 could be involved in repelling spinal axons (and perhaps also neural 






Figure 5.14- Flrt3 expression is altered by Flrt2 siRNA transfection. (A) Flrt3 
expression in a scrambled siRNA-transfected embryo at stage 22 HH. Flrt3 is expressed 
in the ectoderm and posterior half-sclerotome. (B) Transverse section of a scrambled 
siRNA-transfected embryo at stage 22 HH. Flrt3 is expressed in the ectoderm and 
dorsolateral sclerotome. (C) Whole-mount view of Flrt3 expression in a Flrt2 siRNA-
transfected embryo at stage 22 HH. (D) Dorsal higher magnification view of the embryo 
in C, showing variable Flrt3 expression between limb levels. (E) Lateral view of the 
embryo in C, showing the variable Flrt3 expression within the somites. (F) Section 
showing Flrt3 expression in a Flrt2 siRNA-transfected embryo. Flrt3 is not expressed in 
all somites and appears confined between the dermomyotome and anterior half-
sclerotome. (G) Neurofilament immunostaining of the section in F. Axons appear to exit 
segmentally through the anterior half-sclerotome normally, however, some spots of 
neurofilament staining are present in the posterior half-sclerotome. (H,I) Transverse 
sections of the embryo in C. Flrt3 is expressed in medial sclerotome around the neural 




Flrt2 siRNA-transfected chick embryos presented abnormalities in spinal axon 
trajectories at thoracic levels, where some axons were present in the posterior half 
sclerotome by longitudinal sprouting as well as axonal sprouting in the junction of 
sensory and motor axons (Fig. 5.7). Normally spinal axons are restricted to the anterior 
half sclerotome through the expression of repulsive molecules from the surrounding 
structures, such as Sema3A that is secreted from the notochord, neural tube and 
dermomyotome to prevent axons from entering these medial and lateral tissues 
inappropriately (Anderson et al., 2003). Similarly, Sema3A and Sema3F together help 
repel spinal axons from the posterior half sclerotome (Roffers-Agarwal and Gammill, 
2009). In Flrt2 siRNA-transfected embryos, axons start to sprout into many of these 
tissues including the posterior half-sclerotome, myotome and neural tube (Fig. 5.7), 
similar to the phenotype obtained in Sema3A knockout mice (Anderson et al., 2003). 
These results suggest that Flrt2 could act as a chemorepellent for spinal axons, as it does 
for Unc5D-expressing cortical axons and neuronal cell bodies (Yamagishi et al., 2011). 
In the embryos where such a phenotype was visible, the morphology of the 
dermomyotome and notochord were also modified (see later), suggesting that Flrt2 
expression might be necessary to regulate cell adhesion and tissue morphogenesis, 
resulting in the incorrect formation of these structures which may later result in 
inactivation of the expression of secreted repulsive molecules.  
Another abnormality in Flrt2 siRNA-transfected embryos was the presence of 
spots of neurofilament staining in the posterior sclerotome (Fig. 5.7-5.8). This staining 
pattern might reflect aberrantly positioned axon bundles in cross-section, or neural 
crest-derived DRG neurons, which are also normally confined to the anterior half-
sclerotome. DRG neurons start to differentiate as early as E3 in the chick (Marusich, 
1993), and the siRNA-transfected embryos were collected around stage 22-24 HH 
(E3.5-4). It is possible that Flrt2 repels migrating neural crest cells as well as spinal 
axons in chick embryos, or that it helps confine differentiated DRG neurons to the 
anterior sclerotome. Testing these hypotheses would require confirmation of what the 
spots of neurofilament staining in the posterior sclerotome represent. It would have been 
interesting therefore to investigate the expression of the neurogenic transcription factor 
genes Neurogenin1 or Neurogenin2 in Flrt2 siRNA-transfected embryos, as these are 




they were also present in the posterior sclerotome, it would confirm that the spots of 
neurofilament expression indeed represent aberrantly positioned neural crest-derived 
DRG progenitor cells. 
Another effect of Flrt2 siRNA transfection was variation in somite size and 
disturbed neural tube closure (Figs. 5.6, 5.8 and 5.9). Somite size is controlled by Fgf8 
signalling in the PSM (Dubrulle and Pourquié, 2004), and the results obtained in this 
study are similar to that obtained by grafting beads soaked in Fgf8 at the level of the 
neural tube, which results in a shift of somite borders and twisting of the neural tube 
mediated through Pax6 inactivation (Bertrand et al., 2000). Fgf8 suppression in the 
PSM also results in the shift of somite boundaries and changes in the number of cells 
per somite (Dubrulle et al., 2004). It is possible that Flrt2 acts downstream of FGF8 to 
control somite size in chick embryos, but further experiments would be required to test 
this possibility. 
At stage 14 HH, Flrt2 is weakly expressed in the notochord and neural tube with 
stronger expression in the myotome and posterior half-sclerotome (also see section 
3.14). With further development, Flrt2 expression becomes restricted to the posterior 
half sclerotome. Flrt2 siRNA transfection of PSM cells and sclerotome in chick 
embryos at stages 10-13 HH resulted in an abnormal notochord, somites and neural tube 
morphology at vagal and thoracic levels. This corresponds to approximately eight 
already formed somites plus nine still to be formed from the PSM at the time of 
transfection. The reduction of mRNA expression in non-targeted somites suggests that 
transfection affected more tissues than just sclerotome. Flrt2 would be expressed on the 
notochord on time of transfection, and that might have interfered with cell-cell adhesion 
properties and resulted in abnormal notochord morphology. Notochord rigidity 
maintains the embryonic alignment of axial tissues during development and embryo 
elongation (Cleaver and Krieg, 2001). The peri-notochordal sheath, an extracellular 
matrix surrounding the notochord, provides its epithelial configuration, and constrains it 
physically into an axially positioned rod (Carlson and Kenney, 1980). As some Flrt2 
siRNA-transfected embryos appeared to have little confinement of the notochord to an 
axial rod, it is possible that the integrity of the peri-notochordal sheath was lost. Such 




zebrafish, the notochord is required for the development of the heart and its vasculature 
(Goldstein and Fishman, 1998) and in chick it is also important for the formation of the 
dorsal aorta (Fouquet et al., 1997). It is therefore possible that the altered notochord 
morphology in Flrt2 siRNA-transfected embryos might be responsible for some of 
abnormalities observed in body vasculature and heart formation, but further studies 
would be required to test this effect.  
Besides its role in heart and vasculature formation, the notochord also plays an 
important role in patterning the ventral neural tube, including the formation of the floor 
plate (Stemple, 2005; Placzek et al., 1991; Cleaver and Krieg, 2001). Among the signals 
that the notochord secretes is Sonic hedgehog (shh) that together with Shh from the 
floorplate induces a signalling gradient to pattern the ventral neural tube. Neural tube 
patterning can be divided into two regulative mechanisms: dorsally the neural tube is 
regulated by TGF-β/BMP signalling and ventrally by Shh signalling (Muroyama et al., 
2002). The defects shown by Flrt2 siRNA-transfected embryos are present in the dorsal 
neural tube and not in the floor plate (Fig.5.9), however, suggesting that Shh signalling 
was not affected. The neural tube defects included in a small percentage of Flrt2 
siRNA-transfected embryos, the appearance of possessing multiple neural tubes. After 
immunostaining for neurofilament and sectioning, the phenotype appear to emerge from 
the extension of sensory axons beyond the midline, where they joined together on the 
roof plate forming new neural tube (Fig. 5.9). Axons are prevented from crossing the 
neural tube midline due to the balance kept by Slit/Robo signalling (Long et al., 2004). 
Slit genes are also expressed in the notochord and neural tube where they contribute to 
the repulsion of spinal motor column axons (Giovannone et al., 2012; De Bellard et al., 
2003). It would have been interesting to study whether Flrt2 has any interaction with 
any Slit and Robo family members. 
 Flrt2 interaction with Fgf receptors in chick embryos was not very conclusive, it 
appears that Flrt2 knockdown only had an apparent impact on the Fgfr1 receptor, 
slightly reducing its expression in the sclerotome and causing it to be expressed in the 
myotome (Fig. 5.11). More embryos need to be tested to confirm this as a real 
phenotype. The slightly increased expression of Fgfr3 might be due to over-




interaction of Flrts with Fgf receptors are not clear: knockout studies in mice suggested 
that Flrts do not affect Fgf signalling (Müller et al., 2011), however Wei et al. (2011) 
showed that Fgfr2 expression decreases in Flrt2 shRNA-transfected cells. In order to 
understand Flrt2 interaction with Fgf receptors in chick embryos, further assays would 
have been necessary. Flrt3 expression in Flrt2 siRNA-transfected chick embryos was 
greatly reduced, leaving variable punctate spots of expression in the somites. However, 
this was only verified in a small percentage of the Flrt3-immunostained embryos, and it 
would be necessary to do do other assays like Western blots to quantify levels of Flrt3 
expression in transfected embryos so that we could understand if Flrt2-Flrt3 interactions 
in chick embryos.  
Finally, Flrt2 siRNA transfected embryos collected at later stages showed a 
slight bend of the vertebral bodies at tail level, as analysed by Alcian blue staining for 
cartilage. Since I showed that Flrt2 is expressed in the neural arch and vertebral body 
(section 3.14), this might reflect a late requirement for Flrt2 in vertebral body 
development. The Alcian Blue staining also seemed stronger, which is consistent with 
an in vitro study showing that reduction in Flrt2 increases cell-cell interaction and leads 
to a thicker chondrocyte matrix (Wei et al., 2011). However, these experiments would 
need to be repeated and further analysis undertaken to confirm that these phenotypes 
were consistent and specific.  
 
5.9- Conclusion 
The results of my Flrt2 siRNA transfection study suggest that the glycosylated 
transmembrane protein Flrt2 may be involved, directly or indirectly, in repelling spinal 
axons (and perhaps also migrating neural crest cells and/or neural crest-derived DRG 
neurons) from the posterior sclerotome. To confirm the specificity of these and the other 
phenotypes described, it would be important to try to rescue Flrt2 expression in siRNA-
transfected embryos, and/or to use mismatch siRNAs instead of scrambled siRNA as a 
negative control (Buehler et al., 2012). It would also be of interest to transfect Flrt2 
siRNA at earlier time points (e.g. stage 3-4 HH) to determine the role of Flrt2 in early 
and to perform gain-of-function experiments as well by transfecting an expression 
vector encoding full-length Flrt2 into somites. 
  
  
CHAPTER 6- EXPRESSION OF O-GLYCOSYLATION ENZYMES 






Mucin-type O-glycosylation is a common covalent modification at serine and 
threonine residues in eukaryote glycoproteins (Bennett et al., 2012; Tran and Ten 
Hagen, 2013). The UDP-GalNAc:polypeptideN-acetylgalactosaminyltransferase 
(ppGalNAc-T) family of enzymes is responsible for mucin-type O-glycosylation in 
animals (Bennett et al., 2012; Tran and Ten Hagen, 2013). Mucin-type O-glycosylation 
events are necessary during development (Tabak, 2010; Tran and Ten Hagen, 2013), for 
instance for the Notch signalling pathway during somitogenesis (Haines and Irvine, 
2003), while three ppGalNAc-T family members proved to be vital for Drosophila 
viability (Tran et al., 2012). Importantly for this study, there is a significant contribution 
of mucin-type O-glycosylation (Dr. G. Cook, personal communication) to the peanut 
agglutinin (PNA)-binding axonal repellent activity in posterior half-sclerotomes (Stern 
et al. 1986; Davies et al., 1990). Hence, it is possible that an O-glycan-bearing 
glycoprotein is responsible for this activity, and that the ppGalNAc-T enzyme 
responsible for the biosynthesis of the O-glycan-bearing axonal repellent will also be 
differentially expressed in the posterior half-sclerotome. Fluorescently-labelled PNA, 
which specifically binds to the alpha-linked galactose on T antigen (Chacko and 
Appukuttan, 2001), segmentally binds to the posterior half sclerotomes of the somite 
(Stern et al., 1986). PNA binding inhibits the activity of the axonal repellent present in 
the posterior sclerotome (Davies et al. 1990) and also allows migrating neural crest cells 
to enter this normally inhibitory environment (Krull et al. 1995). PNA binding, together 
with chondroitin-6-sulfate expression, labels tissues that act as barriers to axon advance 
in chick embryos (Oakley and Tosney, 1991). Given this, all the glycosylation events in 
the posterior half-sclerotome are of great interest, but they are still poorly understood. 
ppGalNAc-Ts transfer an N-acetylgalactosamine (GalNAc) residue from the 
sugar donor, UDP-GalNAc, to serines and threonines in proteins to form the T-antigen 
(Thomsen-Friedenreich antigen) and initiate O-glycosylation (Young et al., 2003) (Fig. 
6.1). Further modification of O-GalNAc glycans by O-acetylation of sialic acid and O-
sulfation of galactose and N-acetylglucosamine, leads to structural heterogeneity. T 
antigen is recognised by PNA (Ravishankar et al., 1999). Large mucin glycoproteins 
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also share many lectin-binding domains through the presence of numerous GalNAc-
linked saccharides (Raman at al., 2008). 
 
Figure 6.1- The mucin-type O-glycan biosynthesis pathway for the chicken, Gallus 
gallus. T antigen formation is highlighted. Figure obtained from the Kyoto 
Encyclopedia of Genes and Genomes (KEGG) database.   
 
The 20 human GALNT genes can be grouped into closely related subfamilies 
(Fig. 6.2; Bennett et al., 2012). Subfamily I members mostly have peptide substrate 
specificity; subfamily II members mostly have GalNAc-glycopeptide substrate 
specificity (Bennett et al., 2012). This nomenclature (group I versus group II) does not 
reflect the relatedness of the different subfamily groups, however: for example, 
subfamily IIa (GALN-T4/T12) clusters with subfamily Ig (T15) and Ic (T3/T6). 
 
Figure 6.2- Phylogenetic tree of human GALNT 




The ppGalNAc-T family is highly conserved throughout animal evolution (Fig. 
6.3; Bennett et al., 2012) but absent in bacteria, yeast and plants. The expression 
patterns of seven mouse Galnt (genes (Galnt1-5, Galnt7 and Galnt10) were documented 
in the embryonic nervous system, neural crest and tongue (Kingsley et al., 2000). [Note: 
Galnt10 was published in this paper as Galnt9, but this gene is now designated as 
Galnt10 (Bennett et al., 2012).] Expression data for some mouse Galnt genes are also 
available from the Eurexpress website (http://www.eurexpress.org) (Diez-Roux et al., 
2011). Only a single study, the differential microarray screen of Hughes et al. (2009), 
has identified a Galnt gene as being differentially expressed in the posterior sclerotome: 
Galnt4. However, it should be noted that this expression was not reported in the in situ 
hybridization data from Kingsley et al. (2000). Unfortunately, the Galnt4 gene was lost 
in the chicken lineage during evolution (see Fig. 6.3; Bennett et al., 2012). (The Galnt8 
gene from subfamily Ie, and the Galnt20 gene from subfamily If, were also lost in the 
chicken lineage, hence the existence of 17 Galnt genes in chicken instead of the 20 
present in human; Fig. 6.3; Bennett et al., 2012.) Galnt4 is a member of subfamily IIa, 
which also contains Galnt12 (Bennett et al., 2012). According to the phylogenetic tree 
in Fig. 6.2 (Bennett et al., 2012), human GALNT subfamily IIa (T4 and T12) is most 
related to subfamily Ig (T15) and then subfamily Ic (T3 and T6), within a larger cluster 
containing subfamily Ia (T1 and T13). However, this information about subfamily 
groupings was not available at the time the expression study was performed. 
To address whether any Galnt genes are expressed in the posterior half-
sclerotome in chick, the first aim was to identify chick Galnt genes for use in whole-
mount in situ hybridization experiments (WMISH). Several Galnt genes are responsible 
for O-glycan synthesis (Kyoto Encyclopaedia of Genes and Genomes, KEGG; Kanehisa 
et al., 2012; Kanehisa et al., 2000) (Fig. 6.2). In Fig. 6.1, “2.4.1.41” corresponds to 
GalNAc-Ts: T14; T13; T12; T11; T10; T9; T7; T6; TL6; T5; TL4; T3; T2; TL2; T1; 
TL1 and Williams-Beauren syndrome chromosome region 17 (WBSCR17). Fig. 6.1 
shows that mature T antigen is represented by Core 1 glycosylation, synthesised by 
enzyme 2.4.1.122, corresponding to Core 1 synthase, glycoprotein-N-





Figure 6.3- Phylogenetic tree of animal ppGalNAc-Ts. ppGalNAc-T4, encoded by 
Galnt4 and reported in the posterior half-sclerotome (Hughes et al., 2009) is in 
subfamily IIa. The number of Galnt genes identified in each species is indicated on the 
right. Figure from Bennett et al. (2012). 
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6.2- Identifying candidate chick Galnt genes for expression analysis 
As described in the preceding section, the mouse microarray screen detected 
Galnt4 as being present in the posterior half sclerotome (Hughes et al., 2009). A 
nucleotide BLAST of mouse Galnt4 (T4) to the chick database using NCBI software 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) did not reveal any homologous sequences, but a 
BLAST of the amino acid sequence revealed that several chick ppGalNAc-Ts are 
similar to the mouse ppGalNAc-T4 (T4) protein (Fig. 6.4). ppGalNAc-T12 showed the 
greatest similarity with mouse ppGalNAc-T4 (consistent with ppGalNAc-T4 and T12 
forming ppGalNAc-T subfamily IIa; Figs. 6.2 and 6.3), followed by T6 then T3 (i.e., 
subfamily Ic), then T1 and T13 (i.e., subfamily Ia) (Fig. 6.4). These similarities are 
consistent with the relationships of human GALNT genes (Fig. 6.2; Bennett et al., 
2012). While chick ppGalNAc-T12 showed the greatest conservation to mouse T4 (and 
human T4; Fig. 6.3), there was much sequence heterogeneity across the family. For this 
reason, the attempt was made to study the expression of as many chick ppGalNAc-T 
gene family members as possible.  
The whole-mount in situ hybridization (WMISH) data for chick Galnt genes 
were generated using essentially the same protocol as described in sections 2.2 and 2.3. 
Primers designed for these experiments are described in Appendix B. For clarity, each 
gene analysed is introduced followed by a description of its expression pattern. The first 
gene described is the core 1 synthase gene, followed by the various Galnt genes in order 






Figure 6.4- Amino acid alignment of mouse ppGalNAc-T protein T4 to the chicken 




C1GalnT1 (core 1 synthase, glycoprotein-N-acetylgalactosamine-3-beta-
galactosyltransferase) is responsible for the transfer of the galactose from UDP-Gal to 
serine/threonines on Tn antigen to form the final T-antigen, Gal1-3GalNAc, also 
called Core 1 (Tabak, 2010). In Drosophila, C1GalT1 is expressed in the embryonic 
CNS and embryonic hemocytes, and it is of note that it shows a distinct anterior-
posterior pattern of expression in imaginal discs that corresponds to the separation of 
the axons until stage 13 (Lin et al., 2008). C1GalT1 ablation in Drosophila causes an 
elongation of ventral nerve cord and distortion of the brain hemispheres related to 
defects in ECM deposition by hemocytes, which is required for ventral nerve cord 
condensation (Lin et al., 2008), however there was no distortion in axon exit from the 
nerve cord (Yoshida et al., 2008), suggesting that another Galnt gene may be 
responsible for the formation of T antigen. However, there may be some role for 
C1GalT1 in T antigen production, perhaps with other ppGalNAc-Ts, as reduction in 
C1GalT1 leads to partial loss of T antigen (Yoshida et al., 2008). 
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Fig. 6.5 shows chick C1GalT1 expression at HH stages 17, 19 and 25. 
Interestingly, C1GalT1 appears to show differential expression in anterior versus 
posterior half-somites. C1GalT1 is only expressed weakly at stage 17 HH (Fig. 6.5A,B), 
and although somite expression was seen at stage 19 HH (Fig. 6.5C-E), restriction to the 
anterior half-somite was most apparent at stage 25 HH (Fig. 6.5F-H). Sections would be 
required to confirm the specific location of expression, i.e., sclerotome, DRG or 
myotome. C1GalT1 expression in the limb buds (Fig. 6.5F-H) is probably in the pre-
muscle mass, suggesting that C1GalT1 could be involved in limb musculature 
formation, perhaps in cells migrating from myotome to the limbs. Since C1GalT1 did 
















Figure 6.5- WMISH for C1GalT1. (A,B) Embryo at stage 17 HH. C1GalT1 is weakly 
expressed on the dorsal lateral somites (arrow). (C-E) Embryo at stage 19 HH. C1GalT1 
is possibly expressed in the somites and in the neural tube. (F-H) Embryo at stage 25 
HH. C1GalT1 is expressed in the anterior half of the somites (black arrow) and in the 
limb buds (white arrow). Head staining was considered to be background. 
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6.4- Galnt12 (subfamily IIa) 
 Chick ppGalNAc-T12, encoded by Galnt12, groups together with ppGalNAc-T4 
in the IIa subfamily of ppGalNAc-Ts (Figs. 6.2 and 6.3; Bennett et al., 2012). As 
described in section 6.2 (Fig. 6.4), my BLAST search showed that ppGalNAc-T12 is 
the most similar chick protein to mouse ppGalNAc-T4, whose mRNA was identified in 
the posterior sclerotome by Hughes et al. (2009) in their differential microarray screen. 
Young Jr. et al. (2003) found using real-time PCR that Galnt12 (T12) is strongly 
expressed in the adult mouse sublingual gland, and weakly in the colon, spleen, thymus, 
testis and lung. In humans it is present in brain, lung and muscle (Bennett et al., 2012).  
 Fig. 6.6 shows the expression of Galnt12 in chick embryos at HH stages 22 and 
25. At stage 22 HH, Galnt12 is expressed in the floor plate of the neural tube and in the 
notochord, although not in the perinotochordal sheath (Fig. 6.6A-D). It is also expressed 
in the myotome (Fig. 6.6C,D), which explains its expression in whole-mount in the 
anterior half of the somite at stage 25 HH (Fig. 6.6E-G). Galnt12 is also weakly 
expressed in the mesonephros (Fig. 6.6H,I) and in thin stripes that could represent axons 
of the dorsal root ganglia or perhaps blood vessels (Fig. 6.6H,I).  
 The notochordal expression of Galnt12 was interesting (although it was in the 
centre, rather than in the sheath; Fig. 6.6D) because PNA binds the axon-repelling peri-
notochordal ECM and mesenchyme (Tosney and Oakley, 1990; Oakley and Tosney, 
1991). However, it was not expressed in the posterior sclerotome so not studied further.  
 
Figure 6.6- (On next page) Embryos and sections after WMISH for chick Galnt12.  
(A,B) Low and higher power views of embryo at stage 22 HH. Galnt12 is expressed in 
the neural tube (white arrow) and heart. (C,D) Transverse sections at stage 22 HH. 
Galnt12 is expressed in the myotome (black arrow), floor plate (red arrow) and 
notochord (green arrow). (E,F) Low and higher power views of embryo at stage 25 HH. 
Galnt12 is expressed in the neural tube (white arrow), and in the anterior half of the 
somite (black arrow). (G) Longitudinal section of embryo at stage 25 HH. Galnt12 is 
expressed in the middle of the somite (black arrow). (H,I) Low and higher power views 
of longitudinal section at stage 25 HH, Galnt12 is expressed in the mesonephros (black 




Figure 6.6- Legend on previous page. 
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6.5- Galnt6 (subfamily Ic) 
 ppGalNAc-T6, encoded by Galnt6, is in the Ic subfamily, together with 
ppGalNAc-T3 (Fig. 6.2, 6.3; Bennett et al., 2012). My BLAST search ranked 
ppGalNAc-T6 as the second most similar chick protein to mouse ppGalNAc-T4 (Fig. 
6.4). Fig. 6.7 shows a detail from the phylogenetic tree of human GALNT genes 
(Bennett et al., 2012; for the full tree, see Fig. 6.2), showing that the Ic subfamily 
(GALNT6 and GALNT3) is sister group to subfamily IIa (GALNT4 and GALNT12). 
 
 
Human GALNT6 has been reported in human placenta, trachea (Bennett et al., 
1999), brain, cervix,  kidney, lung, muscle and nerves (Bennett et al. 2012). Mouse 
Galnt6 is not present at significant levels in adult tissues by real-time PCR (Young Jr.et 
al., 2003). At E14.5, Eurexpress reports specific Galnt6 expression in the sympathetic 
ganglia (http://www.eurexpress.org/ee/databases/assay.jsp?assayID=euxassay_009167). 
Fig. 6.8 shows chick Galnt6 expression at HH stage 25. (I was also able to detect 
Galnt6 by RT-PCR at stage 22 HH.) It is expressed strongly in the limb buds, as well as 
in the dermomyotome and DRG, giving a segmental expression in whole-mount (Fig. 
6.8A-D). Ventral somite expression in whole-mount (Fig. 6.8B) might be sympathetic 
ganglia, as reported at E14.5 for mouse (see above). It is also expressed in the neural 
tube at both brain and spinal cord levels (Fig. 6B,C,E-G). Given the absence of 
expression in the posterior half sclerotome, further studies were not done.  
Figure 6.7- Detail from phylogenetic tree 
of human GALNT genes. GALNT6 and 
GALNT3 are in subfamily Ic, the sister 
group to subfamily IIa, which contains 
GALNT4 and GALNT12. The percentage 
values refer to the percentage amino acid 
identities of the catalytic domains between 





Figure 6.8- Stage 25 HH embryo and sections after WMISH for Galnt6.  (A,B) Low 
and higher power views in whole-mount. Galnt6 is expressed in the limb buds, heart 
atrium (white arrow), ventral somite (black arrow) and neural tube (red arrow). (C,D) 
Low and higher power views of longitudinal section. Galnt6 is expressed in DRGs, 
dermomyotome and the neural tube. (E) Transverse section showing trunk and eye 
levels. Galnt6 is expressed in the nephric duct (black arrow). (F) Higher power view of 
head section in E. Galnt6 is expressed in different regions of the brain (different colour 
arrows). (G) Transverse section at trunk level. Galnt6 is expressed in the neural tube 




6.6- Galnt3 (subfamily Ic) 
ppGalNAc-T3, encoded by Galnt3, is the other member of the Ic subfamily of 
ppGalNAc-Ts, with ppGalNAc-T6 (see Fig. 6.7; Bennett et al., 2012). My BLAST 
search ranked ppGalNAc-T3 as the third most similar chick protein to mouse 
ppGalNAc-T4 (Fig. 6.4). Galnt3 is expressed in the testis and sublingual gland, and in 
later pregnancy in mouse (Young Jr.et al., 2003; Ten Hagen et al., 2003), and in human 
testis and pancreas (Bennett et al., 1999).  
 Fig. 6.9 shows chick Galnt3 expression at HH stages 19 and 26. Galnt3 may 
have a function in CNS development, as it appears to be expressed in the midbrain, 
hindbrain and floor plate at stage 19 HH (Fig. 6.9A,B), extending further within the 
neural tube by stage 26 HH (Fig. 6.9C,D). Transverse sections would be necessary to 
confirm this, however. Galnt3 is strongly expressed in the limb buds (Fig. 6.9A-D) and 
weakly expressed in the anterior half of the sclerotome (Fig. 6.9B-D), possibly 
myotome since it also seems to be expressed in limb musculature (Fig. 6.9D). 
Furthermore, Galnt3 is expressed in the pharyngeal arches (future jaws). Galnt3 is not 
expressed in the posterior half sclerotome so was not pursued further. 
 
Figure 6.9- WMISH for Galnt3. (A,B) Low and higher power views of a stage 19 HH 
embryo. Galnt3 is expressed in limb buds, brain and floor plate (arrow in B). (C,D) 
Low and higher power views of a stage 26 HH embryo. Galnt3 is expressed in the 
midbrain, hindbrain (white arrow) and neural tube (red arrow), pharyngeal arches (green 
arrow), limb buds (white arrow) and anterior somite (black arrow). 
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6.7- Galnt1 (subfamily Ia) 
ppGalNAc-T1, encoded by Galnt1, is in the Ia subfamily of ppGalNAc-Ts 
together with ppGalNAc-T1 (Bennett et al., 2012). My BLAST search ranked 
ppGalNAc-T1 as the fourth most similar chick protein to mouse ppGalNAc-T4 (Fig. 
6.4).  Fig. 6.10 shows the relationship of the human Ia subfamily to the IIa subfamily 




Human GALNT1 (T1) is expressed in the liver and in the skeletal muscle, and 
Northern blot analysis showed that GALNT1 is highly expressed in neurons and 
astrocytes (White et al., 1995). ppGalNAc-T1 also has multiple structures that can 
recognize several T antigen subtypes (Zhang et al., 2010). In mice, Galnt1 (T1) is 
highly expressed in adult lungs, spleen, testis and prostate (Young Jr. et al., 2003) and is 
present in high quantities throughout the lifespan of the mouse (Young Jr. et al., 2003). 
During mouse development, Galnt1 expression was reported by in situ hybridization as 
relatively ubiquitous (Kingsley et al., 2000; Ten Hagen et al., 2003). It is highly 
expressed in the tail-forming region at E7.5, and by E12.5 also in mandibular bone-
forming neural crest and brain (Ten Hagen et al., 2003). The Eurexpress database 
(http://www.eurexpress.org/ee/databases/assay.jsp?assayID=euxassay_004959) reports 
Figure 6.10- Detail from phylogenetic 
tree of human GALNT genes. GALNT1 
and GALNT13 are in subfamily Ia, 
which is sister to the group that contains 
subfamily IIa (GALNT4 and GALNT12). 
The percentage values refer to the 
percentage amino acid identities of the 
catalytic domains between proteins. 




strong Galnt1 expression at E14.5 in the jaws and teeth, clavicle, ventricular layer of the 
brain, thymus, liver and lung, and moderate expression in the retina, metanephros and 
trachea. Knocking out Galnt1 in mice disturbed Fgf-mediated proliferation and integrin 
signalling, as major basement membrane components accumulated inside cells (Tian et 
al., 2012).   
Fig. 6.11 shows the expression of Galnt1 in chick embryos at HH stages 19 and 
25. At stage 19 HH, Galnt1 was weakly expressed in the somites and limb buds (Fig. 
6.11A). By stage 25 HH, Galnt1 expression was stronger in the anterior half-sclerotome 
(Fig. 6.11B-E). Galnt1 was also weakly expressed in the neural tube, but additional 
WMISH would have been necessary under different conditions to confirm this. The 
WMISH data presented in Fig 6.5 show dark staining in the head that could be 
background, but sections at stage 25 HH showed expression of Galnt1 in the 
mandibular mesenchyme (ventral to the oral cavity) (Fig. 6.11F). This is consistent with 
the reported expression of mouse Galnt1 in mandibular bone-forming neural crest (Ten 
Hagen et al., 2003). It is possible that Galnt1 might be required for cell migration 
and/or formation of the mandibular bone in chick embryos, but since it was not 
expressed in the posterior half-sclerotome, further studies were not done. 
 
6.8- Galnt13 (subfamily Ia) 
ppGalNAc-T13, encoded by Galnt13, is in the Ia subfamily with ppGalNAc-T1 
(Bennett et al., 2012), which was described in section 6.7 above (see Fig. 6.10 for the 
relationship of the Ia subfamily to the IIa subfamily containing GALNT4). My BLAST 
search ranked ppGalNAc-T13 as the fifth most similar chick protein to mouse 
ppGalNAc-T4 (Fig. 6.4). 
Current data for Galnt13 expression are conflicting: human GALNT13 is found 
at high levels in the brain and neurons (Zhang et al., 2003, Bennett et al., 2012), while 
in mouse brain only low levels are found (Young Jr. et al., 2003). Eurexpress 
(http://www.eurexpress.org/ee/databases/assay.jsp?assayID=euxassay_009032) reported 
no regional signal. I was able to detect Galnt13 expression by RT-PCR at stage 22 HH, 




Figure 6.11- Embryos and sections after WMISH for Galnt1. (A) At stage 19 HH, 
Galnt1 is weakly expressed in the somites and limb buds. (B) Embryo at stage 25 HH. 
(C) Higher power view of the vagal area of embryo in B. Galnt1 is segmentally 
expressed in the anterior sclerotome (arrow) and in the limb buds. (D) Transverse 
section of embryo at stage 25 HH. Galnt1 is weakly expressed in the neural tube and 
wing bud. (E) Transverse section of embryo at stage 25 HH. Galnt1 is weakly expressed 
in the neural tube (black arrow) and in the ventral sclerotome. (F) Transverse section of 
embryo at stage 25 HH, Galnt1 is expressed in the mandibular mesenchyme (arrow) 




6.9- Galnt15 (also known as Galntl2) (subfamily Ig) 
 
ppGalNAc-T15, encoded by Galnt15 (also known as Galnt-like 2, Galntl2),  
forms the Ig subfamily (Bennett et al., 2012). The human Ig subfamily (GALNT15) is 
sister to the group containing the Ic and IIa subfamilies, the latter containing GALNT4 
(Fig. 6.10). My BLAST search ranked ppGalNAc-T15 (TL2) as the sixth most similar 
chick protein to mouse ppGalNAc-T4 (Fig. 6.4). It has a unique catalytic activity when 
compared with other ppGalNAc-Ts, especially with ppGalNAc-T2, however, they share 
reaction pathways and transfer up to 7 GalNAc residues to their substrate (Muc1).  
Real-time PCR showed broad expression of human GALNT15, with high levels 
in placenta, and expression in the small intestine, spleen, cerebral cortex, cerebellum, 
ovary and mammary gland, and in fetal brain, thyroid gland, and digestive tissues; the 
only place where Galnt15 was not detected was leukocytes (Cheng et al., 2004). This 
broad expression suggests that it is unlikely to be involved in somite polarity.  
Fig. 6.12 shows Galnt15 expression in a stage 25 HH embryo, the only stage 
when I could detect expression. Galnt15 is expressed in the pharyngeal arches and the 
atrium and ventricle of the heart. It is weakly expressed in the limbs and in the anterior 
half of the somite, possibly in the DRG, but sections of the embryo would be required to 
confirm this. Due to its absence in the posterior half sclerotome, further studies for 
Galnt15 were not pursued. 
 
Figure 6.12- WMISH for Galnt15 at stage 25 HH. (A) Low power view (head 
removed; anterior to the right). (B) Higher power view of embryo in A. Galnt15 shows 
a segmented expression pattern in the anterior half of the somite (red arrow), and is also 
expressed in the heart (white arrow), limb buds and pharyngeal arches (black arrow).  
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6.10- Galnt10 (subfamily IIb) 
ppGalNAc-T10, encoded by Galnt10, is in the IIb subfamily with ppGalNAc-
T17 and ppGalNAc-T7 (Figs. 6.2, 6.3; Bennett et al., 2012). My BLAST search ranked 
ppGalNAc-T10 as the seventh most similar chick protein to mouse ppGalNAc-T4 (Fig. 
6.4), and its sister protein ppGalNAc-T17 (also known as ppGalNAc-T-like 6, TL6), as 
the ninth most similar. Fig. 6.13 shows that the human IIb gene subfamily is only 
distantly related phylogenetically to the IIa gene subfamily containing GALNT4. It 
could be speculated that the greater sequence similarity between the proteins detected 
by BLAST reflects more similar catalytic domains, since the members of subfamily II 
mostly show GalNAc-glycopeptide substrate specificity, while the members of 
subfamily I mostly show peptide substrate specificity (Bennett et al., 2012). 
 
Mouse Galnt10 is found in many adult tissues with greatest expression in the 
testis, followed by the sublingual gland, prostate, spleen and ovary (Young Jr.et al., 
2003). In situ hybridization showed Galnt10 expression at E14.5 in cranial neural crest-
derived cells that will form the mandibular bone and teeth (Kingsley et al., 2000; Ten 
Hagen et al., 2003).  Human GALNT10 is also found in muscle (Bennett et al. 2012). 
Figure 6.13- Detail from phylogenetic tree of 
human GALNT genes. GALNT10, its sister 
gene GALNT17, plus GALNT7 are in subfamily 
IIb, which is only distantly related to subfamily 
IIa, containing GALNT4 and GALNT12. Figure 
adapted from Bennett et al. (2012). 
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Mouse Galnt10 was originally published as Galnt9 (see Bennett et al., 2012), so 
to prevent confusion, both sequences were obtained from Ensembl. In chick, Galnt10 is 
on chromosome 13 and Galnt9 on chromosome 15. Fig. 6.14 shows the expression of 
Galnt10 in chick embryos at HH stages 19 and 25. Galnt10 is strongly expressed in 
limb buds at both stages, with localised expression in mesenchyme (most likely future 
muscle) and also in the apical ectoderm ridge at the tip of the limb bud (Fig. 6.14A,B,D-
F,H). Galnt10 is also expressed in the myotome, with stronger expression in the centre 
of the myotome (Fig. 6.14C,D-H). and in the neural tube, with particularly strong 
expression in the floor plate (Fig. 6.14D,H). Pharyngeal arch expression is seen at both 
stages, which would be consistent with expression in cranial neural crest cells, but 
sectioning would be needed to confirm this. Since Galnt10 was not expressed in the 
posterior half sclerotome, however, it was not studied further. 
 
Figure 6.14- Embryos and sections after WMISH for Galnt10. (A,B) Low and 
higher power views of a stage 19 HH embryo. Galnt10 is expressed in the limb buds 
and neural tube. (C) Longitudinal section at stage 19 HH. Galnt10 is expressed in the 
myotome (black arrow) and neural tube (red arrow). (D) Transverse section at stage 19 
HH. Galnt10 is expressed in the myotome (black arrow), floor plate (red arrow), and at 
the tip of the limb (white arrow), most likely the apical ectodermal ridge. (E,F) Low and 
higher power views of a stage 25 HH embryo Galnt10 is expressed in the neural tube 
(red arrow) and the anterior half somite (black arrow). (G) Coronal section at stage 25 
HH. Galnt10 is expressed in the myotome (black arrow), and in the neural tube (red 
arrow). (H) Transverse section at stage 25 HH. Galnt10 is expressed in the myotome 
(black arrow) and neural tube with stronger expression in the floor plate (red arrow), in 
the limb muscle and in the apical ectodermal ridge at the tip of the limb (white arrow).  
Scale bar: 100 µm.  
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6.11- Galnt7 (subfamily IIb) 
 ppGalNAc-T7, encoded by Galnt7, is in the IIb subfamily together with 
ppGalNAc-T10 (described in section 6.10 above) and ppGalNAc-T17 (Figs. 6.2, 6.3, 
6.13; Bennett et al., 2012). Although my BLAST search only ranked ppGalNAc-T7 as 
the fourteenth most similar chick protein to mouse ppGalNAc-T4 (Fig. 6.4), it is 
described here because it is in the IIb subfamily, like ppGalNAc-T10 (see Fig. 6.13). 
Galnt7 is the most conserved Galnt gene during evolution (i.e., it has the slowest 
rate of nucleotide substitution) (Ten Hagen et al., 2003), which is consistent with an 
important conserved biological function (Bennett et al., 2012). Human GALNT7 is 
expressed in spinal cord, brain, bone, heart, kidney, trachea and digestive tract organs 
(Ten Hagen et al., 2003; Bennett et al., 2012). Mouse Galnt7 is most strongly expressed 
at E7.5, but is found in adult testis, ovary, prostate, and spleen (Young Jr.et al., 2003). 
Eurexpress  reports strong expression of Galnt7 at E14.5 in the stomach and rectum, 
and moderate expression in the midgut, adrenal gland, submandibular gland, 
metanephros, and in the choroid plexus and roof plate of the hindbrain and forebrain 
(http://www.eurexpress.org/ee/databases/assay.jsp?assayID=euxassay_005715), 
Fig. 6.15 shows chick Galnt7 expression at HH stages 17, 19 and 25. Like 
Galnt10, the other IIb subfamily member (section 6.10), Galnt7 is expressed in limb 
buds, myotome, floorplate and perhaps pharyngeal arches (Fig. 6.15). The segmented 
expression in whole-mount is due to stronger expression in the centre of the myotome. 
Expression in myotome and limb buds might indicate a role in limb muscle formation. 
Since it is not expressed in posterior sclerotome, though, it was not studied further. 
Figure 6.15- (next page) Embryos and sections after WMISH for Galnt7. (A,B) 
Low and higher power views at stage 17 HH. Galnt10 is expressed in the neural tube 
(red arrow). (C,D) Low and higher power views at stage 19 HH. Galnt7 is expressed in 
the limb buds, floor plate (red arrow), ventrolateral somite (black arrow) and pharyngeal 
arches. (E) Transverse section at stage 19 HH. Galnt7 is expressed in the floor plate of 
the neural tube and perhaps generally in head mesenchyme. (F) Transverse section at 
stage 19 HH. Galnt7 is expressed in the floor plate (red arrow) and in the lateral 
myotome (black arrow). (G, H) Low and higher power views at stage 25 HH. Galnt7 is 
expressed in the floor plate (red arrow), ventrolateral somite (black arrow) and atrium. 
(I-K) Longitudinal sections at stage 25 HH. Galnt7 is expressed in the medial somite 




Figure 6.15- Legend on previous page. 
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6.12- Galnt2 (subfamily Ib) 
ppGalNAc-T2, encoded by Galnt2, is in the Ib subfamily (Bennett et al., 2012), 
which also contains ppGalNAc-T16 (Galnt16; section 6.13) and its sister gene 
ppGalNAc-T14 (Galnt14; section 6.14) (Fig. 6.16). My BLAST search ranked 
ppGalNAc-T2 as the eighth most similar chick protein to mouse ppGalNAc-T4 (Fig. 




Galnt2 expression is ubiquitous in the adult mouse. It is the most highly 
expressed Galnt gene in the prostate and also in the virgin mammary gland, decreasing 
significantly during pregnancy (Young Jr.et al., 2003). During mouse development, 
Galnt2 expression was reported by in situ hybridization as relatively ubiquitous 
Figure 6.16- Detail from phylogenetic tree of 
human GALNT genes. GALNT2, plus 
GALNT16 and its sister gene GALNT14, are in 
subfamily Ib, which is only distantly related to 
subfamily IIa, containing GALNT4 and 





(Kingsley et al., 2000; Ten Hagen et al., 2003). In E12.5 mouse embryos, Galnt2 shows 
strong expression in the brain; by E14.5, expression is seen in the sublingual gland, and 
at E16.5, expression is found in lungs, intestines, submandibular gland and in the eye 
(Ten Hagen et al., 2003). In humans, GALNT2 is expressed in skeletal muscle and liver 
(White et al., 1995).  
Fig. 6.17 shows Galnt2 expression in chick embryos at HH stages 19 and 25. 
This contrasts with what is known in mice as expression is seen at the edges of the 
dermomyotome and later in the myotome (Fig. 6.17C,D,K,L), suggesting ppGalNAc-T2 
may be required for the cell migration that forms the myotome. Galnt2 is also expressed 
in the mesonephros (Fig. 6.17J-L), neural tube (Fig. 6.17A,B,E,I) and atrium (Fig. 
6.17G). Galnt2 expression in the ventral sclerotome (Fig. 6.17E) was probably due to 
the symmetrical expression of Galnt2 in 2 cell pools on the top of the dorsal aorta, most 
likely the mesonephros (Fig. 6.17J). Since Galnt2 was not expressed in the posterior 






Figure 6.17- (On next page) Embryos and sections after WMISH for Galnt2. (A,B) 
Lower and higher magnification views of a stage 19 HH embryo. Galnt2 is expressed in 
the ventral somite (arrow) and neural tube. (C,D) Lower and higher magnification views 
of a longitudinal section of a stage 19 HH embryo. Galnt2 is expressed at the edges of 
the dermomyotome (arrow). (E) Transverse section at stage 19 HH. Galnt2 is expressed 
in the dermomyotome and dorsal neural tube. (F,G) Lower and higher magnification 
views of a stage 25 HH embryo. Galnt2 is expressed in the limb buds, at sclerotome 
boundaries (arrow) and in the atrium (arrow). (I) Longitudinal section at stage 25 HH, 
Galnt2 is expressed in the middle of the somite (arrow) and in the neural tube. (J) 
Transverse section at stage 25 HH. Galnt2 is expressed in the neural tube and 
symmetrically above the dorsal aorta (arrow), likely the mesonephros. (K,L) Lower and 
higher magnification views of a longitudinal section at stage 25 HH. Galnt2 is 





Figure 6.17- Legend on previous page. 
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6.13- Galnt16 (also known as Galnt-like1, Galntl1) (subfamily Ib) 
  ppGalNAc-T16, encoded by Galnt16 (also known as Galnt-like1, Galntl1), is in 
the Ib subfamily with its sister protein ppGalNAc-T14, described in section 6.14 below, 
and ppGalNAc-T2, described in section 6.12 above (Bennett et al., 2012). My BLAST 
search ranked ppGalNAc-T16 (TL1) as the eleventh most similar chick protein to 
mouse ppGalNAc-T4 (Fig. 6.4), although the phylogenetic tree (Fig. 6.16) suggests 
these are only distantly related.  (Although the If subfamily member ppGalNAc-T11 
was the tenth most similar protein to mouse ppGalNAc-T4, it will be described after the 
other two subfamily Ib members so these can be kept together.) 
 Galnt16 (Galntl1) is expressed in the hypothalamus, thalamus and amygdala of 
the mouse brain (Nelson et al., 2002). In Xenopus, galnt16 (xGalntl-1) is required for 
formation of the cranial neural crest, anterior notochord and spinal cord: it disrupts the 
common TGF-ß type II receptor activin receptor IIB, preventing it from binding to the 
TGF-ß type I receptor specific for activin and BMP signalling (Herr et al., 2008). 
 Fig. 6.18 shows the expression of Galnt16 in chick embryos at HH stages 19 and 
27. At stage 19 HH, Galnt16 has a segmented expression in the anterior sclerotome, and 
is also expressed in the limb buds (Fig. 6.18A,B). There may also be expression in the 
atrium of the heart, though this could be trapping (Fig. 6.18B, white arrow). By stage 27 
HH, the expression in anterior sclerotome is stronger and more defined and there also 
appears to be expression in the neural tube (Fig. 6.18C,D) and in the cardinal vein (Fig. 
6.18D, white arrow). Sections after WMISH would have been necessary to confirm the 
precise location of Galnt16 expression. The apparent expression of Galnt16 in the 
atrium of the heart at stage 19 HH and in the cardinal vein at stage 27 HH might be the 
result of antibody entrapment, however if it is real it might be due to neural crest-
derived cells, since in Xenopus, galnt16 (xGalntl-1) expression was detected in cranial 
neural crest cells (Herr et al., 2008).  





Figure 6.18- WMISH for Galnt16 (Galntl1). (A,B) Low and higher power views of 
embryo at stage 19 HH. Galnt16 is expressed in the anterior somite (black arrow), in the 
limb buds and possibly in the atrium (white arrow, although this could be trapping). 
(C,D) Low and higher power views of embryo at stage 27 HH. The head has been cut 
off; anterior is to the left. Galnt16 is expressed in the neural tube, the proximal part of 
the developing limbs (black arrow in C), the anterior half sclerotome (black arrow in 
D), neural tube and cardinal vein (white arrow in D). 
 
6.14- Galnt14 (subfamily Ib) 
 ppGalNAc-T14, encoded by Galnt14, is also in the Ib subfamily with 
ppGalNAc-T14 (section 6.13) and ppGalNAc-T2 (section 6.12)  (Bennett et al., 2012). 
My BLAST search ranked this as the twelfth most similar chick protein to mouse 
ppGalNAc-T4 (Fig. 6.4), although the phylogenetic tree (Fig. 6.16) suggests these are 
only distantly related.  
In situ hybridization in mouse at E14.5 showed Galnt14 expression in the 




Galnt14 is also expressed in breast cancer, being a potential biomarker (Wu et al., 
2010). Galnt14 was the only gene I was unable to amplify from chick embryo RNA. 
Others have reported difficulty in analysing Galnt14 expression in mouse by RT-PCR 
(Young Jr. et al., 2003). 
 
6.15- Galnt11 (subfamily If) 
 ppGalNAc-T11, encoded by Galnt11, is in the If subfamily with its sister protein 
ppGalNAc-T20 (which was lost in the chicken lineage) (Bennett et al., 2012). My 
BLAST search ranked ppGalNAc-T11 as the tenth most similar chick protein to mouse 
ppGalNAc-T4 (Fig. 6.4), although the phylogenetic tree (Fig. 6.19) suggests these are 
only distantly related. 
 
 
Figure 6.19- Detail from phylogenetic tree of 
human GALNT genes. GALNT11 and its sister 
gene GALNT20 form subfamily If, which is only 
distantly related to subfamily IIa, containing 
GALNT4 and GALNT12. Figure adapted from 




Galnt11 is found in many tissues of adult mouse, mainly in lung but also in 
prostate, sublingual gland, spleen, testis and thymus, and is the most highly expressed 
of all Galnt genes in the thyroid (Young Jr.et al., 2003). Eurexpress 
(http://www.eurexpress.org/ee/databases/assay.jsp?assayID=euxassay_002021) reports 
no regional expression at E14.5. In humans, GALNT11 is only expressed in kidney 
(Schwientek et al., 2002). Even though Galnt11 cDNA was amplified by RT-PCR from 
a chick embryo at stage 27 HH, it was not possible to detect a clear signal by in situ 
hybridization.  
 
6.16- Galnt5 (subfamily Id) 
 ppGalNAc-T5, encoded by Galnt5, is the only member of the Id subfamily  
(Bennett et al., 2012). My BLAST search ranked this as the thirteenth most similar 
chick protein to mouse ppGalNAc-T4 (Fig. 6.4), although the phylogenetic tree (Fig. 
6.20) suggests these are only distantly related. 
 
Figure 6.20- Detail from phylogenetic tree of 
human GALNT genes. GALNT5 forms 
subfamily Id, which is only distantly related to 
subfamily IIa, containing GALNT4 and 





Galnt5 has undergone the most modifications during evolution (Ten Hagen et 
al., 2003). In mouse embryos, Galnt5 expression was reported by in situ hybridization 
in a subset of cells in the ventral part of the maxilla and mandible at E12.5 (Kingsley et 
al., 2000; Ten Hagen et al., 2003). At E14.5, the Eurexpress database 
(http://www.eurexpress.org/ee/databases/assay.jsp?assayID=euxassay_013568) shows 
expression in the skeleton of the maxilla and mandible, as well as in the ribs. 
Fig. 6.21 shows the expression of Galnt5 in chick embryos at HH stages 19 and 
27. At stage 19 HH, Galnt5 is expressed in the dorsal aorta, heart and limb buds (Fig. 
6.21A,B). At stage 27 HH, expression in the heart might be due to entrapment, since 
Galnt5 expression has never been detected in the heart (Bennett et al. 2012). Expression 
between the somites at stage 27 (Fig. 6.21C,D) could represent inter-somitic blood 
vessels. Galnt5 is also expressed in the notochord and limbs.  
Due to absence of expression on the posterior half sclerotome, further studies 
with Galnt5 were not done. 
 
Figure 6.21- WMISH for Galnt5.  (A,B) Low and higher power views of embryo at 
stage 19 HH. Galnt5 is expressed in the dorsal aorta (red arrow), heart and limb buds. 
(C,D) Low and higher power views of embryo at stage 27 HH (head removed; anterior 
towards the top). Galnt5 is expressed in the dorsal aorta (red arrow), between the 
somites (white arrow) and in the notochord (black arrow), heart and limbs. 
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6.17- Galnt9 (subfamily Ie) 
 GALNT9, encoding ppGalNAc-T9, is in the human Ie subfamily with its sister 
gene WBSCR17 (also known as GALNT19, GALNT-like3, GALNTL3) (section 6.18 
below), GALNT18 (also known as GALNT-like4, GALNTL4; section 6.19 below) and 
GALNT8 (lost in the chicken; Bennett et al., 2012) (Fig. 6.22). My BLAST search 
ranked ppGalNAc-T9 as the fifteenth most similar chick protein to mouse ppGalNAc-
T4 (Fig. 6.4). The phylogenetic tree (Fig. 6.22) suggests these are only distantly related. 
 
In mouse and in human, Galnt9 is expressed in cranial sensory ganglia (Zhang et 
al., 2002; Ten Hagen et al., 2003). In mouse embryos at E14.5, the Eurexpress database 
(http://www.eurexpress.org/ee/databases/assay.jsp?assayID=euxassay_006920) reports 
Figure 6.22- Detail from phylogenetic tree of 
human GALNT genes. GALNT19/WBSCR17, 
plus GALNT9, GALNT18 and GALNT8, form 
subfamily Ie, which is only distantly related to 
subfamily IIa, containing GALNT4 and 





Galnt9 expression by in situ hybridization in brain, spinal cord, cranial sensory ganglia 
and dorsal root ganglia, as well as in inter-digital mesenchyme. 
Fig. 6.23 shows the expression of Galnt9 in chick embryos at stage 25 HH. 
Galnt9 is expressed strongly in the neural tube and DRG (Fig. 6.23A-D), consistent 
with the Eurexpress report in mouse. There is also a patch of strong expression at the 
posterior edge of the limb bud (Fig. 6.23A,B). Galnt9 is also expressed weakly in the 
myotome (Fig. 6.23C,D). Due to its absence in the posterior half sclerotome, studies of 
function for Galnt9 were not done. 
 
Figure 6.23- Embryos and sections after WMISH for Galnt9 at stage 25 HH. (A,B) 
Lower and higher magnification views in whole-mount. Galnt9 is strongly expressed in 
the posterior of the limb bud (black arrow), in the neural tube (white arrow), and in the 
anterior half of the somite (red arrow). (C) Transverse and (D) Coronal sections. Galnt9 
is expressed weakly in the myotome (black arrow), and strongly in the DRG (red arrow) 
and neural tube. Scale bar: 100 µm. 
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6.18- WBSCR17 (also known as Galnt19, Galnt-like3, Galntl3) (subfamily Ie) 
The human Williams-Beuren syndrome chromosome region 17 gene, WBSCR17, 
is one of the nine genes whose mutation contributes to Williams-Beuren syndrome, a 
neurodevelopmental disorder associated with mutations on chromosome 7 (Merla et al., 
2002). It is also known as GALNT-like3 (GALNTL3) and was classified by Bennett et al. 
(2012) as ppGalNAc-T19, encoded by GALNT19, in the Ie subfamily with its sister 
gene GALNT9 (section 6.17 above), GALNT18 (section 6.19 below) and GALNT8 (lost 
in the chicken; Bennett et al., 2012) (Fig. 6.22). My BLAST search ranked WBSCR17 
(ppGalNAc-T19) as the sixteenth most similar chick protein to mouse ppGalNAc-T4 
(Fig. 6.4). The phylogenetic tree (Fig. 6.22) suggests these are only distantly related. 
Northern blot analysis of adult mouse tissues detected WBSCR17 in higher 
quantities in the brain, followed by weaker expression in the heart and kidney, with low 
levels in the liver, lung and spleen (Merla et al., 2002). At E14.5, Eurexpress 
(http://www.eurexpress.org/ee/databases/assay.jsp?assayID=euxassay_007480) shows 
strong expression in cerebral cortex, cranial sensory ganglia and DRG, and moderate 
expression in the rest of the brain and spinal cord, as well as axial muscle.  
 Fig. 6.24 shows the expression of WBSCR17 in chick embryos at HH stages 17, 
22 and 25. WBSCR17 is strongly expressed in the brain and trunk neural tube (Fig. 6.24 
all panels), consistent with the mouse expression described above. Strong expression is 
also seen in the limb buds (Fig. 6.24C-E,G,H) and weaker expression in the 
dermomyotome (Fig. 6.24F, J). Since WBSCR17 expression is not seen in the posterior 
sclerotome, further studies were not done. 
Figure 6.24- (On next page) Embryos and sections after WMISH for WBSCR17. 
(A,B) Low and higher power views of a stage 17 HH embryo. WBSCR17 is expressed 
in the neural tube (red arrow). (C,D) Low and higher power views of a stage 22 HH 
embryo. WBSCR17 is expressed in the brain, trunk neural tube (red arrow), somite 
(black arrow) and limb buds. (E) Transverse section at stage 22 HH. WBSCR17 is 
expressed in the ventral part of the limb. (F) Higher power view of E. WBSCR17 is 
expressed in the neural tube (red arrow) and dorsal dermomyotome (black arrow). 
(G,H) Low and higher power views of a stage 25 HH embryo. WBSCR17 is expressed 
in the brain, neural tube (red arrow), ventral somite (black arrow) and limb buds. (I,J) 
Low and higher power views of a transverse section at stage 25 HH. WBSCR17 is 
expressed in the neural tube (red arrow) and in the ventral dermomyotome (black 




Figure 6.24- Legend on previous page. 
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6.19- Galnt18 (also known as Galnt-like 4, Galntl4) (subfamily Ie) 
 
Galnt18 (also known as Galnt-like 4, Galntl4), encoding ppGalNAc-T18 
(ppGalNAc-TL4) is a member of the same Ie subfamily as Galnt9 (section 6.17), and its 
sister gene WBSCR17 (GALNT19) (section 6.18) (Fig. 6.22; Bennett et al., 2012). My 
BLAST search ranked ppGalNAc-T18 (ppGalNAc-TL4) as the seventeenth most 
similar chick protein to mouse ppGalNAc-T4 (Fig. 6.4), and the phylogenetic tree (Fig. 
6.22) suggests these are only distantly related. 
Fig. 6.25 shows the expression of Galnt18 in chick embryos at HH stages 17, 19 
and 22. Galnt18 is expressed at stage 17 HH in the notochord and in the heart (Fig. 
6.24A). At stages 19 and 22 HH, segmental expression in the anterior half of the somite 
can be seen (Fig. 6.25B,C), which sections show to be the DRG (Fig. 6.25D-G), 
although expression is also present in the dermomyotome and myotome (Fig. 6.25D-G), 
and the lateral sclerotome (Fig. 6.25F). Galnt18 is also expressed in the notochord (Fig. 
6.25D,F,G) and the proximal part of the wing bud (Fig. 6.25F). Due to the absence of 





Figure 6.25- Embryos and sections after WMISH for Galnt18. (A) Embryo at stage 
17 HH. Galnt18 is present in the heart and somites. (B) Embryo at stage 19 HH. 
Galnt18 is expressed in the anterior half somite, heart and notochord. (C) Embryo at 
stage HH 22 (head cut off; anterior to left). Galnt18 is expressed in the DRG, limb buds 
and heart. (D) Coronal section at stage 19 HH. Galnt18 is expressed in the DRG, neural 
tube (nt) and notochord. (E) Coronal section at stage 19 HH. Galnt18 is expressed in the 
DRG, neural tube (nt) and myotome. (F) Transverse section at stage 22 HH. Galnt18 is 
expressed in the neural tube with the exception of the ventral neural tube, and in the 
notochord, dermomyotome, lateral sclerotome, and proximal wing bud. (G) Transverse 
section at stage 22 HH. Galnt18 is expressed in the neural tube with the exception of the 




 The assessment of expression patterns for the different Galnt genes in chick 
embryos did not highlight any particular enzyme that could be responsible for mucin-
type O-glycosylation of the protein responsible for the axonal repellent activity 
localised to the posterior half sclerotome. It was not possible to detect any Galnt gene 
that showed restricted expression in the posterior half sclerotome. This may mean that 
an as-yet unidentified enzyme plays this role, or that some other mechanism or 
molecule is employed to add O-glycan groups to the repellent. 
This study has generated many new embryonic expression patterns of the mucin-
type O-glycosylation enzyme gene family that were not previously available in chicken 
or indeed other animals. Fig. 6.26 presents an overview of the expression of 15 genes in 
the trunk at stage 25 HH and Table 6.1 summarises the regional distribution across 8 
embryonic tissues.  
Most of the Galnt genes appear to share similar gene expression patterns (Table 
6.1). These results suggest that the activity of multiple ppGalNAc-T enzymes is 
required for the correct formation of specific structures during development. However, 
these data may also indicate that there is functional redundancy. 
Myotome formation requires epithelial to mesenchyme transitions for cell 
migration from the ventrolateral and dorsolateral dermomyotome to from the myotome 
(Gros et al., 2004). In this study, C1T1, T1, T2, T15 (TL2), T7 are weakly expressed in 
the myotome, however T9, T12, T10 display strong expression in the myotome and later 
in the limbs. It is possible that these ppGalNAc-Ts are required during myotome 
formation, and mesenchymal condensation during limb muscle formation. 
Several Galnt genes are differently expressed in the neural tube. C1T1, T1, T2, 
T3, and T5 are expressed in the mediodorsal neural tube, while T18 (TL4), T9 and 
WBSCR17 are expressed in the lateroventral neural tube. There are also Galnt genes 
expressed in the floor plate of the neural tube such as T5, T7 and T9, and others in the 
notochord. T18 (TL4) is expressed only until stage 22 HH, and T12 is expressed only in 
the central notochord, without being expressed in the perinotochordal sheath. Due to the 
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variety of expression within the neural tube and notochord it is possible that these 
molecules play different roles in CNS development. 
 These regions are known to contain molecules that coordinate migration of 
somites and neural crest cells, like Shh that is expressed by the notochord and the floor 
plate (Chan et al., 2009), and even though there was no Galnt present in both places 
simultaneously, they may have different roles during the migration process. For 
example, Shh requires binding to proteoglycans to promote cell proliferation in the 
cerebellum (Chan et al., 2009). It is possible that Galnt genes such as T5, T7, T9, T12 
and T18 (TL4) might be necessary to form the proteoglycans that regulate Shh 
localisation and signalling. Shh plays critical roles during embryonic development, 
orchestrating the patterning of the brain, spinal cord, craniofacial elements, the axial 
skeleton, limbs and digits (Ingham and McMahon, 2001; Dorus et al., 2006), and it is 
expressed in the notochord, floor plate and the zone of polarizing activity in the limb 
buds (Dorus et al., 2006), the same tissues where most of the detected Galnt genes are 
expressed.  
Overall, the results strongly support a role for ppGalNAc-T enzymes in the 
development of both the central and peripheral nervous systems. 
Table 6.1- Summary of sites of expression of 17 different genes encoding mucin-
type O-glycosylation enzymes across 8 different tissues at stage 25 HH. Different 
shading indicates subfamily relationship according to Bennett et al. (2012). X indicates 





Figure 6.26- Overview of mucin-type 
O-glycosylation enzymes of 14 genes 
in the trunk of chick embryos at 
stage 25 HH. 
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7.1- Background 
The overall objective of the project was to identify genes expressed in the 
posterior half-sclerotome that could be responsible for somite segmentation and/or 
axonal guidance, and test their function. As described in sections 1.6 and 1.7, a variety 
of molecules present in the posterior half-sclerotome had previously been shown to be 
important for repelling motor axons and/or migrating neural crest cells (Fig. 7.1). For 
example, the double knock-out of Sema3F/Neuropilin2 and Sema3A/Neuropilin1 
signalling caused sprouting of motor axons in an apparently unsegmented pattern along 
the spinal cord and fusion of the dorsal root ganglia (Roffers-Agarwal and Gammill, 
2009) (phenotype shown in Fig. 1.25). However, motor axons were still found in 
fasciculated bundles in the double mutants, rather than exploring the surrounding 
tissues, suggesting that other key repellent molecules must be present in the sclerotome.  
 
Figure 7.1- Repulsive molecules present in the posterior half sclerotome identified 
as being important for axonal segmentation. Figure from Bagnard (2007). 
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 One such candidate that was identified during this project is Flrt2, a 
glycosylated transmembrane protein previously shown to repel axons and neurons 
expressing the netrin receptor Unc5D (Yamagishi et al., 2011). Flrt2 mRNA was 
identified in the posterior half-sclerotome in the mouse microarray screen of Hughes et 
al. (2009) and confirmed in this project to be differentially expressed in the posterior 
half-sclerotome of chick embryos (section 3.14). Using the in ovo somite transfection 
technique developed for this project (Chapter 4), siRNA knockdown studies suggested 
that Flrt2 is involved in repelling axons, and perhaps also migrating neural crest cells 
and/or neural crest-derived DRG neurons, from the posterior sclerotome (Chapter 5).  
 It has been known for more than 25 years that a PNA-binding glycoprotein is 
also important for this process, since PNA binds specifically to the posterior sclerotome 
and this allows axons to enter, suggesting that the PNA-binding glycoprotein normally 
repels axons from the posterior sclerotome (Stern et al., 1986; Davies et al., 1990; 
Bagnard, 2007). As described in section 1.7.1, two molecules of molecular weight 48 
kDa and 55 kDa were localised by SDS-PAGE analysis of the PNA-binding 
glycoprotein fraction of somite extract (Davies et al., 1990). However, the identity of 
this glycoprotein was still unknown. Studying the expression of genes encoding the 
ppGalNAc-T family of enzymes responsible for mucin-type O-glycosylation, which 
could glycosylate the PNA-binding glycoprotein, failed to identify any that were 
differentially expressed in the posterior sclerotome (Chapter 6). In this chapter, the 
results are presented of investigating two candidates for the PNA-binding protein itself: 
presenilin1 (section 7.1) and prolyl 4-hydroxylase, beta polypeptide (P4HB; also known 
as protein disulfide isomerase-associated 1, PDIA1) (section 7.2). 
 
7.2-  Presenilin1 
The Columbus mouse mutant, which was isolated in a chemical mutagenesis 
screen for recessive alleles affecting spinal motor neurons (Lewcock et al., 2007), 
showed an even more dramatic motor axon patterning phenotype than the double 
mutants for Neuropilin1 and Neuropilin2 described by Roffers-Agarwal and Gammill 
(2009) (shown in Fig. 1.25). In Columbus mutant mice, the segmentation of spinal 
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motor axons seemed to be lost completely (Fig. 7.2) (Lewcock et al., 2007). Motor 
axons showed no preference for the anterior or posterior sclerotome and exhibited 
severe defects in ventral root formation (Lewcock et al., 2007; Fig. 7.2).  
The Columbus mutation was mapped to the Presenilin1 (Psen1) gene and shown 
to alter Psen1 splicing, severely disrupting Psen1 protein expression (Bai et al., 2011). 
As described in section 1.4, the multi-pass transmembrane protein Psen1 is part of the 
gamma-secretase complex that cleaves the Notch receptor, allowing the Notch 
intracellular domain (NICD) to enter the nucleus and activate transcription, and Notch 
signalling is critical for somite polarity.  
 
 
Figure 7.2- Loss of spinal motor axon patterning in Columbus mutant mice at 
E12.5. (A) Flat-mount of a wild-type embryo in which motor axons are genetically 
labelled with farnesylated GFP (driven by a motor neuron enhancer from the Islet1 
gene) show segmental patterning in the trunk, with discrete nerve roots. (B) Flat mount 
of a Columbus mutant (generated in the same genetic background, with motor axons 
genetically labelled with GFP) showing defective axon pathfinding and loss of discrete 
ventral motor roots. BW, body wall; HL, hindlimb; SC, spinal cord. Figure from 
Lewcock et al. (2007). 
 
The original mouse knockouts of the Psen1 (PS1) gene in 1997 reported defects 
in somite patterning and the axial skeleton (fused vertebrae; no axial skeleton at all 
caudal to the pelvis) and fused dorsal root ganglia over multiple segments, as well as 
CNS defects (Shen et al., 1997; Wong et al., 1997), indicating that Psen1 is necessary 
Assesment of two candidate PNA-binding molecules 
 196 
for anteroposterior somite patterning, even though part of the somites were still formed 
(Koizumi et al., 2001). Bai et al. (2011) confirmed that Psen1 knockout led to similar 
motor axonal pathfinding errors as in the Columbus mutant, including failure to form 
ventral roots (and also midline crossing across the floor plate). As Psen1 is expressed by 
motor neurons and interneurons in the spinal cord, as well as peripheral tissues, Bai et 
al. (2011) used a Nestin-Cre/Psen1flox/flox approach to knock Psen1 out specifically in 
neural tissue. This resulted in aberrant growth of motor axons to the floorplate and 
midline crossing, indicating that Psen1 mutant neurons either lost chemorepulsion from 
the floor plate or acquired responsiveness to a chemoattractant (Bai et al., 2011). 
However, it did not alter peripheral motor axon growth, segmentation or ventral root 
formation, suggesting that loss of non-neural Psen1 (presumably from the somites) was 
responsible for the peripheral motor axon pathfinding defects.  
Despite these insights into the phenotype of the Columbus mutant allele of 
Psen1, somite polarity markers and the potential involvement of PNA had not yet been 
studied in Psen1 mutant mice: results of these investigations are reported in this chapter. 
The Psen1 hypomorphic mice used in the present study had a 500 bp insertion between 
exons six and seven (Rozmahel et al., 2002). As homozygotes, these mice produce a 
very small amount of mutant transcript: this is sufficient to allow normal brain 
development, but the defects in the axial skeleton are severe (Rozmahel et al., 2002). 
These mice were kindly provided as fixed embryos by Prof. Peter St George-Hyslop 
(Cambridge Institute for Medical Research).  
 
7.2.1- Results  
PNS segmentation and somite polarity were assessed at E11.0 by WMISH on 
Psen1 hypomorphic and wild-type embryos for Sox10, encoding a Sry-related high 
mobility group (HMG) transcription factor expressed in migrating neural crest cells, 
neural crest-derived neuroglial precursors, satellite glia in ganglia and Schwann cells 
along nerves (Britsch et al., 2001), thus allowing the identification of dorsal root 
ganglia and nerves, and Uncx4.1 (Uncx), encoding a homeodomain transcription factor 
present in the posterior half-sclerotome (Schrägle et al., 2004).  
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Psen1 hypomorphs were around 30% smaller than wild type (Fig. 7.3) and 
appeared normally segmented, as disruption to segmentation only started caudal to the 
hindlimb (Figs. 7.3, 7.4, 7.5). WMISH was successful for both Sox10 (Fig. 7.4A-H) and 
Uncx4.1 (Fig. 7.4I-S). Sox10 expression in Psen1 hypomorphs began to differ from 
wild-type embryos in the lumbar area, becoming wider relative to wild-type expression, 
and with no visible segmentation in the tail (Fig. 7.3B,G,H). Uncx4.1 expression was 
present in all the somites, and normal rostral to the hindlimb (Fig. 7.4J), however 
posterior to this Uncx4.1 expression varied within the sclerotome, with expression being 
thinner and lost from the dorsolateral sclerotome, although it was still segmented 
(though thinner) within the tail (Fig. 7.4O-R). (Uncx4.1 expression seen in the brain, 
neural tube and mesonephros is normal; Mansouri et al., 1997.) 
 
 
Figure 7.3- Size difference between wild type and hypomorphic Psen1 mutant 
mouse embryos at E11.0 after WMISH for Uncx4.1. (A) Wild type mouse embryo, 
length along indicated line is around 4.15 mm. (B) Psen1 hypomorphic litter mate, 
length along indicated line is around 3 mm. 
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Figure 7.4- Legend on next page. 


















Figure 7.4- (On previous page) Mouse embryos and sections after WMISH for 
Sox10 or Uncx4.1 at E11.0. (A-H) WMISH for Sox10. (A) Psen1 hypomorph (left; -/-) 
and wild type litter-mate (right; +/+). (B) Higher-power view of tail region. Sox10 
expression in the tail of the Psen1 hypomorph (right; -/-) is not segmented (white 
arrow), unlike in the wild type embryo (left). (C-E) Parasagittal sections of a wild type 
embryo, showing (C) segmentation of DRG and spinal nerves; (D) axons to the limbs 
and (E) expression in the tail. (F-H) Parasagittal sections of Psen1 hypomorph (-/-), 
showing (F) segmented pattern of DRG and spinal nerves in trunk; (G) loss of 
segmented pattern of DRG and spinal nerves at the level of the hind limb (arrow); (H) 
total loss segmentation in the tail. (I-S) WMISH for Uncx4.1. (I) Uncx4.1 expression in 
the Psen1 hypomorph (left; -/-) is reduced and shows variation in the expression relative 
to a wild type litter-mate (right; +/+). (J) Detail of the tail region of the embryos in I. 
Uncx4.1 expression is reduced but still segmented in the Psen1 hypomorph (left; -/-). 
(K-M) Parasagittal sections of a wild type embryo, showing Uncx4.1 expression in 
posterior half-sclerotomes (K,L) near the hind limb and (M) in the tail. (N) Parasagittal 
section of a Psen1 hypomorph. Uncx4.1 expression is reduced in the sclerotome. (O-R) 
Transverse sections of a Psen1 hypomorph. Uncx4.1 expression varies through the 
sclerotome. (S) Coronal section of the tail of a Psen1 hypomorph showing segmented 
Uncx4.1 expression. 
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The complementary changes in expression of Uncx4.1 and Sox10 at the same 
location can most easily be seen in embryos side by side in the same dish (Fig. 7.5A-C). 
Despite the changes in Uncx4.1 and Sox10 expression, however, rhodamine-labelled 
PNA treatment showed that Psen1 hypomorphs still display segmented PNA binding 
(Fig. 7.5D-F) even in the tail, where Sox10 was most affected. 
Overall, Psen1 hypomorphic embryos at E11.0 present with defects in the 
sclerotome caudal to the hindlimb. Loss of Uncx4.1 leads to loss of pedicles, transverse 
processes and proximal ribs (Leitges et al., 2000; Mansouri et al., 2000). Since Uncx4.1 
expression abnormalities were seen in Psen1 hypomorphic embryos (Fig. 7.4),  Alcian 
blue staining for cartilage at E14.0 was used to assess any impact on axial skeleton 
formation (Fig. 7.6). As expected, given the severe axial skeleton deformities seen in 6-
week Psen1 hypomorphs (Rozmahel et al., 2002), defects seen at E14.0 included 
vertebral duplications and fusions, shorter or missing pedicles, fused transverse 
processes and fewer ribs (11 instead of 13) (Fig. 7.6). 
 
 
Figure 7.5- Uncx4.1, Sox10 and rhodamine-labelled PNA binding in Psen1 
hypomorphs at E11.0. (A-C) WMISH for Uncx4.1 and Sox10 shows that Uncx4.1 and 
Sox10 expression patterns are complementary in the trunk (A), near the hind limb (B) 
and in the tail (C). Uncx4.1 expression in the sclerotome becomes very thin in the sacral 
region (black arrow in A,B), and from that point to the end of the tail, Sox10 expression 
becomes unsegmented (red arrow). In contrast, near the tail Uncx4.1 expression 
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becomes normal again and continues normal to the end of the tail (arrow in C). (D-F) 
Rhodamine-labelled PNA binding (red) in the cervical area (D), thoracic and lumbar 
area (E) and sacral area (F). 
 
 
Figure 7.6- Alcian blue staining for cartilage in mouse embryos at E14.0. (A,B) 
Low-power and higher-power views of a wild type embryo (left) and a Psen1 
hypomorphic litter-mate (right). In the thoracic area, the Psen1 hypomorph shows 
duplications and fusion of vertebrae (arrow) and fewer ribs; some ribs appear thinner. 
(C) Cervical region of a Psen1 hypomorph, showing duplication of the second vertebral 
body (compare with F). (D) Lumbar vertebrae of a Psen1 hypomorph (arrow) show 
missing pedicles and fusion of the transverse processes (compare with G). (E) Lateral 
view of the lumbar vertebrae in a Psen1 hypomorph (arrow). The pedicles are shortened 
and the transverse process fused. (F) Cervical region of a wild type embryo. (G) 
Lumbar and sacral region of a wild type embryo. (H) Dorsal view of vertebral bodies 
and pedicles in a wild type embryo. 




This study was carried out to explore if Psen1 may play a role in somite polarity 
and whether it could be the PNA-binding glycoprotein in the posterior sclerotome, 
given the striking motor axon guidance defects in mice with the Columbus mutation in 
Psen1, that was later shown to be phenocopied by knocking out Psen1 (Lewcock et al., 
2007: Bai et al., 2011). Although the PNA-binding protein was previously suggested to 
be 55kDa and 48kDa (Davies et al., 1990), and Presenilin1 is 53kDa and 20kDa (Haass 
and De Strooper, 1999), this does not rule out the possibility that there may be a Psen1 
isoform responsible for the PNA-binding reaction. However, the Psen1 hypomorphic 
mice used here, which have severe axial skeletal but not CNS phenotypes (Rozmahel et 
al., 2002) still displayed segmental PNA-binding in the posterior sclerotome (although 
clearer sections of the tail would be helpful to show this more clearly). This suggests 
that Psen1 is not the PNA-binding glycoprotein responsible for axon repulsion in the 
posterior sclerotome and that this molecule still remains to be found. 
In Psen1 hypomorphic mouse embryos at E11.0, segmental expression of Sox10 
and Uncx4.1 is still present in most of the trunk, but changes are seen in the expression 
of both genes beginning in the same region in the lumbar area and moving further 
posteriorly to the tail (Fig. 7.4 and Fig. 7.5). Sox10 expression in the tail is continuous, 
with no visible segmentation, even though Uncx4.1 expression in the tail shows a clear 
segmentation. Similarly, even though Uncx4.1 expression in the rest of the embryo is 
thinner than in wild type embryos, it is still segmented. The neural crest/ganglion 
marker Sox10 has a normal expression pattern within the embryo until the same point 
where Uncx4.1 becomes thin, where Sox10 expression becomes wider, suggesting 
fusion of dorsal root ganglia as previously reported for Psen1-deficient embryos (Shen 
et al., 2007). Presumably the modifications in Uncx4.1 expression could have 
contributed to the phenotypes observed in the axial skeleton. 
The present study found that Psen1 hypomorphic embryos are around 30% 
smaller than wild type embryos, perhaps due to the formation of fewer somites, later 
reflected by a reduction in the number of ribs present (11 instead of 13) (Fig. 7.5). 
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Similarly, Psen1-knockout mice were also smaller and had fewer ribs (Shen et al., 
1997). 
According to Leitges et al. (2000), pedicles, transverse processes and proximal 
ribs develop from the lateral sclerotome. The Psen1 hypomorphic mice in the present 
study have a similar axial skeletal phenotype at E14.0 as Leitges et al. (2000) described 
where the absence of Uncx4.1 expression in the lateral posterior sclerotome caused 
modification in the formation of pedicles, transverse processes and proximal ribs and 
vertebral arches (Leitges et al., 2000). Psen1 hypomorphic mice do not express Uncx4.1 
in the lateral sclerotome at E11.0 (Fig. 7.4O-R), and at E14.0 the embryos formed only 
part of the pedicles, and showed fusion of transverse processes and duplication of 
vertebral bodies. The alterations to the vertebral bodies, pedicles and transverse 
processes are only visible in the lumbar vertebrae, where Uncx4.1 and Sox10 expression 
changes were prominent. In the tail, Sox10 expression lost its segmentation, but 
Uncx4.1 was as segmented as a wild type embryo so did not have any impact on the 
formation of the skeleton.  
It is interesting to note that the Psen1 hypomorphs displayed the abnormal 
phenotype only in the lumbar vertebrae (although at 6 weeks of age, the majority of 
vertebrae in surviving animals were reported to be affected; Rozmahel et al., 2002). 
However, in Psen1 knockout animals, the axial skeleton caudal to the pelvis is 
completely missing and cervical, thoracic, lumbar and sacral vertebrae are fused (Shen 
et al., 1997). Although the whole axial skeleton would need to be examined carefully in 
postnatal animals with the Psen1 hypomorphic mutation to see if there are real 
differences with Psen1-null animals, is possible that the tiny amount of mutant Psen1 
mRNA produced in Psen1 hypomorphs (Rozmahel et al., 2002) partially rescues axial 
skeleton formation relative to Psen1-null animals. In Xenopus, morpholino-based 
knockdown of the Notch ligand XDelta2 showed that this is required for Hox gene 
expression during somite formation and even earlier, from gastrulation stages onward 
(Peres et al., 2006). It would be interesting to study if there is any modification of Hox 
gene expression in Psen1 hypomorphic and Psen1-null mice that could also contribute 
to any differences seen in the axial skeletons of these mice.  
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In conclusion, Psen1 is not the PNA-binding protein responsible for axonal 
repulsion in the posterior sclerotome; however the Psen1 hypomorph (Rozmahel et al., 
2002) would be an interesting model in which to study the contribution of Psen1 to 
vertebra formation. 
 
7.3- Prolyl 4-hydroxylase, beta polypeptide (P4HB)  
Davies et al. (1990) isolated 55 kDa and 48 kDa proteins from a detergent-
soluble glycoprotein fraction that had high affinity with PNA, caused growth cone 
collapse and inhibited neurite extension of dorsal root ganglion neurons. It was not 
possible at that time to identify these proteins. More recently, a new somite extract was 
prepared, and proteins separated by size; the two corresponding bands (55 kDa and 48 
kDa) were removed and sent for sequencing (Prof. R. J. Keynes, personal 
communication). After Edman degradation, the fragments were found to be chick 
retina-cognin (R-cognin), a cell surface form of P4HB (prolyl 4-hydroxylase, beta 
polypeptide), also known as protein disulfide isomerase (PDI) or PDI-associated 1 
(PDIA1) (Bassuk et al., 1991; Phillips et al., 1997; Pariser et al., 2000). P4HB is a 
protein disulfide isomerase (PDI; Fig. 7.7) found in the endoplasmic reticulum of 
almost all cells that catalyzes the formation and isomerisation of disulfide bonds, 
facilitating protein folding (Figs. 7.8 and 7.9) (Bassuk et al., 1991; Phillips et al., 1997; 
Andreu et al., 2012). Several studies have detected PDI expression at the cell surface 
(Täger et al., 1997; Zai et al., 1999; Root et al., 2004; Wan et al., 2012), while Bi et al. 
(2010) showed that cell-surface P4HB binds PNA. Hence, it is indeed possible that the 
PNA-binding axon repellent in the posterior sclerotome is a cell surface isoform of 
P4HB.  
The PDI protein family comprises 21 known members of foldases and 
chaperones (Fig. 7.7) and is necessary for the physiological function of cells (Andreu et 
al., 2012). The accumulation of misfolded proteins generally leads to progressive 
decline of cell function, contributing to neurodegenerative diseases such as Alzheimer’s 
disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS), among others 
(Andreu et al., 2012). The mechanisms by which the abnormal misfolding causes 
modifications in axonal transport, synapse formation, synapse maintenance and redox 
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balance are poorly understood, but it is known that some PDI forms have different 
catalytic centres with specific roles in cellular function, such as apoptosis, production of 
reactive oxygen species (ROS), protein aggregation, cell signalling and endoplasmic 
reticulum-associated degradation (Figs. 7.8 and 7.9) (Andreu et al., 2012). 
PDI family members are characterized by the arrangement of thioredoxin-like 
catalytic domains (blue domains in Fig. 7.7) and non-catalytic domains (green and 
purple domains in Fig. 7.7). The catalytic domains have an active-site motif (CXXC) 
that reacts with thiols and determines the redox potential of PDIs and their role as 
reductase, oxidase or isomerase. The non-catalytic domains stabilize the catalytic 
domain and are responsible for substrate recognition and recruitment, and have 
interaction sites for cofactors (Andreu et al., 2012; Vinaik et al., 2013). 
 
Figure 7.7- The PDI family. Catalytic domains a and a’ are shown in blue; non-
catalytic b and b’ domains in green and purple, respectively. The cross-linker between 
b’ and a’ is in orange and transmembrane domains in dark red. P4HB, also known as 
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PDIA1 and PDI, is highlighted on the top row. Figure modified from Andreu et al. 
(2012). 
 P4HB (PDIA1, PDI) was the first PDI family member to be identified, however 
little is known about its function in vivo; in mammalian cells, P4HB is vital for 
oxidative protein folding (Figs. 7.8 and Fig. 7.9), and in yeast it is essential for cell 
survival (Andreu et al., 2012). P4HB, like other PDI family members, has been linked 
to neurodegenerative diseases (Table 7.1). In the brain ischemia-reperfusion model, 
P4HB was the major protein present in the hypoxia model and its over-expression in 
vivo resulted in improved neuronal survival upon ischemia reperfusion (Andreu et al., 
2012). Interestingly, PNA binding is also present in specific areas in the grey matter of 
the brain (Prof. R. J. Keynes, personal communication): perhaps PNA is also binding to 
P4HB in grey matter. Here, siRNA-mediated knockdown against chick P4HB in 
somites was used to study any impact on axon targeting. 
 
Figure 7.8- The protein folding activity of PDI and the redox relay of PDI and 
ERO1, resulting in the generation of H2O2. PDIOX: oxidized PDI; PDIRED: reduced 
PDI; PDIMIXED: PDI with the bound substrate; ERO1OX: oxidized ERO1; 
ERO1RED: reduced ERO1. PDI domains are coloured as shown in Fig. 7.7. Figure and 
legend from Andreu et al. (2012).  




Figure 7.9- The diverse functions of PDIs, including PH4B (PDIA1), in the 
endoplasmic reticulum (ER). “Newly synthesized unfolded polypeptides are 
translocated into the ER. Folding of glycoproteins requires CNX (green) or CRT (light 
blue) and ERp57 (purple), the components of the CNX/CRT cycle. Non-glycosylated 
polypeptides may acquire a folded state by additional protein folding networks, to 
promote their folding, including, for example, the participation of PDIA1 or ERp72. 
ERp44 (dark red) retains client proteins in the ER preventing premature transport to the 
Golgi until the folding process is completed (GO). Then, folded proteins are exported 
through the secretory pathway. Misfolded proteins (STOP) may bind to PDIA1 (orange) 
and ERp72 (blue) and retro-translocate to the cytosol via the ERAD pathway, where 
ERdj5 has an important function in disrupting disulfide bonds. Under ER stress 
conditions, PDIA1 can be released to the cytosol through activation of BAX and BAK 
at the ER, targeting the mitochondria. This event triggers apoptosome assembly 
resulting in cell death. By modulation of the redox state of calcium channels, such as the 
IP3 receptor and the calcium pump SERCA, PDIs also control ER calcium release. In 
addition, abnormal H2O2 production by ERO1 (dark blue) could result in ROS 
production. These two events may also contribute to trigger mitochondrial outer 
membrane permeabilization and the release of cytochrome c (red circles) and the 
activation of the apoptosome.” Note: PDIA1 is an alternative name for P4HB. Figure 
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Table 7.1- Evidence linking PDI family members to neurodegenerative diseases. 
Note: PDIA1 is an alternative name for P4HB. ALS, amyotrophic lateral sclerosis; PD, 
Parkinson’s disease; AD, Alzheimer’s disease; PrDs, prion diseases; HD, Huntington’s 
disease. Table from Andreu et al. (2012). 
 
 
7.3.1- Chicken P4HB siRNA design 
The flurescein-labelled siRNA used to knock down cell surface P4HB (PDI) in 
chick was designed according to the sequence of an antisense phosphorothioate (S-
oligo; nuclease-resistant oligonucleotide) successfully used to knock down cell surface 
P4HB (PDI) in a human erythroleukemia (HEL) cell line (Zai et al, 1999). These 
authors designed three antisense S-oligos against human P4HB mRNA, however only 
one of the three reduced the cell surface expression of P4HB significantly (by 74  
9.2% compared to the scrambled S-oligo control); moreover, cell viability was 
unaffected after transfection (Zai et al., 1999). The sequence for the successful oligo 
was 5′-GCAGCGAGACTCCGAACACGGTA-3′; this was designed to hybridize with a 
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sequence in the 3’ UTR of the human P4HB mRNA. Following the rules described in 
section 4.2.1, an appropriate target sequence was also found in the 3’ UTR of chicken 
P4HB. The sequence used to target chick P4HB was: 5’-TCGCCCTCACTTGTCTTTA. 
A FITC-labelled control scrambled siRNA with the sequence 5’-
GCTCTCTCGTCTATCTACT was designed using InvivoGen Scramble siRNA 
software (http://www.sirnawizard.com/scrambled.php). All 21 base-pair sequences were 
subjected to NCBI BLAST to ensure that they would not target any other genes. 
 
7.3.2- Testing a commercial anti-P4HB antibody and chick P4HB siRNA 
efficiency in vitro on human astrocytes and chick retinal cells 
The first aim was to assess whether the chick P4HB siRNA worked to knock 
down P4HB. As there was no access to the P4HB-expressing HEL cell line used by Zai 
et al. (1999) in their antisense S-oligo experiments, human astrocyte cell line (Neu7) 
was used to transfect with a siRNA containing their antisense S-oligo sequence (see 
section 7.2.1). An anti-P4HB (anti-PDI) antibody (Sigma) was successfully used in live-
immunostaining experiments in cultured Neu7 cells (Fig. 7.10A-F). P4HB expression 
was only detected in cells that appeared to be dividing and that were much smaller than 
other cells, whether transfected with scrambled siRNA (Fig. 7.10A,C) or untransfected 
(Fig. 7.10D). The knockdown of cell surface P4HB expression using P4HB siRNA was 
not very efficient as not all cells were transfected with FITC-siRNA (Fig. 7.10B,E,F). 
P4HB expression was still present on the cells that were not transfected and highly 
reduced at the surface of the P4HB siRNA-transfected cells, although cytoplasmic 
P4HB expression was still detected (Fig. 7.10E,F).  However, cell adhesion and 
proliferation were affected, as cells kept a rounded shape and did not grow as much as 
non-transfected cells and were individually spread (compare Fig 7.10A and B). The 
anti-PH4B antibody worked well: it was possible to detect cell surface staining at higher 
magnification (Fig. 7.10C,F) and no staining was seen in any controls (Fig. 7.10G-I).  
Combining anti-P4HB live-immunostaining with fluorescein-labelled PNA 
treatment showed that Neu7 cells not only expressed cell-surface P4HB, but also bound 
PNA at the cell surface (Fig. 7.10A), consistent with the hypothesis that P4HB could be 
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the PNA-binding protein in posterior sclerotome cells. The anti-P4HB antibody (which 
was raised against bovine P4HB), was also used successfully in live-immunostaining 
studies to detect P4HB on the surface of chick retinal cells (Fig. 7.11B). This was an 
important positive control, since chick P4HB (R-cognin; retinal-cognin), was first 
identified in these cells (Hausman and Moscona, 1976; Hausman and Moscona, 1979). 
Furthermore, transfection of these cells with FITC-labelled P4HB siRNA led to 













Figure 7.10- (On next page) Assessment of anti-P4HB antibody specificity and 
P4HB siRNA transfection in a human astrocyte line (Neu7). (A) P4HB expression 
(red) and fluorescein-labelled PNA binding (green) in a subset of Neu7 cells (DAPI-
stained nuclei, blue), 16 hours after transfection with FITC-labelled scrambled siRNA. 
(B) P4HB expression 16 hours after transfecting cells with FITC-labelled P4HB siRNA. 
(C) Higher-power view of P4HB expression in scrambled siRNA-transfected cells. (D) 
Higher-power view of P4HB expression (red) and fluorescein-PNA binding (green) in 
untransfected cells. (E) Higher-power view of P4HB siRNA-transfected cells (green, 
FITC-siRNA) immunostained for P4HB (red). Only a subset of cells are transfected. 
(These cells were not treated with fluorescein-labelled PNA.) (F) Same image as in E, 
showing P4HB expression in greyscale. (G-H) Controls for primary antibody 
specificity. (G) Cells immunostained without any primary antibody (i.e., using the 
Alexa594-conjugated goat anti-rabbit secondary antibody alone). (H) Cells 
immunostained using anti-P4HB antibody that had been preadsorbed with P4HB 
protein. (I) Cells incubated with rabbit IgG instead anti-P4HB. Blue: DAPI (nuclei). 
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Figure 7.10- Legend on previous page. 
 
Figure 7.11- P4HB expression in Neu7 cells and chick retinal cells stage 22 HH in 
culture. (A) Cell surface staining of Neu7 cells (DAPI-stained nuclei, blue) for both 
P4HB (red) and dlurescein-labelled PNA (green). (B) Cell surface expression of P4HB 
(red) in chick retinal cells, showing a ring-like effect and some punctate expression. (C) 
Efficient suppression of P4HB expression (red) in chick retinal cells (DAPI-stained 
nuclei, blue) transfected with FITC-labelled P4HB siRNA (green).  
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7.3.3- Assessing P4HB expression and siRNA knockdown efficiency in 
dissociated sclerotome cells in vitro 
 The next step was to see if P4HB expression could be detected on posterior 
sclerotome cells in vitro by live-immunostaining, and, if so, to assess the effect on this 
of P4HB siRNA transfection. It was necessary to optimise the protocol, as it seemed 
very easy for posterior sclerotome cells, depending on the substrate, to differentiate into 
fibroblasts and lose their ability to bind PNA. Including a fragment of notochord in the 
culture was found to help prevent the differentiation of sclerotome cells into fibroblasts. 
Somite strips were explanted, dissociated mechanically with a syringe needle to avoid 
the loss of any cell membrane properties, and cultured for 16 hours before live-
immunostaining. The dissociated somite strips included anterior half-sclerotomes, but 
these never expressed P4HB or bound PNA (see next section).  The substrate was 
important, as posterior sclerotome cells kept their PNA-binding characteristics only 
when cultured on non-coated glass (also, using polylysine-coated slides increased 
antibody background). This assay was verified at least four times.  
 Cell-surface expression of P4HB was detected by live-immunostaining on 
dissociated sclerotome cells (presumably posterior; see next section) (Fig. 7.12A). 
When somite strips that had been transfected in ovo with FITC-labelled scrambled 
siRNA were dissociated and cultured for 16 hours, P4HB expression was still detected 
at the cell surface (Fig. 7.12B). However, P4HB expression was lost in sclerotome cells 
cultured from somite strips that had been transfected in ovo with FITC-labelled P4HB 
siRNA (Fig. 7.11C). Like P4HB siRNA-transfected Neu7 cells (Fig. 7.10B), P4HB 
siRNA-transfected sclerotome cells were also more spread out than scrambled siRNA-
transfected sclerotome cells. 
 
 
Assesment of two candidate PNA-binding molecules 
 213 
 
Figure 7.12- P4HB expression and siRNA_mediated knockdown in chick 
sclerotome cells dissociated and cultured for 16 hours after transfection in ovo. (A) 
Untransfected, dissociated chick sclerotome cells in culture (DAPI-stained nuclei, blue). 
P4HB (red) is expressed at the cell surface (ring-like effect) and there is punctate 
expression in the cytoplasm. (B) Sclerotome cells cultured after transfection in ovo with 
FITC-labelled scrambled siRNA (green). P4HB (red) is still expressed at the cell 
surface. (C) No P4HB expression (red) is seen in sclerotome cells cultured after 
transfection in ovo with FITC-labelled P4HB siRNA (green). Red: anti-P4HB; blue: 
DAPI, green: FITC-siRNA 
 
7.3.4- P4HB expression and PNA-binding overlap in the posterior 
sclerotome 
 Since P4HB expression could be detected on the cell surface of sclerotome cells 
in culture, the next aim was to assess if P4HB expression was coincident with PNA 
binding. Somite strips were explanted from embryos, cultured intact and subjected to 
live immunostaining and treatment with fluorescein-labelled PNA (Fig. 7.13). P4HB 
expression and PNA binding were indeed coincident (Fig. 7.13A-C). At higher 
magnification, the staining for both P4HB and PNA also seemed to be at the cell 
surface. Hence, the protein originally isolated by Davies et al. (1990) and that according 
to Edman degradation corresponds to P4HB, is for the first time detected on the cell 
surface of posterior sclerotome cells, with the same segmented pattern as PNA. 
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Figure 7.13- Legend on next page. 
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Figure 7.13- (On previous page) Live P4HB immunostaining of cultured intact 
somite strips treated with fluorescein-labelled PNA. (A) PNA binds the posterior 
sclerotome and neural tube. (B) P4HB is expressed in the posterior sclerotome. (C) 
Overlay of PNA (green) and P4HB (magenta) shows that both are segmented and 
coincident. (D) Higher magnification view suggesting cell surface binding of PNA. (E) 
Higher magnification view suggesting cell surface expression of P4HB. (F) Overlay of 
PNA-binding (green, from D) and P4HB expression (magenta, from E). PNA binding is 
more extensive than P4HB expression. A, anterior sclerotome; nt, neural tube; p, 
posterior sclerotome. 
 
7.3.5- P4HB siRNA transfection into somites in ovo reduces the intensity and 
extent of PNA-binding to the posterior sclerotome 
Since P4HB expression and PNA binding are both seen at the surface of 
posterior sclerotome cells, it is indeed possible that P4HB may be the molecule 
responsible for axon repulsion in the posterior sclerotome. This was tested by 
transfecting flurescein-labelled P4HB siRNA into somites in ovo and assessing if PNA 
binding to the posterior sclerotome was suppressed. In ovo transfection of somites was 
carried out in chick embryos between stages 10-14 HH and somite strips explanted and 
cultured intact for 16 hours before treatment with fluorescein-conjugated PNA and live 
immunostaining for P4HB. Three embryos were transfected with FITC-labelled P4HB 
siRNA, and two embryos with FITC-labelled scrambled siRNA. One of the lateral sides 
of the neural tube was kept in each somite strip for stability. Somite strips from embryos 
that had been transfected with scrambled siRNA showed the normal segmental pattern 
of PNA binding to the posterior sclerotome (and also binding to the neural tube) (Fig. 
7.14A). However, PNA binding was reduced in intensity and less extensive in the 
posterior sclerotomes of somite strips from embryos that had been transfected with 
P4HB siRNA (Fig. 7.14B). Bright spots of staining in both anterior and posterior 
sclerotomes in the somite strip (Fig. 7.14C) were presumably FITC-labelled siRNA, 
confirming successful transfection. 
  Although preliminary, these siRNA transfection studies suggest not only that the 
P4HB siRNA used knocks down P4HB expression in sclerotome cells (Fig. 7.12) but 
also that it reduces PNA binding. These data strongly support the hypothesis that the 
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PNA-binding glycoprotein found by Davies et al. (1990) and shown to cause collapse of 
DRG axons in vitro (Davies et al., 1990), is indeed P4HB. 
 Cell surface expression of P4HB could only be detected in human Neu7 and 
chick posterior sclerotome cells by live immunostaining. However, it was not possible 
to detect P4HB expression when using whole-mount embryos, as opposed to somite 
strips, even by live immunostaining. Apparently, the presence of any ectoderm or 
endoderm inhibited the antibody from binding; only when all these tissues were 
removed, and sclerotome cells or somite strips were isolated, could P4HB expression be 








Figure 7.14- (On next page) Fluorescein-conjugated PNA binding in somite strips 
cultured from embryos transfected in ovo with FITC-labelled siRNA. (A) 
Scrambled siRNA-transfected somite strip. Fluorescein-PNA binds in a segmented 
pattern to the posterior sclerotomes (and also to the lateral wall of the neural tube, 
retained in the somite strip for stability). (B) P4HB siRNA-transfected somite strip. 
Fluorescein-PNA binding is reduced in intensity and less extensive in the posterior 
sclerotome of the three somites at the left of the image (compare with the two somites 
on the right). (C) P4HB siRNA-transfected somite strip. Fluorescein-PNA binding is 
lower in most sclerotomes (compare with left-most sclerotome). Bright spots, 
presumably FITC-labelled siRNA (arrow) can be seen in some sclerotome cells (both 
anterior and posterior). (a) anterior sclerotome. (p)posterior sclerotome. (nt)neural tube. 
Scale bar: 100 µm 
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Figure 7.14- Legend on previous page. 
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7.3.6- P4HB siRNA transfection into somites in ovo disrupts axon 
segmentation 
The next step was to study the impact of P4HB siRNA transfection on axon 
guidance through the somites. In total, 179 embryos were transfected in ovo in the 
somites with FITC-labelled P4HB siRNA and left to develop until stage 24 HH (E4.0). 
Table 7.2 gives a breakdown of the visible phenotypes of 149 of these embryos: these 
can be compared with those of the 198 embryos similarly transfected similarly with 
FITC-labelled scrambled siRNA, which had no obvious phenotypes (section 4.3.6) and 
also the 119 embryos similarly transfected with FITC-labelled Flrt2 siRNA (Table 5.1). 
The “Columbus” phenotype in Table7.2 is so-called due to the similarity with the 
phenotype of the Columbus mutation in the Psen1 gene (section 7.1) (Lewcock et al., 
2007). Fig. 7.15 shows two examples of visible phenotypic alterations in P4HB siRNA-
transfected embryos. 
 In order to assess any impact on axonal guidance, P4HB siRNA-transfected and 
scrambled siRNA-transfected chick embryos were immunostained for neurofilament 
(Fig. 7.16). Transfection of scrambled siRNA into the somites had no effect on axonal 
segmentation (Fig. 7.16A). In contrast, axon segmentation was lost or disrupted in 
discrete regions of 24 of the P4HB siRNA-transfected embryos (Fig. 7.16B). Axons 
were also seen sprouting from the bundles in the anterior half-sclerotome towards the 
posterior half-sclerotome, and also passing ventrally through the posterior sclerotome 
(Fig. 7.16C). These results suggest that knocking down cell-surface P4HB allows axons 
to enter the posterior sclerotome, hence that cell-surface P4HB normally repels axons 
from the posterior sclerotome. 
 Some P4HB siRNA-transfected transfected embryos were treated with 
rhodamine-conjugated PNA as well as immunostained for neurofilament (Fig. 7.17). On 
the transfected side (Fig. 7.17A,D), axon segmentation was disrupted (Fig. 7.17B,D)  
and PNA-binding reduced in the sclerotome (Fig. 7.17C,D), although the segmental 
pattern of both axons and PNA-binding was still seen on the untransfected side. PNA 
also bound the space between the ectoderm and dermomyotome very strongly, as 
previously reported (Oakley and Tosney, 1991). (The apparent labelling of the 
brightest-stained axons by PNA on the untransfected side of the embryo in this image 
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may be an artefact of using a biotinylated secondary antibody and Neutravidin to detect 
the anti-neurofilament primary antibody.) 
Table 7.2- Visible phenotypic changes in 149 embryos after in ovo somite 
transfection for P4HB siRNA, up to 42 hours post-transfection. 




Changes in blood supply (blood coagulation) 66.4 99 
Changes in vitelline artery  22.1 33 
Changes in extra-embryonic blood vessels 72.5 108 
Malformed head 27.5 41 
Embryo twisted 66.4 99 
Indistinct somite border limits 16.8 25 
Thinner lumbar region and tail 27.5 41 
Abnormalities in limb formation 11.4 17 
“Columbus” (all the above plus incomplete neural tube 
closure) 
11.4 17 





Figure 7.15- Chick embryos at stage 22 HH that had been transfected in ovo in the 
somites with P4HB siRNA, immunostained for neurofilament. (A) Twisting of the 
neural tube. (B)- Abnormal limb positioning, heart morphology and tail formation.  
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Figure 7.16- Legend on next page. 
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Figure 7.16- (On previous page) Neurofilament immunostaining of siRNA-
transfected embryos at stage 22 HH. (A) Scrambled siRNA-transfected embryo 
showing motor axons crossing the anterior sclerotome. (B) P4HB siRNA-transfected 
embryo showing loss of segmentation of sensory axons (arrow). (C) P4HB siRNA-
transfected embryo showing loss of segmentation of motor axons (arrow); axons on the 
non-transfected side and in nearby somites still display segmentation. (D-G) Higher-
power views of P4HB siRNA-transfected embryos with axons in the posterior 
sclerotome (arrow). (a) anterior sclerotome; (p) posterior sclerotome; (nt) neural tube. 












Figure 7.17- (On next page) Combined neurofilament immunostaining and 
rhodamine-conjugated PNA treatment of a P4HB siRNA-transfected embryo at 
stage 22 HH. (A) Green channel in grey-scale, showing FITC-labelled P4HB siRNA in 
transfected somites on the left side in the photograph. (B) Blue channel in grey-scale, 
showing neurofilament expression. Axons exhibit lack of segmentation on the 
transfected side (left), while segmentation is still present on the untransfected side 
(right). (C) Red channel in grey-scale, showing that rhodamine-conjugated PNA-
binding is significantly reduced or absent in the sclerotome on the transfected side (left) 
but present on the untransfected side (right). PNA also binds the space between the 
ectoderm and dermomyotome, as previously reported (Oakley and Tosney, 1991). 
Apparent PNA binding to the most brightly stained axons on the untransfected side may 
be an artefact of using a biotinylated secondary antibody and Neutravidin to detect the 
neurofilament primary antibody. (D) Merge of green (A), blue (B) and red (C) channels, 
showing lack of PNA binding and axon segmentation on the transfected side. n: 
notochord; p: posterior half-sclerotome; a: anterior half-sclerotome. 
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Figure 7.17- Legend on previous page. 
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7.3.7- P4HB siRNA transfection affects expression of posterior but not 
anterior sclerotome markers 
 The impact of P4HB siRNA transfection on polarity was checked using WMISH 
on twelve chick embryos, half of which were hybridized for the posterior half-
sclerotome marker Uncx4.1 (Schrägle et al., 2004) and the other half for the anterior 
half-sclerotome marker Tbx18 (Haenig and Kispert, 2004). Tbx18 hybridization did not 
exhibit any modification in P4HB siRNA-transfected embryos when compared to 
scrambled siRNA-transfected embryos (Fig. 7.18A-D). However, four out of six P4HB 
siRNA-transfected embryos had visible modification in Uncx4.1 expression on both 





Figure 7.18- (On next page) siRNA-transfected embryos and sections after 
WMISH for somite polarity markers. (A-D) WMISH for the anterior sclerotome 
marker Tbx18 at stage 22 HH. (A) In a scrambled siRNA-transfected embryo, Tbx18 is 
present in the anterior sclerotome. (B) In a P4HB siRNA-transfected embryo, Tbx18 is 
present in the anterior sclerotome. (C) Parasagittal section of a scrambled siRNA-
transfected embryo showing segmental Tbx18 expression. (D) Parasagittal section of a 
P4HB siRNA-transfected embryo showing segmental Tbx18 expression. (E,F) WMISH 
for the posterior sclerotome marker Uncx4.1 at stage 22 HH. (E) Scrambled siRNA-
transfected embryo (left) next to a P4HB siRNA-transfected embryo (right). There are 
gaps in Uncx4.1 expression in the P4HB siRNA-transfected embryo (right). (F) Higher-
power view of thoracic region of a scrambled siRNA-transfected embryo (left) next to a 
P4HB siRNA-transfected embryo (right). Uncx4.1 expression is significantly 
suppressed in the P4HB siRNA-transfected embryo (right). (G-L) Uncx4.1 expression at 
stage 19 HH. (G) Lateral view: Uncx4.1 expression varies in the lumbar area (arrow). 
(H) Dorsal view: both sides display loss of segmentation and variations in Uncx4.1 
expression. (I) Dorsal view of another embryo: both sides of the embryo have variable 
Uncx4.1 expression within the somites. Some somites lack Uncx4.1 expression (arrow). 
(J) Parasagittal section: some somites express Ucx4.1 while others lack expression. (K) 
Parasagittal section of the tail: Uncx4.1 is present in a row of somites. (L) Parasagittal 
section of the lumbar region and tail: Uncx4.1 expression varies in each somite; in one 
of them, anterior and posterior segmentation is not visible (arrow). (a) anterior 
sclerotome; (p) posterior sclerotome; (nt) neural tube. Scale bar: 100 µm. 
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Figure 7.18- Legend on previous page. 
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7.3.8- Discussion and Conclusion  
For over 20 years (Davies et al., 1990), the identity of the PNA-binding 
glycoprotein responsible for axon repulsion in the posterior sclerotome during 
development has remained a mystery. In addition, the effects of PNA on axonal 
guidance have been principally assessed in vitro on dorsal root ganglion neurons using 
the growth-cone collapse assay (Davies et al., 1990), so its proposed role in vivo could 
only be speculative. Using Edman degradation, P4HB was identified as the protein 
responsible for PNA-induced axonal repulsion (Prof. R. J. Keynes, personal 
comunication).  
Previous studies had detected P4HB at the cell surface in fixed chick retinal cells 
(Hausman and Moscona, 1976; Hausman and Moscona, 1979) and in various 
mammalian cell lines (e.g. Zai et al., 1999; Bi et al., 2011). Furthermore, Bi et al. 
(2011) showed that cell surface P4HB in a mammalian cell line binds PNA. In the 
present study, P4HB was detected at the surface of posterior sclerotome cells from fresh 
tissue. This was possible following mechanical dissociation of the cells with a needle 
rather than using enzymatic digestion. Membrane permeabilization reagents like 
TritonTM or Tween20TM were not used, and paraformaldehyde fixation was only carried 
out after binding of the primary antibody (i.e., live immunostaining), avoiding the 
destruction of binding sites for the anti-P4HB antibody. However, one of the great 
limitations found with this antibody was its limited permeability. The presence of 
ectoderm, endoderm, laminin, or collagen prevented the antibody from penetrating the 
embryo and reaching the sclerotome, which is why P4HB expression could not be 
detected on whole embryos. Western blot assays could have been done in order to study 
the presence of P4HB protein after P4HB siRNA transfection, but this would require a 
great number of transfected somite strips. For further work, as a complement to P4HB 
protein detection by immunostaining, quantitative RT-PCR should be done, to measure 
the level of P4HB mRNA relative to a housekeeping gene such as actin, in P4HB 
siRNA-transfected embryos versus scrambled siRNA-transfected embryos (or mismatch 
siRNA-transfected embryos; Buehler et al., 2012).  
Posterior sclerotome cells were maintained in an undifferentiated state by co-
culturing them with notochord. Optimisation studies using poly-l-lysine and laminin 
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coating alone or together showed that once sclerotome cells attached to the coated 
surface they differentiated into fibroblasts and lost their ability to bind PNA. Therefore, 
sclerotome cells were grown directly on the glass surface, where PNA-binding cells 
formed aggregates. Cells that became separated from the aggregate did not bind PNA, 
suggesting that the PNA-binding molecule was only present when cells maintained 
physical contact. It was presumably due to this way of culturing posterior sclerotome 
cells that it was possible to detect P4HB expression on the cell surface.  
The chick P4HB siRNA designed in this study significantly reduced P4HB 
protein expression at the cell surface. It was interesting to see that P4HB siRNA 
transfection resulted in the reduced proliferation of human Neu7 cells. Similarly, after 
culturing chick retinal cells transfected with P4HB siRNA, there were fewer cells and 
they were not aggregated. Indeed, cell surface P4HB, as R-cognin, was first identified 
as a cell aggregation factor for retinal cells (Hausman and Moscona, 1976; Hausman 
and Moscona, 1976; Hausman et al., 1993). Knockdown of P4HB in retina resulted in a 
50% reduction in cell re-aggregation (Hausman et al., 1993) and affected subsequent 
neuronal differentiation (Phillips et al., 1997). Similar findings emerged from the 
present study. After P4HB siRNA transfection in cultured posterior sclerotome cells, 
they became more widespread than scrambled siRNA-transfected cells. The posterior 
sclerotome is more condensed than the anterior sclerotome (Keynes and Stern, 1984; 
Christ et al., 2004; Maroto and Whittock, 2008). It would be interesting to see if the 
same density changes occur in sclerotome cells in vivo after transfecting P4HB siRNA. 
It may be that the presence of cell surface P4HB maintains cell-cell interaction and 
further condensation of the posterior scleretomal cells surface by thio-disulfide 
exchange, as occurs in HEL cells (Zai et al., 1999).  
P4HB siRNA transfection also led to significant motor and sensory axon 
pathfinding defects, with loss of segmentation and mistargeted axons migrating within 
the posterior half-sclerotome as well as the anterior half-sclerotome. Presumably once 
cell surface P4HB has been lost, for example after siRNA-mediated knockdown, or 
after P4HB has been bound by PNA, the axon repulsion cue is lost, and (perhaps also 
aided by the sclerotome cells no longer being as tightly packed) axons are then able to 
pass through the entire somite.  
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In platelets, cell surface P4HB promotes T-cell migration and also binds with 
the lectin galectin-9 to regulate integrin function and alter the redox status at the plasma 
membrane, enhancing the susceptibility of T-cells to infection with HIV (Bi et al., 
2011). Cell surface P4HB also inhibits platelet aggregation in the presence of S-
nitrosoglutathione via an integrin-disulfide-exchange route (Root et al., 2004). It would 
be interesting to study nitrosation activity in posterior sclerotome cells after transfecting 
P4HB siRNA versus scrambled (or mismatch) siRNA. 
Furthermore, following P4HB siRNA transfection, the barrier that normally 
keeps the cells of both half-sclerotomes apart became disrupted allowing a free-flow of 
cells and a disordered anteroposterior polarity, as demonstrated by the changes in 
expression of the posterior sclerotome marker Uncx4.1 on both sides of the embryo. 
(The effect on both sides could be due to accidental transfection of tailbud cells, which 
give rise to PSM on both sides, so affecting somite development bilaterally.) These 
changes included expanded expression of Uncx4.1 to the entire somite, or absence of 
any expression, or a “sandwich” pattern within a somite, or Uncx4.1 expression at the 
anterior border of sclerotome. The next step here would be to detect Uncx4.1 
simultaneously with neurofilament immunostaining and treatment with fluorescently-
conjugated PNA, in order to see how segmentation is distributed in the presence of 
variable Uncx4.1 expression.  
In contrast to Uncx4.1, expression of the anterior sclerotome marker did not 
appear to differ between P4HB siRNA-transfected and scrambled siRNA-transfected 
embryos. It is possible that the embryos selected for WMISH did not have enough 
transfected cells, or alternatively that Tbx18 acts upstream of P4HB. Davies et al. 
(1990) reported that the youngest somite with clear PNA-binding is ten somites anterior 
to the most recently formed somite, which is roughly 7 somites anterior to the oldest 
epithelial somite. In contrast, Oakley and Tosney (1991) reported that (using a different 
fixative and anti-PNA immunohistochemistry) they could detect PNA binding to 
posterior somite cells within the cores of recently segmented epithelial somites only two 
somites anterior to the PSM. In either case, if P4HB is responsible for PNA-binding 
activity then this is at a later stage than the establishment of Tbx18 expression, which 
begins in the PSM (Bussen et al., 2004). Knockdown of P4HB would therefore not be 
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expected to affect Tbx18 expression. The specification of the posterior half-somite also 
begins in the PSM, when the Psen1-dependent Notch cascade induces Dll1 expression. 
This cascade leads to the later activation of Uncx4.1 expression in the posterior half-
somite, with continued Uncx4.1 expression being maintained by auto-regulation 
(Bussen et al., 2004). It may therefore be that loss of P4HB somehow leads to mis-
regulation of Dll1, leading to concomitant effects on somite polarity. 
In conclusion, P4HB is a strong candidate for the molecule localised to the surface of 
posterior half-sclerotome cells that prevents axons from inappropriately entering this 
territory. Hence, after more than two decades, the key glycoprotein involved in 
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